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Abstract 
Until recent decades, the inability to produce offspring has been seen as a female-related issue, 
but better understanding has made it evident that male fertility is likewise an essential determinant 
of couple fertility. Infertility in males has numerous causative factors, including lifestyle factors and 
obesity. Obesity has been shown to compromise fertility through changes in several aspects of 
reproductive function, including dysregulation of hormones (the HPG axis) and changes in the 
structure of the reproductive organs. There is, however, a great deal that is still unknown about 
how obesity and infertility interchangeably affect each other. New molecular techniques such as 
proteomics have been shown to provide insights into disease-causing mechanisms. These 
techniques may provide an avenue to discover more intrinsic changes that obesity may give rise 
to; it can also aid in the discovery of mechanisms through which obesity can act to bring about 
changes in male fertility.  
The overall aims of this study were: (1) To examine the effects of obesity on male fertility by 
observing specific macroscopic (anthropometric), microscopic (sperm parameters, histology of the 
testis and epididymis) and molecular (antioxidant enzyme, reproductive hormones) changes in a 
diet-induced obesity animal model; (2) To examine changes in protein expression within the 
reproductive tissues of obese animals, quantify these changes, and identify the affected molecular 
pathways.  
This study made use of an animal model of diet-induced obesity (DIO) to assess the effects of 
obesity on male reproductive organs and sperm parameters. Male Wistar rats (n=40) were 
randomly and equally divided into control (age-matched) and DIO groups and received standard 
rat chow or a high caloric diet ad libitum for 54 weeks, respectively. A long-term diet was chosen to 
mimic the gradual and chronic onset of obesity. At 60 weeks of age, rats were sacrificed by 
euthanasia. Each animal had their body weight measured and immediately examined post-mortem 
to determine visceral fat weight, testis weight and non-fasting blood glucose. Blood was collected 
from the thoracic cavity and used for plasma extraction and haematocrit analysis. Testis and 
epididymides were excised, weighed and preserved appropriately for subsequent sperm 
parameter evaluations (morphology and viability), histological analysis (H & E staining), protein 
determination, antioxidant evaluation (catalase, superoxide dismutase, glutathione, lipid 
peroxidation), and proteomics analysis (Liquid Chromatography Mass Spectrometry (LC-MS/MS)). 
The chronic diet elevated body and visceral fat weights significantly in the DIO group compared to 
controls. Sperm morphology and viability, as well as estradiol production were negatively altered in 
the DIO group. These changes were associated with alterations in several macroscopic, 
microscopic and molecular changes including changes in relative testicular weight, histological 
aberrations, and a reduction in antioxidant enzymes within the testis and epididymis respectively. 
ii 
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Interestingly, testosterone was not significantly reduced, as seen in experiments with a shorter 
DIO feeding duration. This points towards a compensatory mechanism to counteract chronically 
increased testosterone concentrations. Protein expression profiles of the DIO and control groups 
suggest that the predominant molecular pathways affected by th treatment were related to 
metabolism. These seem to be the possible driver of changes in other proteins including those 
involved in the production of reactive oxygen species (ROS). Some lesser researched antioxidant 
proteins were increased in expression to counteract ROS. The negative histological changes 
observed in the DIO group were linked to the underexpression of structural proteins involved in 
cell-to-cell adhesion. Reproductive proteins including those involved in sperm production, 
fertilization and the early stages of embryonic development were reduced in expression in the DIO 
group. These negative changes were possibly instigated by the observed increases in stress 
proteins, redox and inflammatory proteins. 
It is therefore evident that long-term obesity can impair male reproductive parameters and could 
be a contributing factor to the decline in male fertility by affecting sperm and reproductive 
parameters. Proteomic analysis of the epididymis and sperm showed that proteins essential in 
metabolism, ROS production, stress, inflammation and in the regulation of reproductive function as 
well as sperm and epididymis structure were negatively affected. In addition, long-term obesity can 
mask detrimental changes in physiology due to compensatory mechanisms, making changes in 




Tot ‘n paar dekades gelede was die onvermoë om 'n nageslag te produseer, gesien as 'n vroulike 
probleem, maar beter begrip het dit duidelik gemaak dat manlike vrugbaarheid ook 'n noodsaaklike 
bepalende faktor vir egpaarvrugbaarheid is. Onvrugbaarheid by mans het talle oorsaaklike faktore, 
insluitend lewenstylfaktore en vetsug. Daar is getoon dat vetsug vrugbaarheid in gevaar stel deur 
veranderinge in verskeie aspekte van voortplantingsfunksie, insluitend wanregulering van 
hormones (die HPG-as) en veranderinge in die struktuur van die voortplantingsorgane. Daar is 
egter nog baie onbekend oor hoe vetsug en onvrugbaarheid mekaar onderling beïnvloed. Nuwe 
molekulêre tegnieke, soos proteomika, het getoon dat dit insigte kan bied in meganismes wat 
siektes veroorsaak. Hierdie tegnieke kan 'n manier wees om meer intrinsieke veranderinge te 
ontdek waartoe vetsug kan lei; dit kan ook help met die ontdekking van meganismes waardeur 
vetsug kan optree om veranderinge in manlike vrugbaarheid teweeg te bring. 
Die algemene doelstellings van hierdie studie was: (1) Om die effekte van vetsug op manlike 
vrugbaarheid te ondersoek deur spesifieke makroskopiese (antropometriese), mikroskopiese 
(spermparameters, histologie van die testis en epididymis) en molekulêre (antioksidant ensieme, 
voortplantingshormone) se veranderinge waar te neem in 'n dieet-geïnduseerde vetsugtige 
dieremodel; (2) Om veranderinge in proteïenuitdrukking binne die voortplantingsweefsel van 
vetsugtige diere te ondersoek, hierdie veranderinge te kwantifiseer en die aangetaste molekulêre 
paaie te identifiseer. 
In hierdie studie is 'n diermodel van dieet-geïnduseerde vetsug (DIO) gebruik om die gevolge van 
vetsug op manlike geslagsorgane en spermparameters te bepaal. Manlike Wistar-rotte (n = 40) is 
ewekansig en gelykop verdeel in kontrole- (ouderdom-ooreenstemmende) en DIO-groepe en het 
onderskeidelik standard rotkos of 'n hoë kalorie-dieet ad libitum vir 54 weke lank ontvang. 'n 
Langtermyndieet is gekies om die geleidelike en chroniese aanvang van vetsug na te boots. Op 60 
weke ouderdom is rotte deur genadedood geoffer. Elke dier se liggaamsmassa is gemeet en 
onmiddellik nadoods ondersoek om die viserale vetmassa, die testisgewig en die nie-vaste 
bloedglukose te bepaal. Bloed is uit die borsholte versamel en vir plasma-ekstraksie gebruik en 
hematokritanalise. Testis en epididimis is uitgesny, geweeg en toepaslik bewaar vir 
daaropvolgende spermparameter-evaluasies (morfologie en lewensvatbaarheid), histologiese 
analise (H & E-kleuring), proteïenbepaling, anti-oksidant-evaluering (katalase, superoksied-
dismutase, glutathion, lipiedperoksidasie) en proteomika-analise (Vloeistofchromatografie 
massaspektrometrie (LC-MS / MS)). 
Die chroniese dieet het liggaams- en viserale vet-massa aansienlik verhoog in die DIO-groep 




Spermmorfologie en lewensvatbaarheid, sowel as oestradiolproduksie, was negatief verander. Dit 
was geassosieer met veranderinge in verskeie makroskopiese, mikroskopiese en molekulêre 
veranderinge, insluitend 'n verandering in die relatiewe testikulêre gewig, histologiese afwykings en 
'n vermindering in antioksidant ensieme binne die testis en epididimis. Interessant genoeg was 
testosteroon nie betekenisvol verminder, soos gesien in eksperimente met 'n korter DIO-
voedingstydperk, nie. Dit dui op 'n kompenserende meganisme om chroniese verhoogde 
testosteroonkonsentrasies teë te werk. In hierdie geval kan dit toegeskryf word aan moontlike 
aanpassings aan die setpunt van die HPG-as om tekorte in die testikelfunksie of defekte in die 
testosteroon terugvoermeganisme teë te werk. Proteïen-uitdrukkingsprofiele van die DIO en 
kontrolegroepe dui op talle onderliggende veranderinge. Die oorwegende paaie wat geraak was, 
hou verband met metabolisme. Dit blyk die moontlike oorsaak van veranderinge in ander proteïene 
te wees, insluitend proteïene wat betrokke is by die produksie van reaktiewe suurstofspesies 
(ROS). Sommige anti-oksidant proteïene, wat minder ondersoek is, was egter verhoog in 
uitdrukking in 'n poging om ROS teë te werk. Die negatiewe histologiese veranderinge wat in die 
DIO-groep waargeneem is, kan gekoppel word aan die onderuitdrukking van strukturele proteïene 
wat betrokke is by sel-tot-sel-adhesie. Proteïene wat betrokke is by selmotiliteit, sel siklus, DNA 
herstel en replikasie was negatief beïnvloed; dit is noodsaaklik vir lewensvatbaarheid en die 
produksie van funksionele proteïene. Reproduksieproteïene, insluitend proteïene wat betrokke is 
by spermproduksie, bevrugting en die vroeë stadiums van embrionale ontwikkeling, was verminder 
in die DIO-groep. Die negatiewe veranderinge wat gelys is, is moontlik aangewakker deur die 
waargenome toename in stresproteïene, redoks en inflammatoriese proteïene. 
Dit is dus duidelik dat vetsug op die lang termyn manlike reproduksieparameters kan benadeel en 
'n bydraende faktor kan wees tot die afname in manlike vrugbaarheid deur sperm- en 
reproduksieparameters te beïnvloed. Proteomiese analise van die epididimis en sperm het getoon 
dat proteïene wat noodsaaklik is vir metabolisme, ROS-produksie, stres, inflammasie en die 
regulering van die voortplantingsfunksie en die sperm- en epididimis-struktuur negatief beïnvloed 
was. Daarbenewens kan vetsug op die lang termyn skadelike veranderinge in fisiologie as gevolg 
van kompenserende meganismes verberg, wat veranderinge in reproduktiewe parameters moeilik 
verklaarbaar kan maak. 
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1. Chapter 1: Introduction 
1.1. Background 
Until recently, the inability to produce offspring has been seen as a female-related issue, but better 
understanding of the human reproductive system has made it evident that male fertility is likewise 
an essential determinant of couple fertility (Hull et al., 1985; Hammadeh, Filippos & Hamma, 2009; 
Mehta et al., 2016; Rumbold, et al., 2019; Murshidi, Choy & Eisenberg, 2020). Male factor infertility 
encompasses abnormalities within the male reproductive system that can impair structural and 
functional sperm parameters. It can contribute up to 50% to couple infertility (World Health 
Organization, 2014) and has many causative factors including hormonal disturbances, infections, 
genetic, endocrinological and reproductive anomalies (Pellicer et al., 1998). Importantly, however, 
male infertility can also be the result of modifiable risk factors that are the result of lifestyle. These 
include non-communicable diseases and obesity. Obesity, by definition, is an excess of body fat 
that poses a risk to health. The worldwide prevalence of obesity among children and adults 
doubled between 1980 and 2015, with approximately one third of the world’s population now 
classified as overweight or obese (Afshin, et al., 2017; Chooi, Ding & Magkos, 2019). The 
prevalence is generally higher in women than in men, although the highest incidence was recorded 
in males aged 25-29 years residing in low-middle income countries. 
Obesity is an etiological factor of male infertility and reductions in fertility have been shown to 
correspond with increased rates of obesity in countries with high obesity prevalence. Previous 
studies have shown obesity to result in poor sperm quality due to changes in sperm motility, 
morphology, viability, DNA integrity, and concentration (Du Plessis et al., 2010). Postulated 
mechanisms include increased adipokine concentrations, oxidative stress, inflammation (Fraczek 
and Kurpisz, 2007; Furukawa et al., 2004), hormone changes and hyperinsulinaemia (Teerds et 
al., 2011).  
As many complexities regarding obesity-induced infertility and its effects on male fertility are still 
unanswered, molecular analyses are required to allow further insights. Proteomics is an analysis of 
proteins, which analyses the proteins present in an organism (Wilkins et al., 1995; Wilkins et al., 
1997; Plebani et al., 2005). It produces protein profiles which allow the comparison between 
diseased tissues and healthy controls in order to identify affected proteins and disease-causing 
mechanisms (Anderson et al., 2000). This can then provide a great avenue to aid in the discovery 




1.2. Problem Statement 
The principle question of the current study is whether obesity causes any changes in protein 
expression within the reproductive organs and spermatozoa of obese males, specifically in a rat 
model. If any changes are present, which molecular pathways are affected and could these 
alterations explain some of the phenotypic observations that have previously been described within 
obese, infertile males or similar animal models. In addition, can these protein changes describe the 
observations that are made in the current study.  
1.3. Rationale of the Study 
Whilst the effects of obesity on male fertility continues to receive attention, most of the published 
data focusses on observing changes to fertility parameters such as hormone changes and sperm 
parameters that are brought on by obesity. In many instances, the mechanisms leading to the 
observed phenotypic changes are not explored or have not been fully elucidated. As more 
technologies and molecular techniques become available to assess biological changes, more 
information can be gathered about how certain disease characteristics, e.g. obesity-related 
changes in fertility, are able to manifest.  
1.4. Aims of the study 
The overall aims of this study are: 
• To examine the effects of obesity on male fertility by observing specific macroscopic 
(anthropometric), microscopic (sperm parameters, histology of the testis and epididymis) 
and molecular (antioxidant enzyme, reproductive hormones) changes in a diet-induced 
obesity animal model  
• To examine changes in protein expression within the reproductive tissues of obese 
subjects, quantify these changes, and identify the affected molecular pathways  
1.5. Hypothesis 
We hypothesise that the chronic diet-induced obesity model will have a negative effect on sperm 
parameters, and on reproductive proteins that are responsible for normal reproductive function(s). 
1.6. Outline of the Study 
A summary of the literature will be provided in Chapter 2. This chapter will introduce male infertility 




reproductive system outlined. The chapter will end with a focus on proteomics and describe how it 
came into practice. Chapter 3 will provide the study design as well as describe the analyses 
performed within this study. The results will be presented in Chapter 4, along with the statistical 
analysis that were performed. These will be presented alongside the corresponding tables and 
graphs. Chapter 5 will discuss the findings of this study and provide an interpretation of the results. 
This chapter will also compare the findings of this study with those found in literature. The findings 
of this study will be concluded in Chapter 6, after which additional data will be provided in the 
Appendix. 
1.7. Conclusion 
Several reproductive parameters have been affected by the diet and the subsequent weight gain 
observed in the DIO animals. Changes in sperm morphology and viability, as well as estradiol 
production were seen to be affected by a culmination of several macroscopic, microscopic and 
molecular changes within the reproductive system. Among these include increased visceral fat 
weights which correlated to changes in sperm morphology, changes in epididymal catalse levels 
which related to alterations in sperm morphology and estradiol concentrations, as well as changes 
in testicular weight which were related to abberations in sperm viability. At a more molecular level, 
protein expression points towards numerous underlying abnormalities, with several protein 
pathways being affected by diet-induced obesity. The predominant pathways affected were related 
to metabolism, specifically influencing proteins involved in glycolysis, oxidative phosphorylation 
and β-oxidation. In addition, structural proteins involved in cell-to-cell communication, signal 
transduction and cell motility were negatively affected. These are essential for cell viability and the 
propagation of sperm towards to oocyte. Other proteins involved in cell cycle as well as DNA repair 
and replication proteins, which are also essential for cell viability as well as the production of 
functional proteins, were affected by the diet. Regulatory pathways essential for cell transport, 
signal transduction, the immune system, and the removal of aberrant cellular structures were 
dysregulated. These changes were possibly brought on by increases in stress proteins including 
redox, inflammatory and heat shock proteins. This is in agreement with by numerous studies which 
have shown obesity to increase biochemical stressors, which can lead to a cascade of biological 
changes and changes in bodily funtions. In addition to the listed changes, proteins responsible for 
proper reproductive function were differentially expressed between the study groups, including 
those responsible for sperm production, fertilization as well as the early stages of embryonic 
development. It is therefore evident from this study that long term obesity can impair male 
reproductive parameters and could be a contributing factor to the decline in male infertility by 




continuing intervention as it may lead to changes in fertilizing capacity. Lifestyle changes are thus 






2. Chapter 2: Literature Review 
2.1. Introduction 
The continued existence of a society is determined by the fertility of its people (Jauniaux, 2001). 
The desire to procreate is identified as one of our most primal needs, and is appropriately 
acknowledged in psychological ideology. In the works of psychologist Abraham Maslow (Maslow, 
1943), his theory, the “Hierarchy of Needs”, places the need to procreate as one of the Immediate 
Physiological Needs, together with eating, breathing and maintaining homeostasis (Cherry, 2018). 
The inclusion of sexual reproduction at this level of the hierarchy highlights its importance to our 
existence and the propagation of the species.  
In ancient societies, the primary occupation of a couple after establishing a home was to bear their 
own children (Morice, 1995). The inability to do so brought anguish and judgement, and in many 
cultures, this was just cause to allow a couple to separate (Robins, 1993). Furthermore, infertility 
has been recorded since biblical times and in the writings of ancient civilizations (Jones and Sills, 
2013). Lack of reproduction had cultural, economic and political repercussions and was so 
essential to humankind that special consideration has been reserved for it in all existing belief 
systems (Morice et al, 1995).  
The angsts of reproduction were not only reserved for peoples of the past, but are still evident in 
the present day. Until recently, most blamed infertility on the female, but better understanding of 
the human reproductive system in recent decades has made it evident that male fertility is likewise 
an essential determinant of couple fertility (Hull et al., 1985; Hammadeh, Filippos and Hamma, 
2009; Mehta et al., 2016; Rumbold et al., 2019; Murshidi, Choy and Eisenberg, 2020). A 
multicentre study by the World Health Organization (WHO) performed in the 1980’s observed that 
10% of couples sought fertility treatment and amongst them, 20% had a male-related problem; 
27% of the causes were related to both partners and 15% had an unknown cause (Comhaire et al., 
1987). More recently, it was determined that male factor infertility can contribute up to 50% to 
couple infertility (World Health Organization, 2014). Male factor infertility encompasses 
abnormalities within the male reproductive system that can impair structural and functional sperm 
parameters, including genetic, anatomical, endocrine and immunological anomalies. Furthermore, 
chronic illnesses and sexual conditions impairing the male from inseminating his partner are 
included (Zegers-Hochschild et al., 2017).  
The knowledge that men are contributing to couple infertility more than previously believed has 
encouraged the undertaking of more studies in order to understand how male infertility comes 




uncover the derangements that can occur. Laboratory studies aiming to understand the underlying 
mechanisms of various pathologies, including infertility, are carried out in animal models. 
Laboratory rats have the same basic physiology, organ structure and similar body plans to 
humans. Moreover, almost all the disease-linked genes in humans have rat homologues, with rats 
sharing 90 percent of their genome with humans (Twigger, 2004; Iannaccone and Jacob, 2009; 
Jacob, 2010). 
The physiological mechanisms governing male fertility will be reviewed, including the sperm 
parameters measured to determine the fertility of a male. This review will also analyse the 
causative pathologies of male fertility by looking at both human and animal studies and highlight 
the effect of non-communicable diseases on male factor infertility, with special attention to the role 
of obesity. As this study will make the case for why more molecular assessments (specifically 
proteomics) are needed in order for male infertility to be better understood, the sections dealing 
with genetics and genetic causes of infertility will be discussed in detail. This will establish the 
basis for the assessment of fixed versus dynamic molecular changes. Finally, a brief overview of 
the treatments of infertility will be outlined, followed by an analysis of new avenues that are 




2.2. Overview of the Male Reproductive System 
The reproductive system is one of the more complex organ systems of the body. From the 
Hypothalamus to the gonads, it encompasses a co-ordinated interplay between several organs and 
glands interacting together to determine sexual function. The organs, glands, essential hormones 
and processes necessary for the proper functioning of this system will be summarized below.  
The male reproductive system (Figure 2.1) comprises most notably of the external genitalia and 
the testes, accompanied by accessory glands and ducts known as the internal genitalia 
(Silverthorn et al, 2014). The external genitalia, the penis and the scrotum, are the external 
protuberances of the male reproductive system. The testes are housed within the scrotum and are 
responsible for the production of spermatozoa and certain androgens. Internal genitalia, consisting 
of the prostate, seminal vesicles and bulbourethral (Cowper’s) glands, produce secretions which 
contribute to the production of seminal fluid. This fluid is expelled together with spermatozoa as 
semen through the urethra, a shared passageway for both urine and semen. The urethra spans the 
length of the penile shaft and is surrounded by erectile tissue (Mawhinney and Angelo, 2013; 
Silverthorn et al., 2014). 
 
Figure 2.1: Posterior view of the human male reproductive system showing the eternal genitalia, the testes, 




The rat has the same reproductive organs as humans, differing mostly in size and proportion 
(Figure 2.2). The major difference is the protuberance of the penis, which is stored internally until it 
is erect. The rat penis also has a bone inside of it called a baculum (not shown).  
 
Figure 2.2: The male reproductive system of the rat showing the eternal genitalia, the testes, internal 
genitalia and accompanying ducts (Libretexts Biology, 2019) 
 Testes 
As the histology of the testes and epididymis will be analysed in this study, it is worth briefly 
reviewing their structures. The testes (Figure 2) are present in both human and rat males. Testes 
are paired ovoid organs (Heffner and Schust, 2010) located together with the epididymides inside 
an external saclike structure known as the scrotum. The testes develop within the abdominal cavity 
during the foetal period in both humans and rats, and descend into the scrotum before and, in 
some instances, directly after birth. They are housed here due to the temperature requirements of 
spermatogenesis, which is optimally 1 - 2°C below normal body temperature (Silverthorn et al., 
2014). A patent inguinal canal (passageway in the anterior abdominal wall used by testes to 
descend into the scrotum) can be observed in rats, whereas the human equivalent is closed once 
the testes have descended into the scrotum (Werdelin and Nilsonne, 1999). The testes can thus 
communicate with the abdominal cavity in rats, and the inguinal canals are occupied by epididymal 
fat when the testes are in the scrotum. The ability to retract testes allows rats the ability to protect 




The primary functions of the testes include spermatogenesis and hormone production. 
Approximately 80% of the testis is occupied by seminiferous tubules, which are coiled tubes 
clustering into several hundred compartments (lobules) within the organ (Figure 2.3). Seminiferous 
tubules are enveloped by an external fibrous capsule called the tunica albuginea, which sends 
septa (fibrous connective tissue partitions) into the testes, dividing clusters of seminiferous tubules 
into lobules (Aitken et al., 1997). The testicular interstitium is populated by interstitial cells including 
epithelial cells, macrophages, and most importantly, Leydig cells (Roberts and Pryor, 1997). Leydig 
cells are spherical cells containing large amounts of mitochondria and smooth endoplasmic 
reticulum. They are essential to the male reproductive system as they produce steroid hormones 
including the main male androgen, testosterone (Jambor, et al. 2015). During foetal development, 
testosterone production is required for the development and differentiation of male external 
genitalia and the onset of spermatogenesis. Adult Leydig cells are responsible for the androgen 
production necessary for masculinization at puberty and continued sperm production throughout 
the adult male life (Jambor, Tvrda and Lukac, 2015). 
Within the seminiferous tubules are stratified (multiple) layers of male germinal (stem) cells, called 
the seminiferous epithelium. This epithelium is arranged in concentric cell layers progressing from 
primitive to differentiated germinal cells, under considerable support from surrounding somatic cells 
and structures. The most prominent supportive structure, the Sertoli cell, nurtures these cells as 
they divide and differentiate. It maintains the germ cells’ cellular associations to the surrounding 
structures and other germ cells as they progress through spermatogenesis. Sertoli cells extend 
through the height of the seminiferous epithelium, penetrating through the differentiating layers to 
send arms to all germ cells (Hess and de Franca, 2005). These somatic cells are non-dividing, and 
are linked to one another via tight junctions. The junctions prevent passage of proteins and 
macromolecules from the interstitium into the lumen of the seminiferous tubules, where the 
developing spermatids are located (Roberts and Pryor, 1997). Sertoli cell secretions contain 
nutrients necessary for the development of germ cells, and are therefore called the “nurse cells” of 
the seminiferous tubules. Furthermore, they offer physical support for the developing germ cells by 
providing a scaffold onto which these cells can attach as they differentiate and move towards the 
lumen (Roberts and Pryor, 1997). Lastly, Sertoli cells create the blood-testis barrier via their tight 
junctions.  
The seminiferous tubules are continuous with (and empty into) the rete testis, a network of tubules 
at the “exit” of the testes , which is called the hilum. The rete testis are continuous with the efferent 
ducts (ductuli efferentes), the collecting ducts which transport sperm into the epididymis. The 




the propulsion and expulsion of newly synthesized spermatozoa into ductuli efferentes and, 
therefore, into the epididymis. (Aitken et al., 1997) 
 
 Epididymis 
The epididymis carries out the same function in both human and rat reproductive systems; it is the 
storage organ of spermatozoa and the site of sperm maturation. The epididymis is an elongated 
crescent shaped organ tethered to the surface of each testis (Roberts and Pryor, 1997). The 
epididymis is essentially a single, convoluted duct (the ductus epididymis) lined by pseudostratified 
epithelium that is resting on a basement membrane (De Grava Kempinas and Klinefelter, 2015). 
Underlying the basement membrane is a connective tissue lining containing smooth muscle cells. 
The epididymis is functionally divided into 3 regions; the caput (head), corpus (body) and the 
cauda (tail) (Figure 2.3). The caput lies atop the testis on its upper pole and contains the principal 
segment, and is the primary site of sperm maturation (Rogers, 2011). In this region, excess fluid 
from the testes is reabsorbed. Maturation continues in the corpus, where lipid containing secretions 
facilitate modification of the lipid content of the sperm cell membranes. The cauda is the major 
storage region of the epididymis. The cytoplasmic droplets expelled by maturing spermatozoa are 
absorbed. The sperm entering the proximal cauda are fully mature and capable of fertilization. 
Immobilin is then secreted to keep the sperm dormant during storage (De Grava Kempinas and 
Klinefelter, 2015).  
There are slight variations in the structure of the human and rat epididymis. Humans have less 
differentiation between the caput, corpus and cauda; histological assessment shows no presence 














Figure 2.3: Schematic diagram depicting the human testis. Seminiferous tubules, the site of spermatogenesis, 




that is seen in the rat and other mammals (Sullivan and Mieusset, 2016). Furthermore, the cauda 
in humans is poorly distinguishable from the vas deferens and it has a lower capacity to store 
sperm The human epididymis has a smaller lumen diameter, which could be related to the more 
rapid transit of sperm within the human epididymis (Bedford, 1994). Human sperm only takes 2-4 
days to transit through the epididymis, whereas rat sperm take 10-12 days. This small reserve 
capacity in humans does not exceed the number of male gametes necessary to produce 2-3 
normal semen samples (Bedford, 1990). 
 Hormonal regulation 
The current study analyses the concentrations of two essential reproductive hormones, which 
necessitates a summary of the reproductive hormones within the male. The control of reproduction 
begins in the brain. The release of tropic hormones from the hypothalamus and the anterior 
pituitary set off physiological pathways which lead to the regulation of gonadal function (Harris, 
1955; Silverthorn et al., 2014) (Figure 3). The cascade begins with the release of a peptide 
hormone, Gonadotropin Releasing Hormone (GnRH), from the hypothalamus. This stimulates the 
production and release of two hormones from the anterior pituitary gland, Follicle Stimulating 
Hormone (FSH) and Luteinizing Hormone (LH). FSH and LH are hormones which act directly on 
the gonads to initiate spermatogenesis and hormone production (Meethal and Atwood, 2005).  
The release of GnRH is described as pulsatile (Hotchkiss and Knobil, 1996). Periodic secretion of 
this hormone by the hypothalamus every 1-3 hours ensures stimulation of GnRH receptors without 
their desensitization (Heffner and Schust, 2010). GnRH receptors are located on secretory cells of 
the anterior pituitary and their stimulation promotes the production and secretion of FSH and LH, 
the two main endocrine regulators of testicular function (Mutsumoto and Bremner, 2016), into the 
bloodstream (Meethal and Atwood, 2005). The receptors for FSH are located on Sertoli cells and 
activation of these, through a cascade of events, leads to an increase in spermatogenesis. LH 
stimulates Leydig cells in the testicular interstitium to produce estrogen and testosterone. (Gartner 
& Hiatt, 2000; Schulster et al, 2006). Estrogen production in the male is under the control of Leydig 
cells, Sertoli cells and germ cells. Sertoli cells contribute via the secretion of aromatase, an 
enzyme responsible for the conversion of testosterone to estradiol (Schulster, Bernie and 
Ramasamy, 2006). Germ cells also produce estradiol through this mechanism, providing majority 
contribution to the production of this hormone (Hess, 2003). Furthermore, estradiol is the dominant 
form of oestrogen (Schulster, Bernie and Ramasamy, 2006).  
The system encompassing the 3 major organs involved in reproductive hormone production is 
appropriately termed the Hypothalamic-Pituitary-Gonadal (HPG) axis. The HPG axis is regulated 




gonadal hormone production which in turn, alter the secretion of their tropic hormones, GnRH, LH 
and FSH (Huhtaniemi, 1999). LH and FSH themselves inhibit the secretion of GnRH from the 
hypothalamus. The Sertoli cells assist in the regulation of hormone production via the secretion of 
paracrine factors (locally produced molecules which stimulate cell-to-cell communication) (Heffner 
and Schust, 2010). The purpose of these feedback systems is the precise control of hormone 
concentrations. Gonadal hormones always propagate a negative feedback of their stimulatory 
hormones and as their levels increase, their stimulatory hormones decrease. The regulation of the 
HPG axis by feedback mechanisms prevents the continued secretion of hormones by the gonads 
and possible dysregulation of the HPG axis. (Burger, 1988; Skinner et al., 1989). The HPG axis is 
well conserved among vertebrates, differing only by the duration of lifecycles, reproductive cycles 
and behaviours (Sower, Freamat and Kavanaugh, 2009). Experiments using animal models, such 
as the rat, to elucidate changes in HPG axis function during an intervention or disorder can 
therefore be extrapolated to humans with great accuracy. 
Testosterone is the principal hormone of the male reproductive system. This steroid hormone is 
key to the development of the male foetus and in the growth and maturation of male internal and 
external genitalia (Sajjad, 2010; Creasy & Chapin, 2013) . Its release during puberty promotes the 
development of secondary sexual characteristics including facial hair, deeper voices, skull and 
bone virilisation and an enlarged larynx (voice box) (Herman-Giddens et al., 2001). Testosterone is 
produced from cholesterol which undergoes enzymatic reactions and oxidation to become 
testosterone (Lyetjens and Weinbauer, 2012). The actions of testosterone are brought about 
directly by testosterone itself, or through its potent metabolite dihydrotestosterone (DHT). 
Testosterone is converted to DHT by the enzyme 5α-reductase which is present in the testes, 
epididymis, prostate, seminal vesicles, the liver, hair follicles, skin and the brain (Norman and 
Henry, 2015). The conversion to DHT occurs at these target tissues, where DHT has a regulatory 
effect. Both testosterone and DHT bind to androgen receptors (AR) within target tissues to control 
protein expression of essential regulatory proteins, with DHT having a more pronounced effect due 
to its higher potency (Lyetjens and Weinbauer, 2012). Testosterone regulates libido, contributes to 
the determination of bone mass, helps to regulate fat distribution, has an anabolic effect on muscle 
production, stimulates the production of red blood cells through its effect on erythropoietin and 





Figure 2.4 The Hypothalamus-Pituitary-Gonadal (HPG) axis showing the glands, hormones and organs 
involved in the control of gonadal function. The hypothalamus and pituitary in the brain release gonadotropic 
hormones which stimulate the production of androgens from testicular tissue. Feedback systems then 
intricately control the amounts of gonadotropes released from the brain to regulate the production of 






Spermatogenesis describes the cellular transformation of male diploid spermatogonial stem cells 
into haploid spermatozoa through a complex process occurring within the male gonads (Figure 2.5 
and 2.6). This transition occurs via carefully orchestrated cyclic cell ‘stages’ and ‘phases’ controlled 
by intrinsic and extrinsic testicular factors, culminating in continuous sperm production (Hess & de 
Franca, 2008).  
The development of male germ cells is almost identical in all mammals, including humans and rats 
(Adler, 1996). Germ cells develop into spermatozoa within the walls of the seminiferous tubules 
(Roberts and Pryor, 1997). Each germ cell differentiates in close association with Sertoli cells for 
nutritive support during the development process. Development and differentiation occur from the 
basement membrane to the lumen, with spermatogonia, the immature germ cells, resting along the 
basement membrane (Creasy, 2002) (Figure 2.5). These cells undergo several mitotic divisions to 
colonize the seminiferous tubules with an adequate stem cell population and for promotion to 
primary spermatocytes (Gartner and Hiatt, 2000). Meiosis is thereafter the predominating 
mechanism through which germ cells differentiate. Meiotic cell divisions result in the halving of 
genetic material which permit male germ cells to become haploid cells (Mutsumoto and Bremner, 
2016). Meiosis includes two divisions. Prophase of the first division is a lengthy process giving rise 
to several germ cell forms, which are different stages of the primary spermatocytes. These are 
leptotene, zygotene, pachytene and diplotene spermatocytes. This is followed by a diakinesis 
stage in which the chromosomes condense (Heffner and Schust, 2010; Mutsumoto and Bremner, 
2016). The cells then undergo metaphase and anaphase, where the chromosomes line up at the 
equatorial plate and chromatids move to opposite poles of the cell, respectively. In the final stage, 
telophase, cytokinesis results in two secondary spermatocytes, which concludes the first meiotic 
division (Gartner and Hiatt, 2000). The second meiotic division allows sister chromatids to 
separate, giving rise to haploid spermatids with half the genetic material of the somatic stem cells. 
This culminates in 1 primary spermatocyte undergoing two divisions to give rise to 4 spermatids 
(Roberts and Pryor, 1997).  
Spermatids undergo a subsequent maturation process termed spermiogenesis, which results in 
elongated sperm tails (Hess and de Franca, 2008). These endow the sperm with motile 
capabilities, allowing them to traverse the female reproductive system. Furthermore, 
spermiogenesis permits development of the acrosome, extrusion of excess cytoplasm and 
condensation of nuclear material (Creasy and Chapin, 2013). This packages the nuclear chromatin 
tightly to reduce nuclear volume and to protect the nuclear material from damage. The progression 
of germ cells through spermiogenesis allows them to move towards the lumen of the seminiferous 




into the lumen by a process known as spermiation (the release of spermatozoa from Sertoli cells) 
(Mutsumoto and Bremner, 2016). The basement membrane is supported by fibroblasts and myoid 
cells, whose contractions create peristaltic movements that transport the spermatozoa out of the 
seminiferous tubules and into the epididymis (Roberts and Pryor, 1997). 
Similarities and differences in spermatogenesis exists between mammals. Spermatogonial stem 
cells are always present and the process involves slow cycling through the different phases of 
division (Sharpe, 1944). The duration of the spermatogenic cycle, however, differs between 
humans and other mammals. The stages of differentiating spermatogonia last for 10.5 days in the 
rat compared to 16 days in human males. The human cells also only go through two rounds of 
mitotic division whereas the rat goes through six (Adler, 1996). The total process of spermatocyte 
development, including meiosis, takes 19 days in the rat (Figure 2.6) and 25 days in the human 
(Figure 2.5). Finally, spermatids develop for 12 days in the rat and 16 days in humans. 
Pathological insults cause different changes in the development of the spermatogenic series 
(Ehling, Doherty and Malling, 1972).  
Figure 2.5 Schematic diagram depicting spermatogenesis and the structure of the seminiferous tubules. This 
image shows the testicular tissue of a normal fertile male, detailing the seminiferous epithelium and the 
surrounding interstitial tissue. Progression of the spermatogenic series from spermatogonia on the basement 







 Structure of spermatozoa 
Morphological analysis of spermatozoa is one of the reproductive parameters which was carried 
out in this study, so the structure of spermatozoa will be reviewed. Spermatozoa carry male 
genetic material to the female oocyte. Likewise, their structure is designed to optimize this process 
(Anderson and Personne, 1975). Its purpose is to travel towards the oocyte, fuse with its cortex 
and introduce its genetic material to the interior of the oocyte to create a viable embryo.  
Mammalian sperm have a typical morphology, comprising of four separate regions: a head, neck, 
midpiece and tail (Auger, 2018) (Figure 2.7). Spermatozoa are enclosed by a plasma membrane 
largely containing polyunsaturated fatty acids (PUFAs) and glycoproteins. Morphologically normal 
human spermatozoa have an ovoid or piriform head measuring 3.7-4.7µm lengthwise and 2.5-
3.2µm crosswise, with an acrosomal cap covering 40-70% of the head surface and a cytoplasmic 
region encompassing 30% of the head area (World Health Organization, 2010). The acrosome 
 
Figure 2.6 Schematic diagram of spermatogenesis in the rat. Progression of the spermatogenic series from 
spermatogonia on the basement membrane to spermatozoa in the adluminal portion of the seminiferous 




covers the anterior part of the sperm head and encloses the nuclear material (Fléchon, 2016). The 
small residual cytoplasm of the sperm is a hydrodynamic advantage, but results in a lack of 
cytoplasmic material to cope with external insults. Thus, a condensed nucleus is a protective 
mechanism, compensating for a deficiency of DNA repair proteins, allowing the male nuclear 
material to journey safely through the male and female reproductive tract (Auger, 2018).  
The acrosomal cap is a lysosome-like bag, containing digestive enzymes such as hyaluronidase 
necessary for sperm-egg fusion. It is surrounded by inner and outer acrosomal membranes, which 
meet at the equator of the sperm head. The outer membrane closely opposes the nuclear 
membrane while the inner membrane affixes to the sperm plasma membrane. The granules within 
the acrosome are released upon arrival of the sperm at the oocyte membrane (oolemma), a 
process called the acrosome reaction, allowing digestion of the oolemma to facilitate sperm-oocyte 
fusion. (Fléchon, 2016) 
The nucleus contains paternal genetic information densely packaged within chromatin. DNA 
material is wrapped around histones, helically arranged proteins around which DNA can coil like 
thread around spools, allowing tight packaging of sperm DNA (McGhee and Felsenfeld, 1980). 
Further condensation of the male genome occurs during the late spermatid phase of 
spermatogenesis through an exchange of histones with protamines (sperm specific nuclear 
compaction proteins) within the nuclear material. This results in sperm DNA that is tightly packaged 
by protamines, making the chromatin seven times denser than that of a somatic cell (Ward and 
Coffey, 1991). Approximately 10-15% of human spermatozoa remain packaged by histones. This 
small percentage resembles the nuclear organization of somatic cells and is hypothesized to be 
due to the order in which genes need to be expressed upon fertilization (Rousseaux et al., 2008), 
where some nuclear material must remain uncondensed for easier and timeous translation. The 
nuclear cell membrane is closely applied to the nucleus and is devoid of any openings on its 
surface (Auger, 2018).  
The neck of the sperm, occasionally referred to as the connecting piece, is the shortest segment of 
the spermatozoa. Its shape resembles that of a truncated cone, with a large base at its attachment 
to the head, tapering towards its attachment to the tail (Auger, 2018). Its role as the connecting 
piece is reinforced by the filaments found traversing its interior, linking the sperm head to the 
flagellum (tail). These perpendicular fibres make up the axoneme, the core of the connecting piece 
and the flagellum (Jequier, 2008). The axoneme is a collection of microtubules arranged in a 
cylindrical pattern, with 2 microtubules in the centre of the cylinder surrounded by 9 microtubule 
pairs creating its circumference (Figure 5). This, therefore, creates a “9 + 2” pattern, forming the 
core cytoskeleton of the neck and the flagellum. The axoneme is the motor apparatus of the 




The axoneme grows out of the distal centriole, which has the same microtubular structure. The 
proximal centriole is orientated 90 degrees from the distal, and is located at the base of the neck, 
at its attachment to the sperm head (Fawcett, 1970). The proximal centriole is key to fertilization as 
it is one of the materials deposited into the oocyte. After deposition, oocyte centrisomal proteins 
combine with this structure to form the centrosome, which is responsible for setting up the polarity 
of the oocyte and the assembly of the first mitotic spindle of the newly formed zygote (Manandhar 
et al., 2005). 
The midpiece continues from the neck and contains the axoneme, encircled by mitochondria 
(Oates, 1997). These mitochondria are arranged in a helical pattern, end-to-end from one another, 
throughout the midpiece and are termed the mitochondrial sheath. They provide spermatozoa with 
the energy required for motility in the form of adenosine triphosphate (ATP) (Lindemann and 
Lesich, 2016).  
The sperm tail, the longest segment of spermatozoa, is further subdivided into the principal piece 
and the end piece (Fawcett, 1975). The sperm ultrastructure includes a central axoneme 
surrounded by a fibrous sheath. The axoneme contains numerous protein fibres throughout its 
length, from the sperm neck to the tail, with as many as 200 being proposed (Ostrowski et al., 
2002). The “9 + 2” microtubular structure is composed of tubulin proteins, with an additional 9 
circumferential proteins termed outer dense fibres (ODF) found in the tail. This creates a new “9 + 
9 + 2” microtubular pattern. ODFs extend two dynein arms each, which are structural proteins 
containing ATPases that catalyse the use of ATP for flagella movement (Gibbons, 1996). Dynein 
proteins facilitate the movement of flagella by attaching and detaching the axoneme microtubules, 
creating a sliding motion that propagates sperm forward. Each of the 9 outer microtubules attach to 
the central pair by protein fibres, giving the axoneme a wheel-spoke pattern (Afzelius, 1959; Oiwa 
et al., 2009).  
Knowledge of the normal structure and function of the male reproductive system is essential to 
understanding any resulting pathologies from deviations of normality. Internal and external 
changes resulting in aberrations in the normal anatomy and physiology of the male reproductive 
system can reduce a male’s fertilizing potential, leading to infertility.  
Sperm structure maintains the same components (head, midpiece, tail) but varies structurally 
between species. Rat spermatozoa differ most distinctly in head shape compared to human sperm. 
Rat sperm heads, as with most murine rodents, have a falciform, head with an apical hook (Immler 
et al., 2007) (Figure 2.7 and Figure 2.8). This hook varies in size (sperm head length (ARC), sperm 
head width) and curvature (sperm head angle, sperm midpiece-head angle) (Figure 2.8) due to the 




Van der Horst and colleagues (2018) recently characterised the size and curvature of rat 
spermatozoa in order to determine normal rat sperm morphometry measurements in Wistar and 
Sprague Dawley (SD) rats, particularly the sperm head and the anterior part of the tail, using 
CASA. This allowed the determination of upper and lower values of normal sperm morphometry 
parameters in order to allow for the differentiation between rat spermatozoa with normal and 
abnormal morphology. Table 2.1 below shows the minimum and maximum values obtained for 
normal sperm morphometry parameters. Spermatozoa with measurements outside of these ranges 
can be classified as morphologically abnormal. Using these cut off values, Van Der Horst et al. 
(2018) ascertained that, on average, 68-71% of spermatozoa in Wistar and SD rats have a normal 
morphology. Previous studies also determined head, midpiece and tail length of mammalian sperm 
including several wild-life rodents (Cummins, 1983; Cummins and Woodall, 1985; Vashishat, 
Dhanju and Cheema, 2012). Using manual measurements of mammalian spermatozoa, Cummins 
(1983) and Cummins and Woodall (1985) were able to provide insight on these sperm dimensions, 




Figure 2.7: Ultrastructure of spermatozoa. Image A depicts the structure of the human spermatozoa 




analysis. These authors found sperm head length, on average, to be > 25 µm. Van der Horst et al. 
(2018) found an average head length of > 21µm, which they attribute to their use of an 
isotonic/isosmotic stain. The use of staining methods which are not isotonic to that of the sperm 
intracellular fluid alters sperm morphometry measurements as the use of hypertonic or hypotonic 
staining solutions increase or decrease the size of the sperm due to osmosis. Several other sperm 
measurement parameters can be assessed to determine whether rat sperm possess a normal 
morphology, as listed in Table 2.1. The chord refers to the distance between the anterior tip of the 
acrosome and the posterior part of the sperm head; head linearity (LIN) and roughness are 
calculated using the equations outlined in Figure 2.8.  
Sperm viability, motility and morphology are sperm parameters related to the fertility of a semen 
sample and are used to ascertain the fertility potential of an animal. Sperm morphology has been 
argued to be a strong indicator of fertility (Menkveld, Holleboom and Rhemrev, 2011) but it has 
been debated that male fertility cannot depend on the absolute number of a single parameter, nor 
be judged solely on the aforementioned sperm parameters (Bhattacharyya and Kanjilal, 2003; 
Petrunkina et al., 2007; Vashishat, Dhanju and Cheema, 2012). The functional competence of 
sperm, which includes cervical mucous penetration, hypo-osmotic swelling, the hemi-zona assay 
and other in vitro tests, are also essential (Bhattacharyya and Kanjilal, 2003). Thus sperm should 
be subjected to multiple parameter analyses in order to assess fertility and fertilizing potential. 
 
Figure 2.8: Morphology images obtained via computer-aided sperm analysis (CASA) showing normal sperm. The 
Head (blue) and midpiece (green), demarcated using the Sperm Class Analyser (SCA) system, can be assessed 




Table 2.1: Measurement values of rat sperm and mid-piece morphometry parameters as determined by 
Van Der Horst et al. (2018). Deviations from these morphometry values in Wistar and Sprague Dawley 
rats can be classified as having an abnormal sperm morphology. 
Sperm head and mid-piece 
(MP) parameters 
Minimum value Maximum value 
Head  
   Length (Arc) (µm) 191 23 
   Width (µm) 0.9 1.90 
   Perimeter (µm) 40 50 
   Area (µm) 15 23 
   Chord (µm) 8 14 
   Angle (degrees) 50 87 
   Linearity (%) 40 65 
   Roughness 0.08 0.30 
Mid-piece 
   Width (µm) 0.40 1 







Defining infertility is essential for the clinical diagnosis and epidemiological investigation of 
infertility. The many definitions of infertility, stemming from the diverse criteria used to define a 
couple’s fertility status and the many types of studies available to define its prevalence, can 
complicate this. Demographers, in measuring the human population, define infertility as the 
“absence of a live birth in a sexually active, non-contracepting woman” (Pressat and Wilson, 1985). 
The World Health Organization (WHO), however, defines it as “the failure to achieve a clinical 
pregnancy after 12 months or more of regular unprotected sexual intercourse” (World Health 
Organization, 2009). Demographers tend to estimate infertility over 5 years whereas clinical 
definitions prefer shorter periods. This is because clinicians prefer treatment to be initiated 
promptly while epidemiological studies seek to avoid false positives within their data. Furthermore, 
epidemiological research relies on Demographic and Health Surveys which contain complete birth 
histories but lack information regarding stillbirths, miscarriages, spontaneous and induced 
abortions. The WHO definition is preferred as it is clinically beneficial and can be applied in 
research across different disciplines (Larsen, 2005).  
A combined meeting between the WHO and the International Committee for Monitoring Assisted 
Reproductive Technologies (ICMART) convened in 2017 to reassess the definition of infertility. The 
WHO-ICMART meeting expanded the WHO definition to include a wider array of conditions which 
could alter the ability of individuals and couples to reproduce. Furthermore, fertility interventions 
can now be performed prior to the 12 months benchmark, depending on patient age, diagnosis and 
physical findings noted during fertility assessments (Zegers-Hochschild et al., 2017).  
Infertility affects 15% of couples of reproductive age globally (Gerrits et al., 2017). A systematic 
analysis which assessed infertility in 195 countries between 1990 and 2017 found the age-
standardized prevalence of male infertility to increase by 8.22% between 1990 and 2017, while 
female infertility increased by 14.96% (Sun et al., 2019). This represents a 0.293% per year 
increase in infertility in males and a 0.396% increase in females. The Centers for Disease Control 
and Prevention (CDC) of the United States stated that infertility affects quality of life and carries a 
substantial number of public health consequences (Practice Committee of the American Society for 
Reproductive Medicine, 2013; Zegers-Hochschild et al., 2017). These include psychological 
distress, social stigmatization, economic strain, and marital conflict. Furthermore, infertility has 
been shown to be a risk factor for chronic health conditions later in life, including cardiovascular 




 Causes of male infertility 
The complex control of the male reproductive function lends itself to dysfunction, leading to a 
myriad of possible pathological changes. The causes of male infertility may be subdivided into 3 
categories depending on the origin of the dysfunction, namely: pre-testicular, testicular and post-
testicular. 
Pretesticular 
Pre-testicular causes of male infertility arise from extragonadal conditions that impede on testicular 
function by dysregulating the HPG axis, resulting in poor hormonal support to the testes (Wong, 
1974).  
Primary GnRH deficiency manifests in idiopathic hypogonadotropic hypogonadism (IHH) (a 
congenital deficiency of GnRH), Kallman Syndrome (results from a genetic mutation leading to the 
defective migration of GnRH neurons) and Prader-Labhart-Willi syndrome (hypothalamic deficiency 
manifesting in genital hypoplasia, scrotal hypoplasia and a small penis) (Kallman, Schoenfeld and 
Barrera, 1944; Prader, 1956; Hoefnagel, Costello and Hatoum, 1967; Schwanzel-Fukuda, Bick and 
Pfaff, 1989; Chowdhary and Tiwari, 2016). Diseases affecting the hypothalamic function present 
with reduced GnRH, LH, FSH and testosterone concentrations (Chowdhary and Tiwari, 2016). 
Acquired causes of GnRH deficiency result from the destruction of hypothalamic tissue by 
diseases such as tuberculosis, metastatic tumours, hemochromatosis (excessive iron absorption) 
and sarcoidosis (inflammatory disease resulting in connective tissue deposition in the form of 
nodules in certain body organs) (Behre et al., 2010). Other instigators, such as obesity, may result 
in reduced sensitivity of GnRH or hypothalamic receptors, affecting the release of hypothalamic 
hormones and peptides (Teerds et al., 2011). 
Testicular 
Testicular causes of male infertility include primary defects of the testes (Wong et al., 1978) 
resulting in abnormal testicular ultrastructure and possible testicular failure (inability to produce 
sperm or hormones). Causes are predominantly genetic and acquired conditions, but some origins 
are unknown. Genetic causes of testicular abnormalities include chromosomal defects, namely 
Klinefelter syndrome (the inheritance of an extra X chromosome by genetic males) and the loss of 
genetic material from the Y chromosome (Y chromosome microdeletions) (Chowdhary and Tiwari, 
2016). The Y chromosome contains genetic information vital to male development (O’Flynn 




spermatogenic failure. Microdeletions in the long arm of the Y chromosome can affect several 
genes and are always inherited by the male offspring (de Vries et al., 2001; Schlegel, 2004).  
The acquired causes of testicular abnormalities include many well-known aetiologies of male 
infertility. Inflammatory conditions such as bacterial and viral infections resulting in orchitis 
(testicular inflammation), immunological disorders, environmental and lifestyle factors, 
gonadotoxins including drugs and chemotherapeutic agents, testicular cancers, undescended 
testes, systemic diseases such as renal failure, some endocrine and hormone disorders, testicular 
trauma, as well as structural anomalies including testicular torsion (rotation of the testes which 
twists the spermatic cord and the blood vessels within it, impeding blood supply), hydrocele 
(collection of fluid around the testes causing testicular swelling), varicocele (swollen testicular 
veins) and damage or changes brought on by surgery (Wong et al., 1978; Nieschlag et al., 2010).  
Testicular pathologies bring about improper sperm production, resulting in abnormal sperm 
morphology (teratozoospermia), immature sperm, oligozoospermia and azoospermia (Testicular 
Causes of Male Infertilit>, 2018).  
Post-testicular 
Post-testicular causes of male infertility include obstruction of the ducts exiting the testes. These 
succeed adequate sperm production by the male reproductive system and involve complications 
with the ductal system and ejaculation (Wong et al., 1978).  
Genetic aberrations giving rise to post-testicular changes include cystic fibrosis (resulting from a 
mutation of the CFTR gene) which leads to an absence of the vas deferens, and Young Syndrome 
(abnormal mucus secretions leading to bronchiectasis, chronic bronchitis and obstructive 
azoospermia) resulting in inspissated (thick) secretions into the epididymis that block the 
epididymal duct (van Ahlen and Hertle, 2001).  
Acquired post-testicular changes result from trauma, infections and iatrogenic (medical treatment-
related) causes (Chowdhary and Tiwari, 2016), with genital tract infections, hernia repair, 
vasectomy being prominent examples. Ejaculatory disorders include premature ejaculation, 
retrograde ejaculation and anejaculation (the inability to produce and ejaculate (Natarajan and 
Khan, 2019).  
The common causes of male infertility mentioned above are categorised and further elaborated on 
in the sections below. As there are many causes of infertility, these will be briefly reviewed with an 





Genetic causes of male infertility account for approximately 15% of male infertility cases (Ferlin et 
al., 2007) and are alarming due to their ability to affect multiple physiological processes, including 
hormone production and spermatogenesis (O’Flynn O’Brien et al., 2010). Genetic errors may be 
inherited or occur sporadically throughout a male’s life, affecting fertilization, embryogenesis and 
sexual differentiation of the conceptus (Carrell et al., 2006). Furthermore, genetic anomalies can 
impair male fertility, but may further be harmful to a foetus should they be passed on through 
assisted reproduction techniques (ART).  
Approximately 5% of male infertility cases are attributable to chromosomal abnormalities (Ferlin et 
al., 2007). The most common of these are aneuploidies, also referred to as numerical 
chromosomal abnormalities, giving patients an incorrect number of chromosomes. These errors 
result in spermatozoa with an incorrect amount of genetic material and have been demonstrated to 
result in azoospermia (no sperm within the ejaculate) and oligozoospermia (sperm counts of less 
than 20 million spermatozoa/ml) (Carrell et al., 2006; Emery & Carrell, 2006; Ferlin et al., 2007). 
Aneuploid sperm can also successfully fertilize an oocyte, passing on an incorrect number of 
chromosomes to the resulting offspring (Carrell, 2008).  
Translocations (the exchange of genetic material from two chromosomes that are not from the 
same chromosome pair (non-homologous) can cause a gain or loss of genetic material which may 
alter the genetic code (Carrell, 2008). These are an additional source of aneuploidies. The 
consequence can be impaired gametogenesis as gametes can inherit an unbalanced combination 
of parental chromosomes (Ferlin et al., 2007). Many of those with translocations are carriers and 
show no pathologies. Some can result in trisomies (inheritance of the 3 pairs of the same 
chromosome), which are incompatible with life, resulting in natural fetal abortion. Others can lead 
to common birth defects such as Down syndrome (trisomy 21). They can thus lead to a variety of 
phenotypes with varying changes to fertility (Georgiou et al., 2006).  
Genetic variation, referred to as polymorphisms if they occur in >1% of the population, in several 
genes can lead to male infertility. The resultant phenotypes from these variants are modified by 
other genetic factors as well as the environment; this influences the severity to which these 
variations are phenotypically expressed (O’Flynn O’Brien, Varghese and Agarwal, 2010). This 
means that some genetic variants will only be expressed if the correct interaction with other genes 





Hormonal causes of male infertility arise from any disorder which affects the HPG axis and its 
resultant gonadotropins and androgens. These could be initiated by primary deficiencies of the 
hypothalamus, the pituitary or gonads, or arise secondary to disease processes which affect organ 
structure, function and sensitivity.  
GnRH deficiencies are the basis of a number of hormonal disturbances. In an animal model using 
an induced mutant mouse strain of GnRH deficiency, researchers observed a decline in pituitary 
secretion of both FSH and LH (Cattanach et al., 1977). Congenital GnRH deficiencies bring about 
hypogonadism, and sufferers have an abnormal pubertal development as well as low plasma 
levels of LH and FSH (Kottler et al., 1999). Excess GnRH, such as GnRH administration used to 
treat GnRH deficiencies, leads to reduced LH and FSH secretion, due to the reduced sensitivity of 
GnRH receptors from constant stimulation. Therefore, excessive GnRH results in the reduction of 
pituitary gonadotropins (Hotchkiss and Knobil, 1996).  
Hypopituitarism is the interruption of hormone secretion by the anterior pituitary gland (Simmonds, 
1914) due to a primary inability of the pituitary to produce adequate hormones, or as a result of 
insufficient stimulation by hypothalamic hormones. It may also arise from several causes including 
organ damage (radiation ablation, infarction), pituitary neoplasms and tumours, inflammatory 
conditions and surgical intervention (Lamberts et al., 1998; Regal et al., 2002). Genetic causes of 
hypopituitarism are caused by alterations in the transcription factors responsible for the 
development of the pituitary. Aberrant production of these result in hypopituitarism and pituitary 
malformation (Dattani, 2005). GnRH deficiencies can also diminish the secretion of hypothalamic 
hormones. 
Androgen deficiency is the failure of the testes to secrete physiological concentrations of 
testosterone (Bhasin et al., 2010). A diagnosis of androgen deficiency can be made in males with 
consistently low serum total testosterone levels, and in the case of low normal levels, the 
measurement of free testosterone. This must be accompanied by consistent symptoms of low 
serum testosterone (Bhasin et al., 2010). Clinical symptoms of low testosterone have been listed 
as: erectile dysfunction (ED), low libido and hot flushes; non-specific symptoms include fatigue, 
poor concentration, depressed mood, decreased physical performance, irritability, sleeplessness 
and loss of vigour (Zitzmann, Faber and Nieschlag, 2006; Araujo et al., 2007; Hall et al., 2008). 
Clinically, testicular failure can be reversed with adequate hormone therapy, but is potentially 




Therefore, a functional HPG axis and gonads are essential for the hormonal control of the male 
reproductive system. Furthermore, functional ARs are a requirement for the functions of androgens 
to manifest, thereby adequately controlling male reproductive physiology. 
 Infections 
Micro-organisms have the ability to colonize the male genital tract and cause infections (Gimenes 
et al., 2014). These micro-organisms have several origins including endogenous pathogens of the 
urogenital tract, transmission through sexual contact or travel via the bloodstream during a 
systemic infection (Schuppe et al., 2017). They can initiate inflammatory processes within 
segments of the male reproductive tract, i.e. the urethra (urethritis), prostate (prostatitis), the 
epididymis (epididymitis) and testis (orchitis) (Brookings, Goldmeier and Sadeghi-Nejad, 2013), 
and subsequently affect sperm at different levels of their development, maturation and transport 
(Pellati et al., 2008). Colonizing micro-organisms can be bacterial, viral or protozoal in nature 
(Gimenes et al., 2014) and have several sequelae including genital cancer, hepatitis, reduced 
immunocompetence, vasculitis and infertility (Center for Disease Control, 2003). Reproductive tract 
infections can directly and indirectly lead to male infertility. This occurs via the recruitment of 
leukocytes into seminal fluid (Sarkar et al., 2011), potentially resulting in infiltrations of >1 million 
cells per millilitre (M/ml) of semen, a state classified as leukocytospermia (World Health 
Organization, 2009). Leukocytes produce reactive oxygen species (ROS), unstable and highly 
oxidizing by-products of aerobic metabolism which directly damage neighbouring tissues via 
oxidative processes (Sikka, 2001). Spermatozoa are especially susceptible to this damage due to 
the composition of their cell membranes, which predominantly comprise of polyunsaturated fatty 
acids (Zalata et al., 1998).These are damaged via lipid peroxidation, leading to reduced sperm 
viability, abnormal sperm morphology, and impaired spermatogenesis, sperm maturation and 
function (Pilatz et al., 2016). Furthermore, leukocytes indirectly damage spermatozoa through the 
release of intracellular cytokines, thereby producing more ROS (Smith et al., 2014). Inflammation 
additionally contributes to infertility by instigating accessory gland dysfunction and the blockage of 
seminal ducts (Rusz et al., 2012), thereby hampering seminal fluid production and the release of 
spermatozoa via ejaculation. 
 Environment 
Industrialization, urbanization and economic development have led to drastic changes in lifestyle, 
but also to the environment. Many hazardous chemicals from industries and agriculture have been 
released into the environment, exposing both humans and animals to their deleterious effects 
(Mathur and D’Cruz, 2011). Industrialized countries have consequently observed reduced 




observed from 1940 to 1990 has raised concern regarding the contribution of synthetic chemicals 
to this decline (Carlsen et al., 1992; Colborn, Vom Saal and Soto, 1993; Sinawat, 2000).  
Reproductive malfunction is a sensitive indicator of environmental hazards due to the reactiveness 
of testicular tissue to external stressors (Mattison and Thomford, 1987). The testis is appreciably 
more sensitive to radiant heat and radiation than any other bodily organ. Numerous environmental 
agents that humans are exposed to, have been shown to be hazardous to their reproductive 
potential. This was observed from the 1970’s when male reproductive function was seen to be 
reduced in men employed within industrial and agricultural sectors making use of the compound 
1,2-dibromo-3-chloropropane (DBCP) (Whorton et al., 1977; Slutsky, Levin and Levy, 1999). 
Whorton et al. (1977) observed azoospermia, oligozoospermia, and increased LH and FSH within 
pesticide workers exposed to DBCP. After this revelation, subsequent studies interrogated different 
classes of pesticides and solvents in animal models to investigate any effects on reproductive 
parameters (Sundaram and Witorsch, 1995). Rats exposed to the insecticide methoxychlor (MXC) 
have shown numerous effects including cellular apoptosis and reductions in Sertoli cell number 
nuclear volume, implying impairment of spermatogenesis by MXC (Johnson et al., 2002). Certain 
chemicals, though, cause undetectable changes in the testes due to the ability of testicular tissue 
and germ cells to continuously produce spermatozoa (Sharpe, 1944). Thus, reproductive 
parameters could be impaired without noticeable changes in sperm concentrations. 
Several mechanisms have been put forward as to how these chemicals can affect fertility. 
Reproductive function can be impaired via disruptions to hormone secretion and damage to 
testicular microanatomy. By targeting specific cell types including Sertoli cells and germ cells, 
environmental hazards can disrupt the microanatomy of the testes and disturb male fertility. In 
addition, mutations to germ cells may lead to genetic diseases, malformations and miscarriage of 
the fetus. Neurotoxic compounds can disturb hormone production resulting in abnormal erection, 
emission as well as ejaculatory disorders (Telöken, Juncal and Graziottin, 2012). 
Environmental pollutants have been implicated in the disturbance of the antioxidant/pro-oxidant 
system within cells by stimulating the production of ROS (Bagchi and Stohs, 1993). This promotes 
the oxidation of cellular membranes, particularly those of spermatozoa, reducing sperm motility 
and viability (Aitken and Clarkson, 1987; Mathur, Saradha and Vaithinathan, 2008). Endocrine 
disruptors are external sources or pollutants with estrogenic properties that mimic the effects of 
endogenous hormones, thereby disrupting normal endocrine function (Saradha and Mathur, 2006). 
They can to bind estrogen receptors and antagonize or stimulate their natural actions within the 
body (Zava, Blen and Duwe, 1997). Bisphenol A (BPA), an endocrine disruptor used to make hard, 
clear plastics and in regularly used substances such as dental sealants and food cans, has been 




Mathur, 2003); decrease motility and viability (Lukacova et al., 2015); reduce sperm acrosome and 
plasma membrane intactness, and reduce sperm mitochondrial integrity and morphology 
(Wisniewski et al., 2015).  
 Lifestyle factors 
There are many well-established health risks that many individuals are exposed to on a regular 
basis that may affect their fertility. 
Smoking 
The burning of a tobacco cigarette releases approximately 4000 compounds including vaporized 
liquids, gases and particles (Hruska et al., 2000). Cigarette smoke contains high levels of ROS, 
including hydrogen peroxide and hydroxyl anions and radicals (Saleh et al., 2002) as well as 
carcinogens responsible for numerous cancers. Virtually all semen parameters (concentration 
motility, viability, morphology) are negatively affected by cigarette smoke, with some studies 
reporting no “safe” amount of cigarette smoking to be recommended for the maintenance of normal 
semen quality (Gaur, Talekar and Pathak, 2007; Oyeyipo, Maartens and du Plessis, 2014). Since 
human spermatozoa have nicotine receptors, the presence of high amounts of nicotine found in 
male smokers causes activation of these receptors, eliciting deleterious effects which reduce 
normal sperm morphology and concentration (Görnig and Schirren, 1996; Oyeyipo et al., 2011). 
Smoking additionally affects the accessory sex glands, with Pakrashi and co-workers (1995) 
observing significant reductions in the ejaculate contents of seminal vesicles and the prostate in 
smokers. The compounds found within cigarette have been shown to increase ROS and reduce 
antioxidants (Saleh et al., 2002), cause DNA damage within sperm nuclei (Zhang et al., 2000; 
Elshal et al., 2009) and varicocoels (Klaiber et al., 1987). In addition, compounds within cigarettes 
have been shown to reduce sperm proteins such as axonemes and acrosin (a proteolytic enzyme 
which degrades the acrosome membrane during the acrosome reaction) which are responsible for 
normal sperm motility and function (Gerhard et al., 1989; Zavos Ed.S., Ph.D. et al., 1998; Yeung et 
al., 2009). 
Physical exercise 
Physical activity includes any form of movement which relies on muscle contraction (Vaamonde 
Martin et al., 2014). This includes everyday activities such as walking, gardening and housework. 
Exercise is a purposeful and planned activity performed to increase physical fitness which includes 
cycling, running, weight training and swimming. Physical activities and exercise have widespread 
positive effects on the body including the cardiorespiratory, immune and endocrine system, 




osteoporosis (Vaamonde Martin et al., 2014). Resistance training has an anabolic response as it 
increases testosterone production within the body thereby stimulating protein synthesis and muscle 
growth, while also enhancing the production of growth hormone (McArdle, Katch and Katch, 2006). 
This increase in testosterone release is both an increase in frequency and amplitude, which 
decreases during post-exercise rest (Kraemer and Ratamess, 2005). Excessive exercise, though, 
has been shown to reduce testosterone secretion (Hackney, 2005; Vaamonde et al., 2006). In 
endurance and ultra-endurance exercise, hypothalamic and testicular endocrine functions can be 
negatively affected via the suppression of GnRH release (Kujala, Alen and Huhtaniemi, 1990). 
This, however, is related to training volume: runners performing low-to-medium amount of training 
showed either no significant changes in free and total testosterone (Mathur, Toriola and Dada, 
1986; Bagatell and Bremner, 1990; De Souza et al., 1994), or a decrease in free and/or total 
testosterone (Ayers et al., 1985; Griffith et al., 1990; Wheeler et al., 1991); ultra-endurance runners 
training 10-20 hours a week have been shown to be hypogonadal and possess low resting 
testosterone levels (Hackney, Moore and Brownlee, 2005). Regular, moderate exercise has been 
shown to be beneficial to overall health and not detrimental to semen parameters (Vaamonde et 
al., 2006). Moreover, regular exercise is more anabolic than strenuous resistance exercise as it 
increases testosterone levels to a better extent (Viru and Viru, 2003; Grandys et al., 2009). 
According to Rivier and Rivest (1991) and Borer (2003), strenuous exercise stimulates catabolic 
and stress-related hormones including  cortisol, β-endorphins, corticotropin-releasing hormone and 
ACTH, while also decreasing testosterone. Physically active individuals partaking in moderate 
regular exercise were shown by Vaamonde and her colleagues (2012) to have higher testosterone 
and lower cortisol levels than sedentary individuals, which better regulated homeostasis and 
spermatogenesis. They also observed high levels of LH and FSH, as well as higher proportions of 
morphologically normal and progressively motile sperm in these individuals. Conversely, 
individuals taking part in strenuous exercise have lower sperm concentrations, lower motility and 
lower percentages of normal sperm (De Souza et al., 1994; Vaamonde et al., 2006).   
Alcohol consumption 
Binge-drinking (≥ 5 drinks/units at a time) and heavy alcohol consumption (≥ 2 drinks per day) are 
generally considered to be harmful drinking patterns (Stewart et al., 2019). Alcoholic men and 
women as well as laboratory animal models receiving high concentrations of ethanol have evident 
reductions in reproductive function, with high alcohol volumes in males shown to induce 
hypogonadism, testicular and prostatic atrophy, decreased libido, impotence and gynaecomastia 
(Sundaram and Witorsch, 1995). Alcohol-induced testicular dysfunction has been shown to result 
from dysregulation of the HPG axis. Human and animal studies have shown the testes, in 




chorionic gonadotropin (hCG) as subsequent testosterone release is reduced relative to controls 
(Sundaram and Witorsch, 1995). Moderate alcohol consumption (1-2 drinks per day) has not, 
however, been established as a deleterious factor for sperm concentrations (Marinelli et al., 2004; 
Martini et al., 2004; Choi Yoon-Jung Myung Seung-Kwon, 2018), but chronic alcoholism (habitual, 
heavy alcohol consumption for a minimum of 5 days per week for ≥ 1 year) has been observed to 
impair spermatogenesis and reduce testosterone levels (Villalta et al., 1997; Muthusami and 
Chinnaswamy, 2005). Using time-to-pregnancy (the number of contraceptive-free menstrual cycles 
it takes for a couple to conceive) as an outcome, a European study assessed the alcohol 
consumption of 4000 couples and determined time-to-pregnancy to be similar among all alcohol 
intake groups, implying that alcohol had no significant effect on how long a couple will take to 
conceive a child (Olsen et al., 1997). If any detrimental results were observed, however, it was in 
the female partners who conceived ≥ 8 drinks per week. In chronic alcoholics, however, changes in 
sperm count, morphology and viability were observed (Muthusami and Chinnaswamy, 2005). The 
mechanisms of alcohol toxicity within the reproductive system have been investigated: the 
oxidative metabolism of ethanol increases the testicular NADH/NAD+ ratio, thereby causing a 
redox readjustment which reduces the availability of this co-factor to take part in steroid production 
within the testis; long-term administration of ethanol to rats elicits biochemical changes in testicular 
membranes including a decreased glutathione and unsaturated fatty acid content but increased 
saturated fatty acid and malonaldehyde concentration, which predisposes membranes to damage 
via lipid peroxidation; isolated Sertoli cell cultures showed reduced ATP and O2 when exposed to 
alcohol, thereby reducing cell viability, which corroborates reports that ethanol is permeable to the 
blood-testis barrier of Sertoli cells (Sundaram and Witorsch, 1995). Other factors found to affect 
reproductive function in alcoholic men includes the effect of the phytoestrogens identified in the 
non-alcoholic portion of alcoholic beverages which have been found to cause a feminizing effect on 
males. Furthermore, increases in the production of prolactin have been identified as the causative 
factor in gynecomastia in alcoholic males, but this is a controversial finding (Sundaram and 
Witorsch, 1995). 
Psychological stress 
Psychological stress can result from, but also cause, infertility. It has been shown to increase 
serum levels of glucocorticoids and suppress testosterone production within the testes (Whirledge 
and Cidlowski, 2010). Moreover, stress has also been observed to induce both structural and 
meiotic alterations to sperm, thereby making the sperm less capable of locating an oocyte 
(Collodel et al., 2008). On the other hand, couples struggling with fertility can become 






Non-communicable diseases (NCDs) are non-transmissible, non-infectious chronic diseases, 
including cardiovascular diseases, diabetes, cancers and chronic lung diseases (Kim and Oh, 
2013; World Health Organization, 2019), These accounted for 71% (41 million) of global deaths in 
2016, with approximately 31.5 million (over three quarters) disproportionately occurring in low- and 
middle-income countries (World Health Organization, 2018a). NCD mortality has a greater 
probability in Africa, accounting for 22% of NCD deaths worldwide in 2016.  
NCDs largely occur as a result of modifiable lifestyle factors including poor diet, lack of physical 
activity, alcohol abuse and tobacco smoking, which largely result in four physiological changes 
including increased blood glucose, blood pressure, blood lipids and obesity (World Health 
Organization, 2018b). Obesity is both a sequelae of adverse lifestyle factors and a risk factor for 
several NCDs including hypertension, diabetes, stroke, coronary heart disease, cancers and 
obstructive sleep apnea (World Health Organization, 2016a). 
2.4. Obesity 
Obesity, by definition, is an excess of body fat that poses a risk to health. It is assessed clinically 
via the expression of body weight as a function of height – the body mass index (BMI). This is 
calculated by dividing an individual’s weight (in kilograms) by the square of their height (in meters) 
(kg/m2) (World Health Organization, 2018c). BMI is used in adults to delineate overall body fatness 
where a BMI of 18.5 – 24.9 kg/m2 is considered to be normal. Abnormal BMI’s are sub-categorized 
according to severity, where a BMI ≥ 25 kg/m2 is considered to be within the overweight range, 
BMIs ≥ 30 kg/m2 are considered as obesity and BMI ranges ≥ 40 kg/m2 are classified as 
severe/morbid obesity.  
Obesity was largely ignored in the previous millennium (W. P. T. James, 2008). The WHO 
recognised obesity as a disease in 1948 when it was first established but did not recognise it as a 
health problem for a substantial amount of time. When escalations in the number of obese patients 
were noticed in the 1970’s by physicians in the United States and the United Kingdom (UK), 
attempts were made to alert the WHO of this impending public health problem. Obesity was, 
however, regarded as a disease of opulence, easily remedied by the reduction of food intake and 
considered to be irrelevant elsewhere. Furthermore, obesity was not a major concern for the WHO 
as their priority was to deal with malnutrition and the problems of the Third World. By the mid-
1990’s, obesity had become a prominent problem for obesity specialists but was still not being 
taken seriously by most national governments. The International Obesity Task Force (IOTF) was 




establish a new approach on how to deal with the rise in prevalence and to raise awareness. After 
meeting with the WHO, the Organization accepted that more attention was warranted, and it later 
tasked the IOTF with assessing the risk that obesity and other risk factors imposed on premature 
death and disability. Excess adult BMI’s were revealed as part of the top ten risk factors of the 
burden of disease in high, middle- and low-income countries. The WHO and the rest of the world 
have since accepted the role played by obesity in the amplification of many diseases.  
 Epidemiology 
The worldwide prevalence of obesity among children and adults doubled between 1980 and 2015, 
with approximately one third of the world’s population now classified as overweight or obese 
(Afshin et al., 2017; Chooi, Ding and Magkos, 2019). The prevalence is generally higher in women 
than in men, although the highest incidence was recorded in males aged 25-29 years residing in 
low-middle income countries. In children, the obesity prevalence was highest in high-income 
countries, with only a low prevalence amongst boys and girls aged 10-14. In middle and high-
middle income countries, however, this prevalence was highest in boys, but the trend reversed in 
late adolescence. The steepest increase in childhood obesity in the aforementioned time period 
was observed in both girls and boys residing in middle income countries (Afshin et al., 2017). Thus, 
the worldwide prevalence of obesity continues to increase in most countries; although childhood 
obesity was lower than adult obesity over the measured 25-year period, the rate of increase in 
childhood obesity was greater than that of adult obesity.  
Many clinical and epidemiological studies on obesity have been conducted and anthropometric 
measurements are always the basis for the establishment of obesity. Several measurements are 
employed to assess body fat composition, such as height, weight, skinfold thickness, as well as 
chest, waist and hip circumferences. From these measurements, several indices are created to 
establish obesity and body fat content including BMI and the waist-to-hip ratio (WHR) (Bray, 1989). 
The convenient and low-cost nature of these measurements have encouraged their wide use, 
although other, more reproducible measurements may be applied. Magnetic resonance imaging 
(MRI), computerized tomography (CT), total body electrical conductivity, bioelectrical impedance, 
ultrasound and the measurement of body density are some of the more precise measurements that 
may be employed, with the “gold standard” being the assessment of body density by means of 
hydrostatic weighing, from which fat and fat-free mass may be determined (Bray, 1989). Body 
density is determined using Archimedes’ principle of water displacement, where an individual’s 
weight is determined in and out of water; measurements using electrical conductance and 
impedance quantify lean and fat tissue through the ability of electromagnetic waves to pass 
through them, where fat is more resistant to electrical charge (Bray, 1976; Segal et al., 1985; 




and thus quantify regional fat distribution through the ability of fat, muscle and other tissues to 
reflect ultrasonic waves; these permit the measurement of fat thickness in regional locations and 
thus an estimation of intra- and extra-abdominal fat. The availability of these instruments as well as 
the expense of their use, however, is a deterrent and widely limits their use.  
Measuring the WHR provides an indication of regional body fat distribution; the accumulation of fat 
around the waist/abdomen, which indicates a visceral deposition of fat, is referred to as central 
obesity and colloquially as the “apple-shape”, whilst the deposition of fat around the hips/buttocks 
indicates a subcutaneous (beneath the skin) accumulation of fat and is commonly referred to as 
the “pear-shape” (Segula, 2014). Central obesity is classified clinically as a WHR ≥ 0.95 in females 
and ≥ 0.85 in males (Castro et al., 2003). 
Body fatness is a useful predictor of health and provides a guide of an individual’s health risk 
(Bray, 1989). The accumulation of fat, especially in the abdominal region, carries a high risk for 
morbidity and mortality as this increases and individual’s odds of suffering from obesity-related 
diseases including diabetes, cardiovascular disease, strokes and cancer (Vague, 1947). 
Furthermore, the risk of developing these chronic ailments progressively increases at BMIs above 
21 kg/m2 (Wilding, 2001).  
Animal studies which measure the effects of obesity also employ anthropometric measurements to 
assess body fatness within animal models. Many previous studies of obesity in animals generally 
accepted any significant increase in energy content or body weight relative to the control animals 
as obesity (Rothwell and Stock, 1984). More recently, obesity in animals is predominantly 
measured using 2 approaches. The Lee index, a similar measure to BMI, assesses the dimensions 
of the animal; it is defined by the cube root of the animal’s body weight in grams divided by the 
naso-anal length of the animal (cm) multiplied by a thousand [(body weight3/length) x 1000]. The 
second measurement of obesity in animals is the assessment of body fat content, which can be 
quantified by comparing the body weight (or fat) of the obesity group with that of the controls (Hariri 
and Thibault, 2010), or by measuring the adiposity index (Leopoldo et al., 2016). The adiposity 
index (AI) is defined by the total body weight divided by total body fat (epididymal + retroperitoneal 
+ visceral/omental fat) multiplied by a hundred [(total body weight/total body fat) x 100] (Truett et 
al., 1991; Leopoldo et al., 2016). Using the Lee index, obesity can be classified in animals with 
values above 310, whereas the AI and percentage increase in body weight/fat compared to 
controls are less defined (Hariri and Thibault, 2010). Studies using the percentage increase in body 
weight/fat compared to the control group define 10-25% increases in body weight/fat as moderate 
obesity, and >40% increases as severe obesity (Harrold, Williams and Widdowson, 2000; Levin 
and Dunn-Meynell, 2002; Woods et al., 2003; Hariri and Thibault, 2010). The measurement of 




animals (Woods et al., 2003). A universally adopted categorization of animal obesity according to 
the AI has not been established although a study by Leopoldo et al. (2016) has attempted to do so 
by means of a cluster analysis in an experiment using animals fed control or high fat diets. At the 
end of the feeding protocol, 84 animals were stratified according to their AI (mean ± SD) into 
normal (≤ 4.36 ± 0.49), overweight (≤ 5.96 ± 0.60) and obese (≤ 8.78 ± 1.62) categories, with the 
obese group showing significantly higher total body fat and AIs compared to the overweight group. 
The animals on the high fat diet showed obesity indicators that resemble human obesity and its 
comorbidities including hyperinsulinaemia, hyperlipidaemia and high levels of total cholesterol, 
triglycerides and glucose. The classification of animal obesity by Leopoldo can be seen as a 
potential means of characterising degrees of adiposity in animals that represents obesity in 
humans. Furthermore, experiments presently stratify experimental animals, including rats, into 
obesity prone or resistant categories based on their body weight/fat gain at the end of the 
experimental period (Hariri and Thibault, 2010; Leopoldo et al., 2016). In the exposure of study 
animals to obesogenic diets ad libitum, the sensitive (obesity prone) animals become obese while 
others grow normally and resist the obesogenic effects of the diet (obesity resistant) (Levin and 
Dunn-Meynell, 2002).  
 Control of body weight 
To understand how the body controls food intake and how the dysregulation of this system can 
lead to obesity in humans and animals, the control of body weight will be reviewed. This literature 
also provides a background for experimental models used to induce obesity. 
The brain is central to the regulation of food intake and energy balance. Peptides released by 
several tissues and organisms within the body such as adipose tissue (Schuster, 2009), gut 
microbiota (Tehrani et al., 2012) and the gastrointestinal tract (Griffen et al., 1981) stimulate 
specific regions of the brain, especially the hypothalamus, which have an abundance of receptors 
responsible for the central pathways which regulate the energy balance. Approximately 40 
neurotransmitters have been implicated in the control of body weight, which can be categorized as 
those involved in stimulating the intake of food while decreasing energy expenditure (orexigenic) 
and those which decrease food intake while increasing energy expenditure (anorexigenic) (Wilding, 
Widdowson and Williams, 1997). The control of body weight is thus a highly precise endeavour 
which makes use of several homeostatic mechanisms. The combined goal of these mechanisms is 
to control the energy balance, thereby minimizing excessive loss or gain in body weight (Martinez, 
2000).  
Adipose tissue, or fat, is the principle storage site for energy. It has the ability to buffer energy 




Fat mass is dependent on the number of adipocytes present in the body and the independent size 
of each adipocyte. It can increase through the differentiation of preadipocytes into adipocytes and 
via increased lipid deposition into existing adipocytes (Knittle et al., 1979; Ailhaud, 1982). Beyond 
its function of storing excess energy, adipose tissue plays a pivotal role in numerous homeostatic 
processes such as appetite regulation, energy expenditure and glucose regulation. It is also 
involved in regulating the immune response, thyroid gland function, reproductive processes and 
blood clotting via the secretion of numerous hormones. Furthermore, it is an active endocrine 
organ responsible for the secretion of a variety of adipokines (cytokines secreted by adipose 
tissue) including leptin, adiponectin, free fatty acids, angiotensinogen, complement factor 3, adipsin 
and the important inflammatory mediators tumour necrosis factor alpha (TNF-α) and interleukin-6 
(IL-6) (Kissebah et al., 1982). The dysregulation of these processes is linked to many obesity-
related disorders such as cardiovascular disease, stroke and lipid disorders (Schuster, 2009).  
Fat is distributed and stored in different regions within the body. The two major storage depots are 
beneath the skin (subcutaneous – superficial and deep) and surrounding intra-abdominal organs 
(visceral), with the superficial subcutaneous layer believed to be the primary adipose tissue 
storage compartment (Sniderman et al., 2007). The superficial and deep subcutaneous layers are 
separated by facia and differ in the organization of their fat lobules, where the superficial 
subcutaneous compartment displays well organized, tightly packed lobules compared to the larger, 
irregular and less organized lobules observed in the deep subcutaneous compartment 
(Goodpaster et al., 1997; Misra, 1997; Kelley et al., 2000; Smith et al., 2001). Visceral adipose 
tissue has more blood supply (more vascularized), with less defined lobules; it is the smallest of 
the 3 compartments but is substantially more metabolically active. The expansion of these fat 
depots brings about different disease risks. Expansion of the deep subcutaneous and visceral 
adipose tissue has been shown to have adverse metabolic outcomes as this has been linked to 
dyslipidaemia (high mounts of blood triglycerides and low-density lipoproteins, and reduced levels 
of high-density lipoproteins) and vascular disease (Abate et al., 1995; Tchernof et al., 1996).   
Energy expenditure comprises of 3 essential elements: the basal metabolic rate (BMR), dietary 
thermogenesis and energy utilization during physical activity (Bray, 1987). BMR is the energy 
required to maintain normal metabolism in all cells during the resting state; it accounts for 70% of 
total body energy expenditure and is influenced by age, gender, weight, climate and genetics 
(Bray, 1976). BMR is related most accurately to fat-free body mass; it is also closely related to total 
body weight and skin surface area as heat is primarily lost via dissipation through the skin. Higher 
metabolic rates are thus correlated with increased body weight and higher percentages of lean 
body mass, as observed in obese and lean males (Bray, 1989). On the other hand, low resting 




reduced physical activity and a higher likelihood of becoming obese (Ravussin et al., 1988). 
Dietary thermogenesis is the energy required to digest, absorb and store a meal. The metabolic 
rate increases after food consumption and remains elevated for several hours thereafter. During 
this process, 10-15% of the total caloric value of the meal is expensed in order to digest and 
absorb the meal and store its nutrients. This increased in metabolic rate has been attributed to the 
increased activity of the sympathetic nervous system (Glick, Teague and Bray, 1981). Physical 
activity accounts for variable amounts of energy expenditure. Experiments on energy expenditure 
during physical activity, for instance in cycling, assess the effectiveness of energy usage by 
exercising muscle and have found that approximately 30% of total body energy is required by 
muscle to turn a flywheel on an exercise bike during cycling (Bray, 1983). Obese individuals have, 
however, been observed to expend more energy than leaner individuals while performing the same 
task, i.e. walking the same distance (Wilding, 2006). A positive energy balance where energy 
intake is greater than expenditure, results in increased energy storage in the form of fat. A 
continued positive balance is associated with an increase in body weight and thus and increased 
tendency towards obesity (Ravussin, 2005). 
Leptin is a hormone predominantly secreted by adipocytes (Zhang et al., 1994; Halaas et al., 
1995). The serum concentration of this hormone is proportional to an individual’s adipose tissue 
mass; its secretion results in the activation of hypothalamic receptors responsible for reduced food 
intake and increased energy expenditure (Considine et al., 1996; Bray and York, 1997). It is 
therefore viewed as the “switch” which signals a change from the fed to the starved state (Ahlma et 
al., 1996). It is produced by the Ob (obesity) gene, which has a well-conserved sequence between 
different species including human, mice and rats (Friedman et al., 1991; Wang et al., 1996). Leptin 
secretion is controlled by hormones such as insulin (Houseknecht et al., 1998) where it stimulates 
expression of the leptin gene in adipocytes, thereby increasing leptin levels in blood. The release 
of leptin results in its binding to leptin receptors predominantly concentrated within the central 
nervous system, where the main receptor isoform is highly expressed within the hypothalamus in a 
region central to appetite control (Houseknecht and Portocarrero, 1998). Other tissues where 
shorter isoforms of the leptin receptor have been located include the liver, kidney, pancreatic β-
cells, the lung, muscle (Löllmann et al., 1997) and almost all tissues responsible for the regulation 
of energy expenditure (Houseknecht and Portocarrero, 1998). This can explain the direct effect 
that the release of this hormone can have on the respective organ functions (Cohen, Novick and 
Rubinstein, 1996; Muoio et al., 1997) including the reproductive system. Leptin reduces food 
intake, stimulates thermogenesis (Collins et al., 1996) and reduces the size of adipocyte tissue due 
to the mobilization of lipid stores and apoptosis of adipocytes; obese people have been shown to 




concentrations of this hormone, but they have a lack of leptin receptor activation, indicating leptin 
resistance. Their energy intake and expenditure are thus, in many cases, dysregulated.  
The binding of leptin to its hypothalamic receptors affects the release of several neuropeptides; 
anorexigenic neuropeptides such as pro-opiomelanocortin (POMC) and cocaine- and 
amphetamine-regulated transcript (CART) are synthesized whilst orexigenic neuropeptides agouti-
related peptide (AgRP) and neuropeptide Y (NPY) are inhibited, thereby decreasing food intake 
and increasing energy expenditure (Anand and Brobeck, 1951). Leptin also inhibits neuropeptides 
melanin-concentrating hormone (MCH) and orexin, both released from the lateral hypothalamus, 
resulting in reduced food intake (Kishi and Elmquist, 2005). The leptin-induced synthesis of POMC 
results in the production of peptides classified as melanocortins (Pantel and Cone, 2013), which 
are formed by the cleavage of POMC. A prominent and important melanocortin is alpha-
melanocyte-stimulating hormone (α-MSH), an important regulator of body weight, food intake, 
glucose homeostasis, and an essential mediator of numerous biological actions of leptin (Cone, 
2006). It acts by stimulating the melanocortin-4 receptor (MC4R) which is widely distributed with 
the central nervous system (CNS) (Mountjoy et al., 1994) and the peripheral nervous system 
(Gautron et al., 2010). Stimulation of this receptor results in activation of the sympathetic nervous 
system, activating sympathetic tone in brown adipose tissue (BAT), muscle, and kidney, for 
instance, (Haynes et al., 1999) thereby stimulating thermogenic metabolism and thus energy 
expenditure (Egawa, Yoshimatsu and Bray, 1991). The MC4R is inhibited by AgRP where 
overexpression of AgRP has been shown to lead to a drastic increase in hyperphagia and thus 
obesity (Ollmann et al., 1997). During the fasting state, leptin levels are reduced, thereby 
stimulating AgRP and NPY, resulting in increased food intake and reduced energy usage, which is 
further illustrated by increases insulin and glucocorticoids (Spiegelman and Flier, 1996; Flier, 1998; 
Friedman and Halaas, 1998; Ahima et al., 1999; Cowley et al., 2001). Ghrelin, a hormone released 
from the gut and also synthesized in the hypothalamus, works in concert with leptin (Kojima et al., 
1999; Pusztai et al., 2008). Its levels increase during starvation and thus acts as a signal for 
hunger, with its levels being highest just prior to meals (Cummings et al., 2001, 2002). Ghrelin is 
secreted to increase appetite and reduce energy usage, while leptin is simultaneously reduced so 
as to not antagonize the actions of ghrelin (Saper, Chou and Elmquist, 2002). The stimulation of 
ghrelin receptors in the hypothalamus stimulates NPY production (Luckman, Rosenzweig and 
Dickson, 1999; Willesen, Kristensen and Rømer, 1999). The stimulation or inhibition of 
anorexigenic and orexigenic neuropeptides from the hypothalamus thereafter affects the release of 
numerous hormones from the pituitary, and influence the adrenal, thyroid and reproductive axes, 
thereby affecting energy use and production (Swerdloff, Batt and Bray, 1976; Ahlma et al., 1996; 
Légràdi et al., 1997; Guo et al., 2004). It is therefore essential that energy is regulated and food 




 Causes of obesity 
Obesity is an unintended consequence of modernization (Martinez, 2000) where economic, social 
and technological advances (Pi-Sunyer, 2002) have resulted in urbanisation and reduced physical 
activity (Walker, Adam and Walker, 2001). Diets have transitioned from natural, organic foods to 
refined, high fat and high sugar alternatives, leading to a nutrition transition parallel to the observed 
economic growth (Alaba and Chola, 2014). These changes have led to a rapid increase in the 
prevalence of obesity (Martinez, 2000).  
As a historically Western disease, obesity was largely localized to developed countries until recent 
decades where middle- and low income-countries began to experience rates comparable to those 
of high income countries. The rapid economic expansion and modernization experienced by middle 
and low income countries, as well as changing diets, are the greatest contributors to this epidemic 
(Alaba and Chola, 2014) as more and more of these countries adopt Western diets and lifestyles. 
Close to 30% of the populations within middle income countries are classified as overweight or 
obese, with South Africa (SA) having the highest prevalence in sub-Saharan Africa, where the 
prevalence was reported to be 27% in adults over the age of 18 years in 2016 (World Health 
Organization, 2018b).  
While the predominant causes of the energy imbalance seen in obesity are inadequate physical 
activity and unhealthy diets, not all those who are exposed to these unfavourable behaviours will 
develop the disease. Obesity is a multifactorial disease and many underlying factors 
disproportionately predispose subsects of the population to its development, and several of these 
are non-modifiable factors including age, gender, race, and genetics. These will be discussed 
below. 
 Genetics 
Family studies together with twin and adoption studies have revealed a high heritability of obesity, 
where the offspring of obese individuals have a 40-70% probability of inheriting the condition 
(Apalasamy and Mohamed, 2015). The BMI of adoptees has been shown to correlate with that of 
their birth parents and not with that of their adoptive parents. Obesity amongst twins has been 
shown to range between 0.6 and 0.9, with only slightly reduced levels observed in twins raised 
apart versus those raised together (Stunkard et al., 1986). Thus, an individual’s risk of being obese 
are amplified if any of their relatives are obese. The mechanisms of this heritability have been 
examined using in vivo (animal) and in vitro (primary cell culture, three-dimensional cell culture and 
co-culture) models, which have revealed genes, growth factors and hormones that are instrumental 




(Apalasamy and Mohamed, 2015). Monogenetic obesity (obesity caused by a mutation in a single 
gene), as well as polygenic obesity (the interaction of environmental and genetic factors) 
investigated using both in vivo and in vitro models have revealed genes which are mutated in 
obese mice. These studies have also assessed the role of environmental factors in the body’s 
responses to high fat or high sugar diets, and the epigenetic (heritable non-genetic changes in 
DNA which can affect gene expression/activity) changes elicited by obesogenic environments 
(Speakman et al., 2008; National Institutes of Health National Library of Medicine, 2019). Several 
genes found to partake in the control of central and peripheral pathways of energy intake and 
expenditure in the aforementioned models have subsequently been analysed in humans, with the 
most recent version of the Gene obesity map (2006) implicating over 600 genetic contributions 
(genes, chromosomal regions and genetic markers) to the development of obesity and body weight 
regulation.  
The mutations resulting in monogenetic obesity have a large effect size; they result in severe 
obesity of early onset, with hyperphagia as a principal feature accompanied by numerous 
endocrine abnormalities (Clement, 2006). There are several predominant genes whose mutations 
give rise to monogenetic obesity, namely the leptin (LEP), leptin receptor (LEPR), proprotein 
convertase 1 (PSCK1), POMC, MC4R, single-minded homology 1 (SIM1), brain-derived 
neurotrophic factor (BDNF) and the neurotrophic tyrosine receptor kinase 2 (NTRK2) gene 
(Montague et al., 1997; Holder, Butte and Zinn, 2000; Yeo et al., 2004; Farooqi et al., 2006, 2007; 
Gray et al., 2006; Dubern et al., 2007; Benzinou et al., 2008). The discovery and understanding of 
these gene mutations were facilitated by animal models, barring SIM1 which was discovered by 
means of in vitro cell lines (Holder, Butte and Zinn, 2000). The majority of the aforementioned 
genes produce proteins which are critical to the leptin-melanocortin pathway, which positions this 
pathway as an essential regulator of energy homeostasis (Mutch and Clément, 2006). The 
knowledge of these gene mutations has enabled a better understanding of the biological pathways 
of the disease. Mutations in the LEP gene lead to obesity as abnormal versions of this protein are 
produced, or its production is impaired. For instance, a frameshift mutation in the leptin gene of two 
Pakistani cousins resulted in leptin deficiency as this mutation led to the production of a truncated 
leptin protein sequence and therefore a lack of leptin secretion (Farooqi, 2005). This deficiency 
resulted in the typical characteristics of monogenetic obesity including hyperphagia and increased 
insulin levels, which stimulate obesity. Furthermore, in a study assessing patients with mutations in 
the leptin receptor gene, the phenotypic expression of obesity was similar to those with leptin 
deficiency, exhibiting rapid weight gain in early life, severe hyperphagia, normal resting metabolic 
rates, basal temperature, cortisol and glucose levels, but high plasma leptin and insulin levels 
(Zurbano et al., 2004; Farooqi, 2005). Mutations in the LEP gene in mice has been shown to result 




(Houseknecht and Portocarrero, 1998). While familial transmission of obesity is high and clear 
genetic contributions at the level of overall obesity have been established through such studies, 
these mutations, however, only account for about 6-11% of obesity cases within a population 
(Tchernof and Després, 2013). Thus DNA alone cannot explain the high heritability rates of 
obesity, which has necessitated the observance of gene-gene and gene-environment interactions 
in order for a broader understanding of obesity genetics to be acquired.  
Polygenic obesity is a more common form of obesity, with the obese phenotype stemming from 
numerous genes making minor contributions towards its development (Glazier, Nadeau and 
Aitman, 2002). These genetic contributions are common in the general population and make an 
individual susceptible to obesity; it is the interplay between this genetic susceptibility and the 
individual’s lifestyle and environment which determine whether obesity will develop (Hinney and 
Hebebrand, 2008). Obesogenic environmental factors are those which stimulate energy 
consumption above energy expenditure such as lack of physical activity and food abundance 
(Mutch and Clément, 2006). These factors together with individual genetic susceptibility lead to the 
typical form of obesity that is rampant in society today. Genetic variances in humans determine an 
individual’s energy storage and expenditure, lipid and glucose metabolism and the development of 
their adipose tissue (Rankinen et al., 2006); these contribute to whether individuals exposed to an 
identical obesogenic environment will develop obesity (Martínez-Hernández et al., 2007). Gene-
environment interactions arise when environmental changes can give rise to a particular 
phenotype, i.e. obesity, depending on the genotype or genetic susceptibility of an individual 
(Martinez, 2000). Two established genetic variants which predispose individuals to obesity include 
the MC4R and FTO (fat mass and obesity associated) genes (Herbert et al., 2006; Frayling et al., 
2007). Initially observed in rodent studies showing increased body weight and obesity in 
homozygous and heterozygous knockout mice respectively, human studies of the MC4R gene 
were initially carried out where population screening for mutations yielded a small number of 
different mutations, which were found in obese individuals only (Vaisse et al., 1998; Hinney et al., 
1999; Yeo et al., 2003). Further analyses uncovered numerous but infrequent mutations of the 
MC4R gene in humans, with the majority of the mutations observed in individuals with extreme 
obesity (Hinney et al., 2006). Large population screenings for mutations of the MC4R gene and 
subsequent meta-analyses uncovered a polygenic mode of inheritance for the gene due to its 
small effect size and the environmental dependence of the phenotypic expression of this mutation 
(Geller et al., 2004). Most cases of MC4R mutations have been shown to either significantly 
predispose individuals to obesity or provide them with a minor protective effect against it (Hinney 
and Hebebrand, 2008). Thus, different individuals have a genetic predisposition towards obesity 
(Farooqi, 2005) but such genetic differences only infer the risk of developing obesity and not 




A number of clinical syndromes arising from genetic defects and chromosomal abnormalities have 
obesity as a prominent feature. Following the definition of a syndrome, which is a “collection of 
signs and symptoms which frequently occur together” (Kaur et al., 2017), syndromic obesity was 
coined to represent the presence of obesity along with other frequently accompanying clinical 
symptoms which frequently includes developmental abnormalities, dysmorphic features and mental 
retardation (Bell, Walley and Froguel, 2005). Approximately 30 such syndromes exist and most of 
these arise from the mutation of a single gene, where at least 4 are known to elicit hyperphagia in 
addition to hypothalamic dysfunction (Lunsky and Meyre, 2019). Of the known obesity syndromes, 
Prader-Willi, Bardet–Biedl and Alström syndrome are the most frequently occurring (Chung, 2012). 
Prader-Willi syndrome (PWS) is characterised by hyperphagia, endocrine abnormalities, early-
onset obesity, mental retardation, short stature and hypogonadotropic hypogonadism (Prader, 
1956; Muscogiuri et al., 2019). It occurs in one out of 10,000 to 30,000 individuals and is the result 
of the loss of expression of a paternally inherited gene on chromosome 15 (specifically 15q11-q13) 
(Angulo, Butler and Cataletto, 2015). PWS has also been shown to affect fertility. Although the 
mechanisms of this disease are not fully understood, patience with PWS show changes in food 
intake and energy expenditure which are ascribed to dysfunctions within the satiety centre of the 
hypothalamus, as well as the hormonal pathways that it is linked to, resulting in hormone 
deficiencies (Burman, Ritzén and Lindgren, 2001; Butler et al., 2007). Syndromic obesity data 
seems to suggest specific neuroanatomical and functional aberrations, specifically of the 
hypothalamus, which occur as a result of genetic abnormalities that lead to changes in food intake 
as the predominant mechanism of obesity development (Chung, 2012).   
 Ethnicity 
The distribution of adipose tissue within the body varies between different ethnic groups (Tchernof 
and Després, 2013). Some ethnic groups are predisposed to store excess adipose tissue 
subcutaneously while others are more prone to a visceral accumulation of fat (Lovejoy et al., 
1996). An American study assessing ethnic differences in obesity by oversampling minority groups 
such as African-Americans and Hispanics found these groups to have a higher risk of obesity 
compared to white people of European decent (McTigue, Garrett and Popkin, 2002), where the 
onset of obesity occurred 2 times earlier for African-Americans and 1.5 times earlier for Hispanics 
compared to Whites. A wider meta-analysis of ethnic differences in body fatness conducted by 
Deurenberg et al. (1998) revealed significant differences in BMI among African-Americans, Whites, 
Ethiopians, Polynesians, Chinese, Thais and Indonesians of the same age, gender and body fat 
content. Asian populations have been shown to have lower BMI values at a higher body fat content 
in comparison to Whites, which could be attributed to ethnic differences in body fat composition 




These differences in body fatness among ethnicities necessitated a revision of the WHO BMI 
threshold applied in the classification of obesity for different age groups (children and adults), 
especially for Chinese, South Asians and Aboriginals as lower BMI values were shown to already 
exhibit high levels of blood glucose, hypertension and dyslipidaemia in these ethnic groups 
compared to those of European descent (Razak et al., 2007).  
Ethnic groups can also be stratified according to their tendency to store fat in visceral fat depots. 
White people have significantly more visceral adipose tissue than African-Americans at 
comparable levels of total adiposity, while Asians and Indian-Asians are even more susceptible to 
visceral obesity than other ethnic groups despite having lower total adiposity levels (Kadowaki et 
al., 2006; Lear et al., 2009; Misra and Khurana, 2009). Attempts to explain the physiological 
mechanisms behind these differences have led to genetic and epigenetic differences being 
proposed as the major determinants of body fat deposition (Albu et al., 1997; Després et al., 2000; 
Misra and Khurana, 2009), although these mechanisms need further clarification. Sniderman et al. 
(2007) have proposed ethnic differences in the development of the superficial adipose tissue 
compartment to be an underlying mechanism for the propensity towards visceral obesity. These 
authors have hypothesized the primary adipose tissue compartment of South Asians to be less 
developed compared to Whites and have thus a reduced capacity to store adipose tissue. South 
Asians make earlier use of their secondary storage compartments, the deep subcutaneous and 
visceral adipose tissue, making them more prone to the development of visceral obesity. This 
hypothesis, which Sniderman and colleagues (2007) have termed “the adipose tissue overflow 
hypothesis” is also proposed by Sniderman to possibly explain why Whites are less prone to fat 
storage in visceral fat depots and are thus more protected against the complications of visceral 
obesity, such as metabolic syndrome and diabetes, compared to other ethnic groups including 
South Asians, native Americans, Africans and populations of the Middle East (Forouhi, 2006). A 
multi-ethnic cohort study assessing the propensity for intra-abdominal and hepatic adiposity in 5 
different ethnic groups showed, however, that African-Americans had the lowest relative amounts 
of visceral fat, Japanese-Americans had the highest, and the other races comprising of European 
(white), Latino and Native Hawaiian ancestry were intermediate (Lim et al., 2019). This is 
supported by several other studies (Gillum, 1999; Carroll et al., 2008; Kelly, Wilson and 
Heymsfield, 2009; Heo et al., 2013; Barreira et al., 2014; Eastwood et al., 2015). Therefore, in 
most studies, South Asians have more visceral adipose tissue than whites, whereas those of 
African descent have less; the amount of visceral adiposity is thus unlikely to be an explanation for 





Body fat distribution varies amongst human males and females (Pond, 1992). Females have a 
higher body fat percentage and a different body distribution pattern to males (Karastergiou et al., 
2012). Males have a tendency to store excess fat in the upper body region including the 
trunk/abdomen, whereas women have a propensity to store fat in the lower body such as the hips 
and thighs (gluteofemoral); these are classified as android (male) and gynoid (female) fat 
distributions, respectively (Vague, 1947; Krotkiewski et al., 1983; Pond, 1992). Krotkiewski et al. 
(1983) hypothesized sex hormones to be the regulating factors behind these gender differences in 
fat deposition. They further added that males have possibly more fat cells in the trunk region while 
females have more cells in the gluteofemoral region. The hormone hypothesis has been shown to 
have some clout in body fat distribution due to observation of males and females undergoing 
hormone therapy for the purpose of gender reassignment. In female-to-male transsexuals 
administering intramuscular testosterone injections, a shift in fat deposition from the gynoid to the 
android distribution was observed. Similarly, male-to-female reassignment via estrogen injections 
significantly increased subcutaneous fat deposition in the thigh and hip region in transitioning 
males (Elbers et al., 1997, 1999, 2003). An android fat distribution and high WHR has been 
observed in females with high testosterone levels (Evans, Barth and Burke, 1988; Wild, 1995). 
Studies have observed visceral adipose tissue to accumulate in males as total body fat increases, 
whereas the gynoid pattern of deposition is less dependent on total body fat. Even correcting for 
body fat mass has shown a lower visceral adipose tissue accumulation in females and, for any 
given increase in waist circumference, males displayed a higher accumulation of visceral fat tissue 
than females (Seidell et al., 1988; Ross et al., 1992; Pouliot et al., 1994; Kuk et al., 2005). 
Furthermore, for the same BMI, women generally present with a ± 10% higher body fat content 
than males (Womersley and Durnin, 1977; Jackson et al., 2002). 
 Age 
Adults gain weight as they age (Heymsfield et al., 2016). In young men and women, and women of 
middle age, excess energy is predominantly stored in the subcutaneous adipose tissue (Enzi et al., 
1986). This preferential storage changes with age where fat storage begins to accumulate within 
visceral adipose tissue, with increased visceral fat accumulation observed in both older men and 
postmenopausal women (Kotani et al., 1994). The Baltimore Longitudinal Study of Aging also 
reported an increase in the WHR with age in both men and women (Shimokata et al., 1989), which 
can be attributed to an abdominal adipose tissue accumulation, as fat is more likely to amass in the 
abdominal region with age as opposed to the gluteofemoral region (Lanska et al., 1985). 




endogenous estrogens, a protection that is diminished once menopause begins (Godsland et al., 
1987; Scheffer et al., 1997).  
2.5. Effect of Obesity on the Male Reproductive System 
Urbanization and increased economic activity have redefined the occupations that men partake in, 
with professional, managerial and administrative careers now dominating over more physical 
employment (Alaba and Chola, 2014). This has encouraged sedentary behaviour, which is 
contributing significantly to the rise in obesity amongst males. In low- and middle-income countries 
such as South Africa, obesity is more prevalent in higher socioeconomic groups (Steyn and 
Damasceno, 2006), where wealthier individuals are more likely to be obese, and the obesity risk is 
more pronounced in men. However, as countries transition from middle- to high-income, the higher 
prevalence in obesity is observed in poorer socioeconomic groups (Sobal and Stunkard, 1989; 
Steyn and Damasceno, 2006). Cultural perceptions are also implicated in the prevalence of obesity 
as a larger body size, particularly in black South Africans, is seen as a sign of health, prosperity 
and wealth which has spurred on the obesity prevalence, especially in wealthy men (Mvo, 1999; 
Puoane et al., 2002; Alaba and Chola, 2014).  
Obesity has been reported to cause male infertility, as reductions in reproductive potential have 
been observed in countries with high obesity prevalence (Carlsen et al, 1992; Du Plessis, Cabler, 
McAlister, Sabanegh & Agarwal, 2010). The female contribution to infertility has long been 
researched as couple infertility is largely viewed as a female issue. It is only in the recent decades 
that the contribution of males has been explored, with obesity being researched as one of its more 
modern etiological factors (Du Plessis et al., 2010). One study published in 2005 studied couples 
presenting themselves for fertility treatment and observed the obese male patients to have a three-
fold higher likelihood of having poor semen quality (Magnusdottir et al., 2005), and higher BMIs 
further correlated with reduced sperm concentration. Other studies assessing couples undergoing 
assisted reproductive treatment (ART) have reported obese male partners to contribute to reduced 
pregnancy rates, loss of pregnancy and an increased time to pregnancy (Magnusdottir et al., 2005; 
Ramlau-Hansen et al., 2007; Keltz et al., 2010; Sermondade et al., 2013).  
Perhaps the most basic measurement of infertility is the analysis of microscopic sperm parameters 
including sperm motility, viability, concentration (count) and sperm morphology (World Health 
Organization, 2010). Studies on the effect of obesity on male fertility have yielded variable results 
regarding the extent to which these parameters are altered. An analysis of semen quality in relation 
to BMI amongst a cohort of young males in a general Denmark population showed reduced total 




with normal BMIs (Jensen et al., 2004). In addition, these authors observed no changes in the 
percentage of motile sperm between normal and obese individuals.  
In a Chinese study of fertile males from their general population, Qin et al. (2007) noted reduced 
sperm motility in overweight and obese males, but the association lost statistical significance when 
the study adjusted for age, existing reproductive disorders, lifestyle factors, etc., thus finding no 
change in sperm motility. They also found no association between semen volume and changes in 
BMI. A Hungarian assessment of normozoospermic (semen samples with normal sperm 
concentration, motility and morphology) males attending fertility treatment at a clinic reported 
reduced sperm concentrations in the obese patients compared to men with a normal BMI, a 
change observed to worsen with age (Koloszár et al., 2005). In contrast, an assessment of 
subfertile men with oligozoospermia (low sperm concentration) presenting for ART within the same 
country observed males with BMIs > 25 kg/m2 to have reduced sperm concentrations compared to 
men with lower BMIs (Fejes et al., 2006).  
Hammoud et al. (2008) performed a retrospective analysis of American couples undergoing fertility 
treatment and observed higher incidences of oligozoospermia with increasing BMI as well as a low 
progressive sperm concentration in males with higher BMIs. A recent study performed in India 
assessing sperm quality in obese males found obesity to be related to lower sperm volume, 
concentration, motility and morphology, as well as a higher likelihood of having oligozoospermia 
and asthenozoospermia (low number of progressively motile sperm) compared to males with lower 
BMIs  
Animal studies have also been performed to assess the relationship between obesity and male 
fertility, with equally variable results. In a study of diet-induced obesity by Bakos et al. (2011a), six-
week-old male mice were placed on a high fat diet (HFD) in order for their sperm parameters and 
other molecular parameters to be assessed. These authors noted no changes in the sperm 
concentrations in the obese mice compared to lean controls, although the percentage of motile 
sperm declined in the HFD group. Similarly, Ghanayem and his co-workers (2010) corroborated 
this finding by observing a reduced motility in their obese mice. Rat studies have also observed 
similar results, where motility in the obese rats examined by Jia and colleagues (2018) was 
reduced compared to controls, along with higher amounts of abnormal sperm. The change was 
supported in another rat study analysing the alteration in sperm function within obese male rats 
where a higher proportion of sperm head defects were observed in obese rats compared to their 
leaner controls (Vigueras-Villaseñor et al., 2011). A longer term intervention where rats were given 
a HFD for 15, 30 and 45 weeks showed normal sperm counts but decreases in progressively 




Several mechanisms have been implicated in the reduction of fertility within obese subjects 
including perturbations of the HPG axis, disruptions in endocrine regulation, oxidative stress, 
genetic inheritance and alterations, the additive effects of environmental toxins and the physical 
changes and strain brought on by increases in body weight, amongst others. These will be 
discussed in brief below. 
 Dysregulation of the HPG axis 
The most important cause of infertility is the failure of spermatogenesis. This is a process that is 
tightly controlled by numerous proteins, most essentially the reproductive hormones. 
Spermatogenesis is largely controlled by the HPG axis, which early studies by Glass et al. (1977), 
Amatruda et al. (1978) and Strain et al. (1982) observed to be affected by obesity. These studies 
showed obese males to have normal LH, but reduced total testosterone and sex hormone binding 
globulin (SHBG) levels and thus compromising spermatogenesis. Later studies (Zumoff et al., 
1990; Vermeulen, Kaufman and Giagulli, 1996) were further able to show correlations between 
BMI, testosterone and SHBG where men with higher BMIs exhibited lower testosterone and SHBG 
levels. Data from studies analysing free testosterone levels in obese males has been discordant as 
the use of BMI as a variable differed in the respective studies. Using different categories of BMI 
namely obese (BMI ≥ 30-40) and morbid obesity (BMI ≥ 40), Giagulli and co-workers (1994) 
observed obese males to have normal levels of free testosterone within their plasma in contrast to 
morbidly obese males who had reduced free testosterone. Furthermore, LH levels remained 
normal in the obese males whereas LH secretion and LH amplitude in the morbidly obese were 
reduced. This decrease in LH amplitude was also observed by Vermeulen (1996). Levels of 
testosterone are affected by the increased adipose tissue observed within obese males. Adipose 
tissue releases an enzyme called aromatase which converts testosterone into estradiol in a 
process called aromatization (Yoshio et al., 1987); this subsequently results in a negative feedback 
loop where the HPG axis is inhibited (Schneider et al., 1979; Kley et al., 1980). The Massachusetts 
Male Aging Study, a longitudinal study of 942 males aged 40-70, corroborated earlier findings of 
reduced SHBG as well as total and free testosterone, adding that these reductions become more 
sever with age (Derby et al., 2006).  
Leptin released from white adipose tissue has been shown by numerous studies to affect the HPG 
axis. It stimulates GnRH release from the hypothalamus and LH and FSH from the anterior 
pituitary (Yu et al., 1997). It was also observed to be a direct regulator of testosterone production in 
the testes via the stimulation of leptin receptors on the Leydig cells (Ishikawa et al., 2007). In 
obesity, leptin resistance predominates, resulting in high plasma levels of leptin. This, in turn, 
causes reduced testosterone production, which was observed by Isidori et al. (1999) to show a 




 Disruptions in the Endocrine System 
In line with the findings by Vague (1947), adipose tissue is not only a storage site for excess fat but 
an active endocrine organ which affects lipid and glucose metabolism. In addition to its release of 
endocrine factors such as leptin and adiponectin, and inflammatory mediators such as TNFα and 
interleukins, adipose tissue is the site of production for numerous autocrine, paracrine and 
neuroendocrine molecules responsible for energy regulation, the oxidation of lipids, immune 
functions and vascular function (La Merrill et al., 2013). 
Excess adipose tissue is associated with numerous perturbations of the endocrine system, such as 
changes in hormone and protein concentrations via alterations in their secretion, metabolism, 
transport and their ability to act on their target tissues (Kahn and Flier, 2000; Pinkney and 
Kopelman, 2004). Whether the changes in these hormones and proteins precede or result from 
excess adipose accumulation is still under debate. It was previously believed that these changes 
were brought on by obesity and alleviated through weight loss, but further evidence has implicated 
these endocrine changes as part of the underlying mechanism of obesity development, with these 
preceding the onset of obesity and its accompanying metabolic disorders (Wajchenberg, 2000).  
Obesity affects lipid and glucose metabolism differentially based on the amount and distribution of 
adipose tissue within the body. The “android” pattern of fat distribution is correlated with increased 
mortality as well as numerous disorders including diabetes, hypertension atherosclerosis and 
stroke to a higher extent than the “gynoid” pattern (Lapidus et al., 1984; Larsson et al., 1984; 
Ducimetiere, Richard and Cambien, 1986; Donahue et al., 1987). Subsequent studies have more 
clearly ascribed these detrimental changes to accumulations of fat within the intra-abdominal fat 
depots (omental, mesenteric and retroperitoneal fat) with the aid of CT scans; fat accumulation in 
this region has been correlated with hyperinsulinemia, glucose intolerance, alterations in plasma 
lipoprotein lipid (dyslipidaemia) and cholesterol concentrations due to its high metabolic activity 
and easier drainage of secreted factors into systemic circulation (Despres et al., 1989; Park et al., 
1991; Pouliot et al., 1992). Further to this, the endocrine abnormalities observed in obesity 
involving growth hormone, steroid hormones and insulin was already conceptualized more than a 
decade ago to stimulate abdominal fat accumulation (Björntorp, 1991, 1995). The concept of 
visceral fat being more stimulatory of insulin insensitivity than subcutaneous fat has, however, 
been challenged. Using MRI and CT, Abate et al. (1995) and Goodpaster et al. (1997) were able to 
show that subcutaneous fat correlated at least as strongly to insulin insensitivity as visceral fat. 
Furthermore, a review of 23 published manuscripts on weight loss interventions by Smith and 
Zachwieja (1999) highlighted that individuals with larger visceral fat depots lose more total body fat 
during weight loss, with the greatest loss seen from visceral fat depots. This is because visceral fat 




these studies into consideration, it appears that both visceral and subcutaneous tissue lead to 
disruptions in glucose metabolism and thus insulin insensitivity, but visceral fat is likely to be more 
deleterious due to its increased metabolic activity and expansive activation of cardiovascular 
disease risk factors such as dyslipidaemia and hyperinsulinemia.  
Lipid mobilization, the “net release of free fatty acids (FFAs) from triglycerides stored within 
adipose tissue to other organs”, is controlled by numerous hormones as well as the nervous 
system (Carlson, Boberg and HÖgstedt, 2011). It is stimulated by the sympathetic nervous system 
as well as increased levels of norepinephrine and epinephrine, growth hormone and glucagon. 
Similarly, obesity increases sympathetic nervous system activation and causes activation of the 
hypothalamic-pituitary-adrenal (HPA) axis, thus increasing cortisol (Björntorp, 1995). It does, 
however, also lead to reduced growth hormone and sex hormones, as well as an increase in 
insulin production. It would appear then, that obesity favours lipid accumulation over mobilization, 
as insulin, growth hormone, testosterone and cortisol stimulate lipid accumulation within adipocytes 
and thus an increase in fat mass (Bjorntorp et al., 1990). Visceral adipose tissue, however, is more 
sensitive to lipolytic stimuli (Björntorp, 1990), thus the combination of increased visceral adipose 
tissue and increased sympathetic tone can more greatly increase lipid mobilization within obese 
patients, especially those with central obesity. Large adipose tissue masses lead to increased 
FFAs making their way into blood circulation due to lipid mobilization which occurs within adipose 
tissue; visceral fat, specifically, drains into the portal vein, which pumps directly into the liver 
circulation (Carlson, Boberg and HÖgstedt, 2011).  
High levels of FFAs in the portal vein have been shown to inhibit adequate insulin uptake by the 
liver, thus resulting in hyperinsulinemia (Svedberg et al., 1991). Elevated portal FFAs have been 
postulated to lead to elevated liver triglycerides, as excess FFAs are transferred into existing 
triglycerides within the liver. In an experiment comparing insulin clearance between obese and lean 
rats, a strong negative correlation was observed by Strömblad and Björntorp (1986) between 
insulin uptake and liver triglyceride levels within study animals, suggesting this hypothesis to be 
valid (Svedberg et al., 1991). Increased triglycerides and FFAs within the liver do not only lead to 
the storage of these molecules. FFAs in the liver are incorporated into lipoproteins, especially into 
very low density lipoproteins (VLDL), and are oxidised to form ketone bodies (Borgström and 
Carlson, 1957; Langdon, 1957; Carlson, 1960; Engel and Amatruda, 1963). Ketosis may result if 
the production of ketone bodies exceeds the rate at which they are utilized within the peripheral 
circulation, which can lead to metabolic acidosis (Laurell, 1956; Bressler, 1963; Engel and 
Amatruda, 1963). Furthermore, the mobilization of FFAs and lipid into plasma influences glucose 
metabolism. Increased FFAs within blood reduces glucose uptake into the liver and its metabolism 




Increased FFAs in peripheral circulation causes hyperlipidaemia and can also stimulate FFA 
deposition within other organs including blood vessel walls and the heart myocardium itself (Maling 
and Highman, 1958). This can lead to vascular complications including atherosclerosis, 
hypertension and cardiovascular disease. Taken together, obese individuals, especially those with 
central obesity, are prone to increased peripheral FFAs which stimulate hyperlipidaemia, 
hyperinsulinaemia and thus insulin resistance, as well as cardiovascular disease and diabetes, all 
of which are hallmarks of metabolic syndrome. 
Metabolic syndrome itself has been observed to lead to male infertility (Kasturi, Tannir and 
Brannigan, 2008). High levels of visceral obesity and insulin insensitivity affect the production of 
GnRH and SHBG, dysregulating the HPG axis and thereby affecting spermatogenesis (Pasquali, 
2006). Insulin insensitivity has also been found by authors such as Pitteloud and colleagues (2005) 
to directly reduce testosterone production at the level of the testis, which can lead to 
hypogonadotropic hypogonadism and a reduction in fertility. Cardiovascular disease, in particular 
hypertension, is a risk factor for erectile dysfunction which affects the ability to copulate and thus 
affects the formation of a conceptus (Esposito et al., 2005). End-organ damage as a result of 
hypertension can also target the testes, subsequently affecting spermatogenesis, but the 
mechanism in which this occurs needs more clarity (Kasturi, Tannir and Brannigan, 2008). 
Hypertension has been shown by several studies to be correlated with reduced total plasma 
testosterone, free testosterone and SHBG (Khaw and Barrett-Connor, 1988; Phillips et al., 1993; 
Fogari, Preti, et al., 2002; Fogari, Zoppi, et al., 2002). Some authors have suggested that the 
resultant arterial stiffness caused by hypertension is the underlying instigator of this androgen 
deficiency (Dockery et al., 2003).  
 Oxidative Stress 
Free radicals are highly reactive molecules formed during regular oxygen metabolism within cells 
(Griveau and Lannou, 1997). Due to this origin, they are termed reactive oxygen species (ROS); 
other forms of free radicals are derived from the chemical alteration of nitric oxide (NO) and are 
termed reactive nitrogen species (RNS) (Aitken and Clarkson, 1987; Sikka, 2001). Free radicals 
have physiological functions within the male reproductive system and have now been established 
as prominent signalling molecules involved in the regulation of spermatogenesis, capacitation, 
hyperactivation, the acrosome reaction and sperm-oocyte fusion (Kothari et al., 2010). The quantity 
of free radicals within the male reproductive system is kept at homeostatic levels by endogenous 
antioxidants (Sikka, 1996). Antioxidants stabilize free radicals by donating electrons to their atomic 
structure and by scavenging them from a system (Aitken, 1994). Should there be an increase in 
free radicals due to their heightened production or an inability of antioxidants to maintain their 




stress results in damage to cellular components of all forms, including lipids, proteins and DNA 
(Schafer and Buettner, 2001). Spermatozoa are susceptible to damage by free radicals as their 
membranes are predominantly composed of lipids, specifically PUFAs, which are prone to 
peroxidation by ROS (Aitken and Clarkson, 1987). 
Together with their susceptibility to peroxidative damage, spermatozoa have a limited capacity to 
protect themselves from an attack by free radicals as they have small cytoplasms and a limited 
capacity to repair their membranes (Jones, Mann and Sherins, 1979). Sperm are also active 
producers of free radicals and were interestingly the first cells discovered to produce ROS 
(Thompson, Agarwal and Plessis, 2013). Mounting evidence points towards OS as a central 
mechanism in the etiology of sperm damage and thus infertility (Aitken, 1994). Sperm under stress 
from a variety of disorders can produce ROS and be additionally attacked by increased free 
radicals from numerous endogenous and exogenous sources. Furthermore, the peroxidative 
damage incurred by sperm during OS damages their membranes and makes them non-viable, and 
their membranes lose the fluidity conferred to them by PUFAs, which is necessary for sperm-
oocyte fusion and the acrosome reaction (Aitken and Clarkson, 1987).  
Obesity is said to both cause and result from OS. Adipose tissue secretes pro-inflammatory 
cytokines such as TNF-α, IL-1β, and IL-6, as well as adipokines; these induce the production of 
ROS within the body, thereby attacking nearby tissues at sites of ROS accumulation (Fonseca-
Alaniz et al., 2007; Fernández-Sánchez et al., 2011a). Moreover, the attack of adipocytes by ROS 
begets the production of more ROS, exacerbating OS. TNF-α stimulates the immune system to 
instigate an inflammatory response, adipocyte apoptosis, lipid metabolism, insulin signalling and 
ROS production; the latter is activated via the binding of TNF-α to receptors that promote Nuclear 
Factor Kappa B (NF-κB) signalling (Chandel, Schumacker and Arch, 2001; Wang and Trayhurn, 
2006). TNF-α is heightened in obesity and is also found to increase the interaction between 
electrons and oxygen, thereby generating superoxide anions (O2-) which are the most predominant 
ROS species in the male reproductive system (Wang and Trayhurn, 2006). IL-6 regulates energy 
homeostasis as well as inflammation and influences the transition from acute to chronic 
inflammation, therefore stimulating chronic inflammation in obesity as well as insulin resistance 
(Naugler and Karin, 2008). Arguments for ROS preceding obesity state that ROS stimulate insulin 
insensitivity within adipose cells and peripheral tissue, which is a hallmark of obesity and metabolic 
syndrome (Sowers, Whaley-Connell and Hayden, 2011). Furthermore, Youn et al. (2014) used the 
premise that obesity is associated with vascular dysfunction and vascular OS to establish that 
vascular-derived ROS is generated via NADPH oxidase activation of vascular smooth muscle cells. 
This predisposes individuals to obesity. After genetic alteration of genes responsible for NADPH 




diet and found that the mice with increased NADPH function acquired exaggerated obesity, gaining 
50% more weight than the control mice.  
OS hampers male fertility by affecting basic sperm parameters as it reduces sperm motility (Jones, 
Mann and Sherins, 1979; Aitken and Clarkson, 1987; De Lamirande and Gagnon, 1992), viability 
(Jones, Mann and Sherins, 1979; Mahfouz et al., 2010), normal sperm morphology (Gil-Guzman et 
al., 2001) as well as sperm function including capacitation (Rivlin et al., 2004), hyperactivation (S 
Oehninger et al., 1995), sperm-oocyte fusion (Aitken, Buckingham and Harkiss, 1993; Aitken, 
1999; Das et al., 2008) and causes spontaneous acrosome reactions (S Oehninger et al., 1995).  
 Environmental toxins 
Adipose tissue is an important site for the bioaccumulation of toxins (Jackson et al., 2017). Organic 
pollutants are lipophilic compounds that are considerably stable and resistant to environmental 
degradation, more especially persistent organic pollutants (POPs) such as 
dichlorodiphenyltrichloroethane (DDT), polychlorinated dibenzo-p-dioxins (dioxins) and polycyclic 
aromatic hydrocarbons (US EPA, no date). The principal human exposure to POPs is via diet, 
through the consumption of contaminated fatty foods of animal origin such as meat, fish and dairy, 
exposing individuals to many classes of POPs (Jackson et al., 2017). A few studies have 
suggested that adipose tissue plays an important role in the storage and toxicokinetics of 
hydrophobic xenobiotic POPs (Kim et al., 2011, 2012). Xenobiotic chemicals are well metabolised 
by the body via an extensive metabolizing system including receptors, transporters and 
metabolizing enzymes which assist in their elimination from the body (Barouki, 2010). POPs are, 
however, resistant to metabolism. Instead, they distribute to lipophilic compartments within the 
body, especially adipose tissue (Jackson et al., 2017). They are absorbed into adipocytes and can 
be localized within lipid droplets. The storage of POPs within adipose cells has both beneficial and 
detrimental consequences. Their deposition within lipophilic tissues removes them from blood 
circulation and reduces their bioavailability, thereby protecting other tissues from their toxic effects. 
This was shown by Geyer et al. (1993) where the 30 day exposure of 20 terrestrial animals to a 
POP showed reduced toxic effect in the species with the higher fat masses. Conversely, higher 
amounts of POPs can accumulate in individuals with higher adiposity, and their fat will become a 
long term reservoir (La Merrill et al., 2013). When these individuals lose weight, however, these 
POPs are released into circulation, exposing other body cells to their toxic effects (De Roos et al., 
2012; Dirinck et al., 2015). This was shown in both human and animal studies after weight loss via 
lifestyle changes or bariatric surgery in humans (Ohmiya and Nakai, 1977; Jandacek et al., 2005; 
Hue et al., 2006; Kim et al., 2011) or periods of starvation in animals. The pre-treatment of mice 
with DDT by Ohmiya and Nakai (1977) showed increased blood concentrations of DDT after 




kidney, liver and brain. Furthermore, the newly released POPs in blood will circle back into the 
remaining adipose tissue, thereby becoming more concentrated within the adipocytes (Dewailly et 
al., 2000; Kim et al., 2011). As mentioned previously, environmental pollutants such as POPs have 
a negative effect on hormone concentrations and fertility parameters. They further exacerbate the 
effects of obesity on male fertility by affecting the normal functions of adipose tissues. POPs have 
been shown to increase the release of adipokines (Taxvig et al., 2012) and inflammatory mediators 
from adipose tissue (Kern et al., 2002; Li, Vogel and Matsumura, 2007; Arsenescu et al., 2008; 
Nishiumi et al., 2010), thereby promoting inflammation and affecting insulin signalling and fertility.  
 Physical changes 
The increased fat deposition observed in obesity can result in fat being deposited directly above 
the pubic area, the upper thigh region and the scrotum (Shafik and Olfat, 1981). This increased 
amount of fat can raise the temperature around the scrotum, which is usually 2°C below core body 
temperature (Chowdhury and Steinberger, 1970; Mieusset and Bujan, 1995). All tissues and 
organs are susceptible to the heat damage associated with increased body temperature, but the 
testes are unique in that they are damaged by normal core body temperature (Setchell, 1998). 
Increased fat around the scrotum as well as sedentary behaviour such as extended periods of 
sitting, exposes the scrotum (and thus the testes) to normal body temperature, causing heat stress 
and damage within the genitalia (Durairajanayagam, Agarwal and Ong, 2015).  
Spermatogenesis requires lower temperatures for optimal functioning and increases in scrotal 
temperature have been shown to negatively affect sperm quality (Hjollund et al., 2000). Even small 
increases of 1°C in scrotal temperature have a negative effect on sperm production, reducing 
spermatogenesis by approximately 14% (Durairajanayagam, Agarwal and Ong, 2015). Studies 
have shown genital heat stress to result in reduced sperm counts, spermatogenic arrest and 
atrophy of the germinal epithelia (Chowdhury and Steinberger, 1970), but Hjollund et al. (2002) 
observed no changes in sperm motility and morphology as well an semen pH. A study on young 
male rats exposed to 33-35°C for 3-5 weeks showed decreased levels of testosterone (Bedrak, 
Chap and Fried, 1980) which can explain the observation by other studies which observed marked 
decrease in testis size due to heat stress (Setchell, 1998).  
Erectile dysfunction (ED), the consistent inability to achieve and/or maintain penile erection over a 
3 month period, is the sequelae of hyperglycaemia, hyperlipidemia and cardiovascular disease, all 
of which are conditions that can be instigated by obesity (Seftel, Sun and Swindle, 2004; Fisher et 
al., 2009; Montorsi et al., 2010; Dong, Zhang and Qin, 2011; Dursun et al., 2018). Other causes of 
ED include smoking, low level of testosterone, anemia, peripheral vascular disease, drug and 




Zhang and Qin, 2011). ED is an obvious cause of infertility due to its hindrance of sexual activity 
within couples (Fisher et al., 2009) and is a commonly reported symptom in obese and diabetic 
males. A study by Corona et al. (2006) reported 96,5% of their study participants with metabolic 
syndrome to have ED. A Health Professionals Follow-up Study observed that men with a BMI < 25 
had a 30% reduction in their risk of developing ED (Bacon et al., 2003), while a study by Andersen 
et al. (2008) observed higher BMIs in young and elderly men to correlate with increased frequency 
of ED. The co-morbidities of obesity impair the release of NO from vascular endothelia to cause 
changes to endothelial function and reduce plasma testosterone levels, which promote ED (Feeley 
and Traish, 2009). In addition, adipose tissue also secretes numerous cytokines and adipokines 
which stimulate inflammation, endothelial dysfunction and insulin resistance, all contributing 
towards the pathophysiology of ED (Guzik, Mangalat and Korbut, 2006). The testosterone 
deficiency observed in obesity and ED have been linked to further alterations in fertility. Insulin 
resistance has been shown to reduce testosterone levels as insulin is a known stimulant of 
testosterone production (Pasquali et al., 1995). Further to that, leptin receptors are found in the 
testes and the binding of leptin to these can reduce androgen production, as observed by Caprio et 
al. (1999). This mechanism explains the hypogonadism observed in obese men and those with ED, 
which can further affect fertilizing potential via the reduction of basic sperm parameters.  
Sleep apnea, which is shallow or infrequent breathing during sleep, is common among obese 
individuals (Katib, 2015). It is more common in males with central obesity (Luboshitzky et al., 
2005). Sleep apnea commonly leads to disrupted sleep which has been shown to disrupt the 
nocturnal rhythm of testosterone production, with studies showing this to lead to reduced 
functioning of the HPG axis and a reduction in the morning levels of testosterone (Luboshitzky et 
al., 2001).   
2.6. Animal models of obesity 
Having observed the similarities between laboratory animals and humans, it is evident that these 
mammals can interchangeably be assessed in order for disruptions in normal physiology to be 
understood.  
Obesity is assessed in both rats and mice in order for the observed clinical changes in humans to 
be better assessed in a laboratory setting and for therapies to be devised. These models induce 
obesity in a manner that would normally occur in humans, including alterations to genetics, diet, 
physical activity, hormone dysregulations, endocrine changes, aging and via exposure to 
environmental toxins and medications that predispose laboratory animals to obesity. The most 





Genetically induced obesity animal models are classified according to the mode of inheritance, e.g. 
monogenic (single-gene dominant, single gene recessive) and polygenic obesity. Monogenic 
models of obesity have been widely used, with dominant models being obese (ob/ob), diabetic 
(db/db) and Zucker or fatty rats (fa/fa) (Sclafani, 1984). It has been argued, though, that polygenic 
obesity is more representative of human obesity as animals with these mutations become 
spontaneously obese or acquire obesity via additional exposure to cafeteria, high fat or high 
carbohydrate diets (Festing, 1979; N. J. Rothwell, Saville and Stock, 1982). Mutations of the leptin 
(ob) gene create the genetically obese ob/ob model by preventing the production leptin (Orahilly, 
2009). This results in early-onset obesity, hyperphagia, reduced energy expenditure, insulin 
resistance, hyperglycaemia, and hyperinsulinaemia. Mutating the leptin receptor (db) gene creates 
the diabetic db/db animal model, which is phenotypically similar to the ob/ob model, but the 
animals develop leptin resistance and marked hyperleptinaemia (Lutz and Woods, 2012). Zucker 
rats are leptin receptor deficient rats with mutations in the extracellular domain of this receptor. 
This is an autosomal recessive form of obesity, and also exhibits hyperphagia and reduced energy 
expenditure (Bray, 1977). They do, however, have normal blood glucose levels. POMC, AgRP, and 
MC4R mutations are also utilized as monogenic models of obesity.  
 Diet-induced  
Although genetics plays an essential role in the regulation of body weight, body composition, body 
size and the metabolic response to feeding, an exponential increase in weight gain in humans and 
animals over a short period of time cannot be explained by genetics (Hariri and Thibault, 2010). 
Individual susceptibility to obesity that is conferred by genetics is influenced by environmental 
factors including diet (Bouchard and Tremblay, 1997; Jéquier, 2002; W. James, 2008). Diets are 
crucial determinants of health and disease, and habits that cause an unbalanced diet are a 
significant risk factor in the development of obesity and its related metabolic disorders (Preguiça et 
al., 2020).  
Maintaining laboratory rats on a modified ad libitum diet is a widely applied approach to inducing 
weight gain in laboratory animals. Additionally, overfeeding is employed as a direct approach 
where tube feeding (gavaging) animals at intervals throughout the day has shown vast increases in 
body weight (Hansen, 1979). Altering the palatability and/or calories of food seems to be the 
easiest method to increase weight gain, where high fat and/or high sugar diets are provided ad 
libitum to elicit diet-induced obesity models (Sclafani, 1978). Standard rat chow is most often in the 
form of pellets that contain carbohydrates derived from wheat, corn and barley. These are whole 




resistance and obesity (Isken et al., 2010). The addition of sugars (fructose, sucrose, glucose), 
polysaccharides and highly palatable calorie-rich foods such as sweetened milk and processed 
meats can increase the palatability of the standard chow, causing hyperphagia (Sclafani and 
Springer, 1976; Rolls, Rowe and Turner, 1980; N. J. Rothwell, Saville and Stock, 1982). Some 
studies place experimental animals on normal rat chow after obesogenic feeding; in these 
experiments, some of the animals in the treatment/diet group are observed to lose weight whereas 
others remain obese (Rolls, Rowe and Turner, 1980). This is anticipated to be the result of 
changes in adipocyte cellularity, the length of diet duration and differences in rat or mouse strains 
(I M Faust et al., 1978; Sclafani, 1978; Mandenoff, Lenoir and Apfelbaum, 1982). Diet-induced 
obesity (DIO) animals exhibit reduced insulin and leptin sensitivity, and seem to directly affect 
intracellular signalling pathways of the hypothalamus which control body energy. The standard 
animals used in dietary obesity studies include Wistar, Sprague-Dawley and C57BL/6C rats (Hariri 
and Thibault, 2010).  
There are several types of animal diets used to induce obesity, namely tube feeding, high-fat, high-
carbohydrate, low-protein and varied diets.  
 Tube feeding 
Force feeding of animals involves the delivery of liquid diets orally or via gastric intubation, which is 
used to administer several large meals per day. This can lead to obesity as it reduces dietary 
thermogenesis, thereby increasing fat deposition (Rothwell and Stock, 1984). These meals are 
usually provided during the day-time, which differs from the normal nocturnal feeding pattern 
observed in rodents. Rats ingest 70-80% of their meals at night (during the dark phase), with the 
two peaks in meal frequency occurring at the beginning of the night (dusk) and towards the end 
(dawn) (Le Magnen and Devos, 1970).Tube-fed rats have been found to gain significantly more 
weight than their controls, and their percentage weight gain is in proportion to the intake provided 
via intubation (Rothwell and Stock, 1984). 
 High fat diets 
Epidemiological studies in humans have shown that as the fat content of a diet increases, the 
incidence of obesity also increases (Saris et al., 2000; Hariri and Thibault, 2010; Piché et al., 
2018). High-fat diets have been proposed to lead to obesity as fat is an energy dense 
macronutrient. It is also less satiating than either carbohydrates and proteins, leading to passive 
overconsumption (Moussavi, Gavino and Receveur, 2008). High fat diets are diets with 40-60% of 
the macronutrient composition derived from lipids (Fernandes et al., 2016). The lipid sources in 




excessive weight gain. They are more palatable than regular chow/pellets alone and are more 
energy dense. These diets also require less energy for fat storage as dietary energy is derived 
directly from lipids, which have a lower energy cost than de novo lipogenesis from carbohydrate 
sources (6 vs 14 kJ/g) (Rothwell and Stock, 1984). This results in more efficient weight gain. Some 
researchers have reported increased weight gain in the high fat diet groups despite there not being 
a significant increase in food intake compared to controls (Lemonnier, 1972; Herberg et al., 1974). 
In a review of animal models of obesity using experiments published 2010-2016, Fernandes et al., 
(2016) showed that diets containing 60% lipid gained weight in all high fat groups regardless of 
strain. In addition, these animals gained epididymal fat and exhibited hyperglycaemia and insulin 
resistance. Obesity has, however, been shown to be induced using diets with as low as 13% of 
total energy derived from fat, but these were high-energy diets (Harrold, Williams and Widdowson, 
2000). This is because a rat’s daily fat requirement is only 5%. Furthermore, high-fat diets have 
been shown to derive up to 85% of their macronutrient composition from lipids (Mickelsen, 
Takahashi and Craig, 1955). The type of fat used in high fat diets is important. This is because the 
metabolic behaviours (i.e. oxidation and deposition rate) of fatty acids differ. The characteristics of 
dietary fatty acids, such as structure, chain length, degree of saturation, and the configuration and 
position of double bonds, can affect this metabolic behaviour (DeLany et al., 2000; Madsen, 
Petersen and Kristiansen, 2005). Metabolic studies in animals and humans have shown that short- 
and medium-chain fatty acid are preferentially oxidised compared to long-chain fatty acids (Leyton, 
Drury and Crawford, 1987; DeLany et al., 2000). Diets high in medium-chain fatty acids (C6-C12) 
have been shown to gain less weight than diets using lipids with longer chain fatty acids such as 
corn oil or lard (Gurr, Rothwell and Stock, 1979). This is because the fatty acid composition of fat 
sources can affect the cellularity (i.e. the fat cell number and volume) of adipose tissue (Moussavi, 
Gavino and Receveur, 2008).  
 High carbohydrate diets  
Diets with a 60% mean proportion of macronutrients derived from carbohydrates constitute a high 
carbohydrate diet. These carbohydrates are derived from corn starch, sucrose and fructose and 
other starches and sugars. Animals on high carbohydrate diets show increases in body weight and 
body fat, as well as increased triglycerides, hypertension and hyperglycaemia (Fernandes et al., 
2016). Many animals show a preference for foods with carbohydrates, especially those with a high 
sugar content. These also increase the palatability of foods and can cause hyperphagia. In a study 
observing the difference in dietary thermogenesis of sucrose and glucose solutions administered 
via gastric intubation over several weeks, the two sugars were shown to have the same acute 




the balance towards a higher energy intake) and a higher oxygen consumption (N J Rothwell, 
Saville and Stock, 1982). 
 Low protein diets 
Protein-deficient diets in rats have a range of 4-13% of the macronutrient composition derived from 
protein (Langley-Evans, 2000; Lieberman, Yeghiayan and Maher, 2005; Malta et al., 2014; 
Pezeshki et al., 2016; Ajuogu et al., 2020). Normal daily intake of protein in rodent diets is 
approximately 22% and reductions in this macronutrient results in malnutrition, increased food 
consumption and increased body weight and fat mass (Pezeshki et al., 2016). Furthermore, 
moderate protein restriction in rodents has been shown to be associated with changes in body 
composition such as reduced lean muscle mass, increased fat weight and a fatty liver (Du, 
Higginbotham and White, 2000; White, Porter and Martin, 2000; Huang et al., 2013; Solon-Biet et 
al., 2015). These changes are the result of alterations in food consumption and dietary 
thermogenesis following a low protein diet. Reduced dietary protein concentrations lead to the 
overconsumption of fats and carbohydrates in order to compensate for insufficient protein intake, 
leading to an increase in total energy consumption (White, Porter and Martin, 2000; Pezeshki et 
al., 2016). The thermogenesis required to break down protein is 20-35% of dietary energy 
consumed, in comparison to the 5-15% required for carbohydrates (Westerterp, Wilson and 
Rolland, 1999). The lower thermic effect of low protein diets, especially those supplemented by 
higher carbohydrate and fat consumption, result in reduced energy expenditure and increased 
energy (fat) storage (Dauncey and Bingham, 1983; Karst et al., 1984; Crovetti et al., 1998; Halton 
and Hu, 2004).  
 Varied 
Some diets do not fit the characteristics of the aforementioned high-fat, high-carbohydrate, low-
protein diets, and cannot be classified. The key is to make sure that the diet exhibits higher or 
lower macromolecule proportions compared to the control diet, and that the high-energy 
macromolecule percentages are above those that are required daily by the experimental animals. 
In addition, the macromolecule proportions, e.g. percentage of fat, included in a diet intervention 
can be based on quantities previously shown by other DIO experiments to be sufficient to elicit 
weight gain. 
High fat, high-salt, low-fibre, energy-dense diets are used in animal experiments to induce obesity. 
An example of this includes the cafeteria diet. This diet includes highly palatable, energy dense 
foods consisting of human food items such as chocolate chip cookies, cheese, marshmallows, 




1976; Sampey et al., 2011; Johnson et al., 2016). Cafeteria diets are designed to mimic the variety 
of energy dense foods consumed by humans on a Westernized diet, and it induces hyperphagia 
and rapid weight gain (Sampey et al., 2011). Furthermore, energy-dense foods are known to alter 
normal appetite regulation as they disable the regular homeostatic mechanisms used by the body 
for normal energy balance, most possibly via the activation of neural reward systems (Erlanson-
Albertsson, 2005; Rolls, 2009; Sampey et al., 2011). In addition, high-sugar, high-fat foods 
upregulate the expression of hunger signals while suppressing satiety signals, leading to increased 
food consumption (Erlanson-Albertsson, 2005). Animals on cafeteria diets have been shown to 
develop prediabetic parameters including hyperinsulinaemia and glucose intolerance, and an 
increase in fat mass and obesity-related inflammation (Johnson et al., 2016). Other highly 
palatable diets may also be termed as hyperphagic diets. 
 Diet duration  
The duration of exposure to obesogenic diets in animal models varies between studies. Previous 
research has shown that it is more effective to begin obesogenic diets in animal models at a young 
age (after weaning, ± 4-6 weeks of age) and for the period of feeding to continue for several weeks 
to months after its inception (Peckham, Entenman and Carroll, 1962; Quinn, 2005; Sengupta, 
2013; Dutta and Sengupta, 2016). Increases in body weight can be observed from as few as 2 
weeks after the commencement of obesogenic feeding, but the obese phenotype becomes more 
apparent after 4 weeks or more of feeding (Buettner, Schölmerich and Bollheimer, 2007). The 
majority of existing models are predominantly acute as animals are placed on varying diets for ± 4-
28 weeks to bring about the obese phenotype (Woods et al., 2003; Carroll, Zenebe and Strange, 
2006; Parasuraman et al., 2010, 2013; Puig et al., 2012; Shao et al., 2012). Although findings from 
these studies are relevant, they may not wholly mimic the true onset of obesity and its chronic 
nature in the adult human. Several studies using feeding periods between 4 – 28 weeks have 
reported increases in body weight/fat in the DIO animals, but studies including those from Harrold 
(2000), Chang (1990) and Leopoldo (2016) reported obesity to occur in only the obesity prone 
animals, with a large proportion of their rats unable to attain the obese phenotype. Furthermore, 
some studies report the length of their diets as insufficient, stating that a longer treatment duration 
would be beneficial in yielding results more representative of the of the obese condition (Sampey 
et al., 2011; Watson, Bruggeman and Parent, 2012; Selfridge et al., 2014; Cecconello et al., 2015; 
Oosterman et al., 2015; Aly and Polotsky, 2017). Prolonged periods of obesogenic feeding can 
produce 10 – 20% increases in body weight in the DIO group compared to controls (Buettner, 
Schölmerich and Bollheimer, 2007). A study by Peckham et al. (1962) established a 62 week 
hypercaloric diet and was able to attain a 37% increase in the body weights of DIO rats compared 




DIO rats. Other long-term diets have found significant increases in body weight after extended 
exposure of rats to hyperphagic diets or excessive amounts of chow. Oscai (1982) induced severe 
obesity in a rat model by providing unrestricted access to a high-fat, hyperphagic diet to rats 
immediately after weaning and continuing with the diet until the rats reached 29 – 58 weeks of age. 
Body weights stabilized at a sizable 1,213 ± 62g in the high fat diet group. Scotellaro et al. (1991) 
took a group of 100 rat pups and placed them in individual cages after weaning to remove food 
competition and created an excess supply of normal rat chow for 10 weeks. After this period, the 
heaviest and lightest rats were fed for another 40 weeks, and the obese rats were observed to 
consume significantly more food than the lean rats and attain 59.53% more body fat. Schemmel et 
al. (1969) fed male and female weanlings normal rat chow or a high fat diet for 64 weeks and 
managed to attain weights of ± 1,050 g in the obese animals compared to ± 600 g in the control 
group, a significant increase in body weight which correlated with a higher body fat mass. From 
this information it can be deduced that diet durations applied in obesity research using animal 
models vary. Calorie-dense diets can cause obesity in short term diets from 2 weeks of feeding, 
with long term diets being shown to be very effective in inducing obesity that is representative of 
the accumulative increase in body and fat weight observed in the obese condition.  
 Endocrine 
Several methods are used as endocrine-related obesity models (Wade and Gray, 1979). Methods 
of induction include chronic administration of hormones including insulin, hormones and 
glucocorticoids (Hollifield, 1968; Lotter and Woods, 1977). The excessive administration of a 
glucocorticoid, such as cortisol and growth hormone, is a common example of obesity induced by 
known inciting agents. In an experiment where 11-dehydrocorticosterone was administered via a 
subcutaneously implanted pellet, increased fat was observed in the older mice (Hollifield and 
Parson, 1959). This was not as a result of increased food intake or weight gain but from increased 
gluconeogenesis and insulin production, which resulted in increased fat synthesis by adipose 
tissue and decreased protein synthesis. In addition, observances from glucocorticoid-induced 
obesity studies have revealed that excess glucocorticoids do not induce obesity in young animals 
and humans during their growth period (Blodgett et al., 1956; Hollifield and Parson, 1959; Morris et 
al., 1968). Fluctuations in circulating levels of hormones are able to alter body composition and 
body weight, including the behaviours which control body weight, e.g. food intake and exercise 
(Wade and Gray, 1979). Numerous gonadectomy and hormone replacement experiments have 
been performed over the past few decades to establish the effect of ovarian and testicular 
hormones on body weight and regulatory behaviours (Hausberger and Hausberger, 1966; 
Krotkiewski, Kral and Karlsson, 1980; Holmäng and Björntorp, 1992; Ouerghi, Rivest and Richard, 




rats, different androgens have been administered to animal models and their effect on eating and 
body weight vary depending on the type and concentration of androgen used. Androgens regulate 
energy metabolism in males. One of the mechanisms in which this occurs is via direct stimulation 
of the androgen receptor or the indirect stimulation of oestrogen receptors after the aromatization 
of androgens (Movérare-Skrtic et al., 2006). A heightened activation of the androgen receptor can 
result in obesity via the alteration of lipid metabolism and glucose oxidation (Movérare-Skrtic et al., 
2006). Testosterone, however, has been shown to supress adiposity over a range of 
concentrations (Wade and Gray, 1979). This is because testosterone is an anabolic hormone with 
influence on male body fat distribution. It has been shown to influence glucose and insulin 
concentrations, as well as the levels of circulating triglycerides and cholesterol (Christoffersen et 
al., 2006). Furthermore, testosterone deficiency increases body fat, which can alter carbohydrate 
and fat metabolism (Seidell et al., 1990; Mauras et al., 1998). Castration (the surgical removal or 
artificial destruction of gonads) has been used as a model to study extreme testosterone deficiency 
in animals. Orchiectomy (the removal of one or both testes) increases fat content in male rats 
(Hoskins, 1925; Kemnitz, Goy and Keesey, 1977; Drago et al., 1982; Christoffersen et al., 2006; 
Movérare-Skrtic et al., 2006). Furthermore, castration has been shown to reduce food intake, 
increase fat percentage and reduce lean body mass via the direct alteration of glucose and fat 
metabolism in rats, among other mechanisms (Gentry and Wade, 1976; Krotkiewski, Kral and 
Karlsson, 1980; Holmäng and Björntorp, 1992).  
 Neural  
Hypothalamic obesity is the most well-known neural model of obesity. These models of obesity 
affect feeding behaviour as the “satiety centre” of the brain is targeted. The original induction of 
hypothalamic obesity was via an electrolytic lesion to the ventromedial hypothalamus (VMH) to 
induce overeating and obesity (Bray, 1977).This region of the hypothalamus contains a large 
proportion of neurons which are gluco-responsive, as well as neurons responding to histamine, 
dopamine and serotonin stimulation (King, 1991, 2006; Paasch et al., 2010). VMH lesions most 
likely lead to the destruction of POMC neurones, resulting in these animals showing a decrease in 
sympathetic tone and an increase in parasympathetic tone. Furthermore, VMH-lesioned rats 
display elevated circulating insulin. Other methods include knife-cuts to the medial hypothalamus 
(MH), lesions to the paraventricular hypothalamus (PVH) and the injection of certain substances 
such as monosodium glutamate (MSG), bipieridyl mustard and gold thioglucose to destroy the 
arcuate nucleus (ARC) (Sclafani, 1984). ARC lesions result in hyperphagia, insulin resistence and 




2.7. Treatments of male infertility 
In the case of infertility caused by lifestyle factors, the simplest intervention is lifestyle modification 
(Anderson, Nisenblat and Norman, 2010). Weight loss in males has been shown to increase SHBG 
as well as total and free testosterone, with an increased LH being observed in more marked weight 
loss (Chambers and Anderson, 2015). Furthermore, serum concentrations of insulin and leptin are 
reduced after weight loss (Kaukua et al., 2003; Niskanen et al., 2004; Sharman and Volek, 2004). 
Regular, moderate exercise as well as low-to-moderate resistance training is further able to 
increase testosterone production (Kraemer and Ratamess, 2005; Vaamonde Martin et al., 2014; 
Chambers and Anderson, 2015), thereby assisting to possibly restore function to the HPG axis of 
infertile men. 
Medical treatment of an underlying illness or disorder responsible for the initiation of infertility may 
alleviate the cause of infertility. The treatment of infections, especially those of the reproductive 
tract, should be resolved in order to reduce inflammation and halt the generation of ROS. 
Leukocytospermia can occur as the result of an infection; antibiotic treatment and frequent 
ejaculation have been shown to resolve this, but no immediate changes in male fertility parameters 
were observed by some researchers (Branigan and Muller, 1994; Kamischke and Nieschlag, 1999) 
while others observed an improvement in semen quality and/or fertility (Aparicio et al., 1980; 
Berger et al., 1983; Giamarellou et al., 1984).  
Obesity can be treated with medication where lifestyle modifications have been deemed 
insufficient. Anti-obesity drugs reducing the absorption of fat via the intestine (Orlistat) and 
suppressing appetite via deactivation of norepinephrine, serotonin and dopamine (Sibutramine) 
have been approved by the Food and Drug Administration (FDA) for long-term use but weight loss 
with these drugs is modest. Aromatase inhibitors have been prescribed to obese males with 
elevated estradiol and low testosterone levels; these prevent the production of aromatase, thereby 
reducing the conversion of testosterone to estradiol. Aromatase inhibitors have been found to be 
effective in improving fertility, but with varying efficacy. A study comparing aromatase inhibitors 
Anastrozole and Testolactone on lean, overweight and obese patients, showed both drugs to 
improve patient testosterone levels, thereby improving their testosterone:estradiol ratio and 
increasing semen parameters with varying effectiveness (Raman and Schlegel, 2002). Morbidly 
obese, infertile patients treated with Anastrozole were seen to have increased LH, FSH and 
testosterone levels and an improvement in spermatogenesis (Roth, Amory and Page, 2008).  
Testosterone replacement therapy can be prescribed to men with low testosterone concentrations 
and symptoms of hypogonadism. The use of these medicines is, however, controversial as it has 




mass, bone density, erythropoiesis and body composition) as well as detrimental side effects (liver 
toxicity, exacerbation of benign prostatic hypertrophy, dysregulation of the HPG axis, 
erythrocytosis and hyperviscosity, and sever heart failure) (Bassil, Alkaade and Morley, 2009). 
Antioxidants are used to help alleviate some of the sequelae of OS. Several studies have reported 
the use of antioxidants to treat male infertility. Glutathione has been shown to increase progressive 
motility and morphology (Lenzi, Gandini and Picardo, 1998) and reduce lipid peroxidation (LPO) of 
sperm membranes (Dabaja and Schlegel, 2014). Superoxide dismutase (SOD), which catalyses 
the conversation of superoxide anions to oxygen and water, has also been observed to prevent 
LPO, thereby increasing sperm motility (Naz and Kamal, 2017). Vitamin C and E supplementation 
in healthy men has been shown by Eskenazi et al. (2005) to increase sperm concentration and 
progressive motility respectively. Although the abovementioned antioxidants have been shown to 
have positive effects on male fertility, a single antioxidant is limited in its capacity to tackle OS in 
infertile men and a combination of them has been recommended as a better approach (Lanzafame 
et al., 2009). As free radicals are necessary for normal sperm functions, caution should be taken 
not to reduce concentrations too drastically as this can be detrimental to sperm function.  
Leptin has been found to affect the function of GnRH within the brain (Quennell et al., 2009) and 
controlling the levels of this hormone can treat male infertility. Leptin deficiency as seen in obese 
individuals can be treated with leptin therapy. Leptin therapy given to leptin deficient mice due to a 
LEP mutation showed a correction in the infertility of the mice, with increases in testis weight, 
spermatogenesis and improved Leydig cell morphology (Mounzih, Lu and Chehab, 1997); leptin 
therapy has, however, been shown to have limited therapeutic action in polygenic/common obesity 
in humans, but impressive effects have been elicited in congenital leptin deficiency individuals 
(Yildiz and Haznedaroglu, 2006). 
Perhaps the most well-known treatment for infertility is ART, which is performed in numerous 
fertility clinics the world over. The most widely used methods of ART include in vitro fertilization 
(IVF) and intracytoplasmic sperm injection (ICSI) which have shown considerable success in the 
treatment of couple infertility (MacDonald et al., 2009). IVF is the placement of sperm and oocytes 
into a laboratory (petri) dish to allow for conception to occur while ICSI pertains to the direct 
insertion/injection of a sperm cell into an oocyte in vitro (Practice Committee of the American 
Society for Reproductive Medicine, 2017). ART does, however, bypass the underlying causes of 
infertility and in most cases, these issues are not adequately dealt with (Siddiq and Sigman, 2002). 
As long as some viable spermatozoa can be extracted from the male, the underlying cause of 
infertility is overlooked and curative measures are mostly not attempted. ART is also expensive 




Surgical methods are additionally used in the attempt to improve male fertility. These can be 
divided according to the intended purpose of the surgery, including diagnostic surgery, surgery for 
the improvement of sperm production, surgery for the improvement of sperm delivery, and surgery 
for the retrieval of spermatozoa (Lopushnyan and Walsh, 2012). Diagnostic methods including 
testicular biopsy, can be used to determine the presence of cancers as well as spermatozoa within 
the testes. In the case of non-obstructive azoospermia, a needle can be inserted into the testes to 
assess the presence of sperm to determine whether these cells can be extracted for ART (Saleh et 
al., 2010). Sperm production can be facilitated through the relief of anomalies impeding normal 
spermatogenesis. Varicocele (the enlargement of the veins within the scrotum) results in reduced 
thickness of the germinal epithelium and disorganized spermatogenesis due to hypoxic damage to 
spermatozoa and oxidative stress, which can be reversed via varicocelectomy (Masson and 
Brannigan, 2014). Obstruction within the ducts of the male reproductive system can be alleviated 
through surgery in order to facilitate the delivery of sperm to the female genital tract. Ejaculatory 
duct obstruction, for example, results in low semen volume, low seminal pH and/or the absence of 
fructose in seminal plasma (Pryor and Hendry, 1991). This can be treated by a resection of the 
ejaculatory ducts (Farley and Barnes, 1973). Sperm retrieval can be performed on patients with 
azoospermia. These include testicular sperm aspiration (TESA), testicular sperm extraction 
(TESE), percutaneous epididymal sperm aspiration (PESA) and microscopic epididymal sperm 
aspiration (MESA) (Lopushnyan and Walsh, 2012). These allow for sperm to be directly extracted 
from the testes and epididymis, respectively.  
These interventions have shown success. In the endeavour to develop more curative treatment 
strategies, additional knowledge needs to be gained on the mechanisms underlying infertility, 
especially those governing the interactions between infertility and the innumerable diseases and 
disorders which can alter fertility potential such as obesity. Furthermore at least 25% of men with 
infertility have an unidentifiable cause (Siddiq and Sigman, 2002). Their medical work up including 
history and examination are normal but their semen parameters are below WHO recommended 
ranges. New strategies need to be considered in order for the causative factors of such cases to 
be elucidated. 
2.8. Novel approaches for treatment 
Previous research, especially using in vivo and in vitro models, have only explained certain 
aspects of obesity and male infertility; animal and cell models need to be further examined through 
the use of new molecular techniques in order for a better understanding of the pathophysiology of 
obesity to be acquired, thus permitting the exploration of improved and novel therapeutic 




Genetics is believed to play a significant role in both obesity and infertility and several studies have 
endeavoured to reveal the intricacies of this aetiology, with the most recent using novel genetic 
methods to gain new insights. Gene analyses such as candidate gene association studies 
(associations between genetic variations and specific genes, phenotypes and diseases), linkage 
analyses (studies establishing links between genes) and genome-wide association studies 
(genome-wide assessments of genetic variations in multiple individuals to establish if a variant is 
associated with a trait) have been employed for the identification of novel susceptibility genes in an 
effort to further elucidate the genetic processes underlying function; these techniques have been 
used in obesity research to understand the regulation of body weight, but with limited success 
(Bouchard and Pérusse, 1996; Rankinen et al., 2006; Goodarzi, 2018). Lack of knowledge 
regarding the numerous genetic variations that exist among humans prohibited the thorough 
elucidation of these processes, until the successful sequencing of the entire human genome by the 
Human Genome Project (HGP) in 2001 (Craig Venter et al., 2001). This significantly expanded our 
knowledge of variations within the human genome that are responsible for diseases and allowed 
the expansion of the molecular techniques that are available for the further elucidation of disease 
mechanisms.  
The major limitation of genetics research is that genetic mutations confer susceptibility to certain 
diseases, but unless the mutation is monogenic, these mutations merely predispose individuals to 
certain diseases without necessarily determining whether the phenotype will be expressed. 
Individuals can inherit a mutation but not develop a disease, and whether or not this mutation will 
be expressed can be determined by an environment. Furthermore, the environment can confer 
new mutations that predispose individuals to new diseases. 
Another limitation which hampers genetic research is the dynamic nature of a cell. Gene 
sequences do not necessarily determine the day-to-day functioning of a cell and gene products 
can vary based on a cell’s physiological state. According to the central dogma of molecular biology, 
DNA undergoes transcription into ribonucleic acid (RNA) which, by means of messenger RNA 
(mRNA), is translated into proteins (Crick, 1958). Due to the dynamic nature of a cell, not all 
encoded genes are transcribed, and not all transcribed genes are translated into proteins. 
Furthermore, a single gene can give rise to multiple gene products: RNA processing into mRNA 
can generate numerous RNA transcripts, mRNAs produced by a cell are dependent on the efficacy 
and stability of translation, and the numerous protein products that can be generated by a cell are 
determined by the RNA transcripts that have been produced. Furthermore, protein sequences can 
be altered by post-translational modifications, proteolysis and protein compartmentalization 
(Graves and Haystead, 2002). Therefore, it is now recognised that cellular information cannot be 




assessment of the numerous gene products that can inform the functioning of a cell as opposed to 
only genes themselves.  
New molecular research has expanded to include genomics (the study of genes and their 
functions), transcriptomics (the translation of genetic information into transcripts and thus functional 
proteins), proteomics (the study of proteins and their functions) and metabolomics (study of the 
chemical processes concerning metabolites, the substrates, intermediates and products of 
metabolism) in order to understand the biology of diseases and to elucidate disease mechanisms 
(European Bioinformatics Institute, no date; Plebani, 2005; Shah, 2011; World Health Organization, 
2016b; Lowe et al., 2017; Manzoni et al., 2018). All the “omics” biomolecular techniques have their 
appropriate applications as well as their unique advantages and disadvantages. Genomic material, 
unless altered by the environment, is quite static and eludes to the possible phenotypes that can 
occur; transcriptomics can show which genes and transcripts are active and exerting an influence 
on an organism, but does not elude to the concentrations of proteins produced by the mRNA 
transcripts; proteomics can provide information regarding the structure, function, abundance, 
interactions and properties of proteins but, at this stage, only known proteins can be identified and 
further work is necessary to trace their origins and functions (Plebani, 2005; Gupta and Kumar, 
2014).  
Even with the challenge that the novelty of the field of proteomics presents regarding the number 
of proteins (and their variants) that are yet to be discovered, it continues to be an attractive 
molecular technique as it is able to capture the dynamic state of a cell during different physiological 
and pathological states, thereby representing the link between genes, proteins and diseases 
(Petricoin et al., 2002).  
 Proteomics 
Proteins are the actual “factories” of a cell. They control cellular functions (in the form of receptors, 
enzymes, transporters, regulatory proteins and co-factors) and give structure to all cells. The 
production of proteins is greatly dependent on the physiological state of a cell, and it is therefore 
proteins that are responsible for cell phenotypes. (Graves and Haystead, 2002; Plebani, 2005; 
Wright et al., 2012; Silverthorn et al., 2014) 
Proteomics can also be described as the characterization of the complete protein complement of 
an organism, cell or tissue (O’Farrell, 1975; Wasinger et al., 1995; Wilkins et al., 1996). Protein 
expression and function are altered in different physiological conditions and diseases, and the goal 
of proteomics is to assesses the signalling, metabolic and regulatory proteins (and thus networks) 




occur (Anderson, Matheson and Steiner, 2000). Furthermore, the comparison of protein expression 
between different samples (e.g. normal vs. diseased tissue) that differ by some variable, known as 
expression proteomics, enables the identification of disease-specific proteins and markers, 
allowing for the elucidation of disease mechanisms.  
A typical proteomics experiment has 3 phases: i) separation and isolation of proteins; ii) elucidation 
of protein structural information for the identification and characterization of proteins present; iii) 
searching of protein sequences in a database to identify proteins and their functions (Graves and 
Haystead, 2002).  
 Protein separation and isolation 
Proteins are complex and made of multiple amino acid sequences that are folded into different 
structures with differing complexities (Silverthorn et al., 2014). These proteins therefore need to be 
broken down into their individual components so that they can be visualized and their sequences 
identified and characterized. 
Two predominant methods are utilized for this purpose: gel electrophoresis and/or protein 
digestion. During the earlier years of proteomics, gel electrophoresis was a gold-standard method 
for the separation of proteins. In this method, proteins are solubilized using sodium dodecyl 
sulphate (SDS) and separated by electrophoresis through a polyacrylamide gel according to mass 
(1-dimensional electrophoresis, 1-DE) or mass and charge (2-dimensional electrophoresis, 2-DE) 
(Aebersold et al., 1987; Anderson and Anderson, 1996). The more complex protein mixtures, such 
as protein lysates, are resolved using 2-DE. This method is also able to resolve proteins which 
have undergone post-translational modification as this modification results in a difference in protein 
charge and a difference in mass. 1-DE and 2-DE produce gels with spots which denote the 
presence of different proteins, and it allows the quantitative and qualitative comparison of gels from 
different samples (e.g. control and diseased); the appearance or disappearance of spots denotes 
the presence or absence of a protein compared to the other sample, while the intensity of the spot 
denotes the quantity of the protein present (its expression) (Plebani, 2005). Gel electrophoresis 
has advantages and disadvantages: it is reproducible and can resolve a wide range of protein 
masses, but it is time consuming. Additionally, large hydrophobic proteins do not enter the gel and 
extremely acidic or basic proteins are not well resolved. It also does not allow for proteins found in 
small concentrations to be analysed, even though the change in expression between samples 
could be significantly different (Celis and Gromov, 1999; Görg et al., 2000).  
Protein digestion is the conversion of proteins into peptides by means proteolytic enzymes, usually 




purified via several different methods such as liquid chromatography (LC) before being analysed 
(Opiteck et al., 1997; Link et al., 1999). This method bypasses gel electrophoresis and significantly 
more proteins can be represented in the peptide mixture.  
 Elucidation of protein structure 
Proteins that have been separated by gel electrophoresis can either be digested directly from the 
gel (in-gel digestion) via a protease, or be transferred electrophoretically (electroblotted) onto an 
inert membrane such as nitrocellulose in order for proteins to be visualized on the membrane 
surface. In the latter, the proteins are excised from the membrane and fragmented via cleavage of 
proteins at methionine or tryptophan residues into large peptide fragments. If in-gel digestion has 
been used, the proteins are digested into peptides directly from the gel and not placed on a 
membrane (Snevechenko et al., 1996). The peptides then need to be purified to remove 
contaminants that are generated during an in-gel digest including detergents, salts and buffers 
which could interfere with the sequencing instrument (Yates, 1998); this can be done using 
methods such as high-pressure liquid chromatography (HPLC). The protein fragments are then 
placed into a sequencing instrument in order for amino acid sequences to be elucidated. This was 
previously performed on an Edman sequencer but more regularly a mass spectrophotometer (MS) 
(Aebersold et al., 1987; Celis and Gromov, 1999; Graves and Haystead, 2002).  
MS is an analytical method which allows structural information about proteins and peptides to be 
obtained, such as peptide masses and amino acid sequences. This information can then be used 
in protein identification and to determine the presence and location of protein modifications 
(LibreTexts Chemistry, no date; Graves and Haystead, 2002).  
Sequencing via MS requires peptide molecules to be charged and dried, which occurs via 
ionization. The predominant forms of ionization includes electrospray ionization (ESI) and matrix-
assisted laser desorption/ionization (MALDI). In ESI, peptides are allowed to flow into the 
microcapillary tubing of the MS instrument to make their way to the opening (inlet) of the MS, a 
process which creates a potential difference between the capillary tubing and the inlet, resulting in 
the peptides being dispersed into a fine mist of charged droplets as they enter the MS. The 
electrospray can additionally be connected to an LC system, which purifies the droplets as they 
enter into the MS. In MALDI, proteins are ionized by being incorporated into organic molecules 
which absorb UV radiation (called matrix molecules) and then irradiating the proteins and peptides 
with a laser (Karas and Hillenkamp, 1988; Yates, 1998).  
The MS has a built-in mass analyser which is a component that takes ionized proteins and 




detector. The detector then senses the proteins and creates a digital output (Yates, 1998). The 
masses of the individual peptides are measured and a mass spectrum is created. There are 
several mass analysers available, each with different applications: 
Quadrupole mass analysers transmit ions through an electrical field created by four parallel metal 
rods, known as the quadrupole. It either filters ions according to their m/z ratio before they are 
transmitted or it transmits all ions through the electrical field. If multiple quadrupoles are combined, 
as seen in triple quadrupoles, they can effectively obtain information regarding the amino acid 
sequence of a peptide (Yates, 1998; Graves and Haystead, 2002). 
Time-of-flight (TOF) mass analysers make use of a tube which is a vacuum containing two parallel 
electrodes and a detector at the end of the tube. Ionized proteins and peptides (ions) are energized 
by the electrodes (which create an electrostatic field at the beginning of the mass analyser) and 
this energy creates a beam of high energy ions that “shoots” the ions towards the detector. The 
beam of ions moves through a 1-2 meter portion of the tube with no electrical or magnetic field 
(field-free region) before striking the detector. The ions essentially “fly” through this field-free region 
due to their newly acquired energy – the field-free region is therefore named a “flight tube”. TOF 
measures the protein and peptide m/z ratios by measuring the time that it takes for ions to move 
through the length of the flight tube. The heavier ions will take longer to reach the sensor. (Karas 
and Hillenkamp, 1988; Guilhaus, Mlynski and Selby, 1997; Guilhaus, Selby and Mlynski, 2000) 
Ion trap analysers make use of electric or magnetic fields to trap ions within the mass analyser 
(Clarke, 2016). This is similar to the quadrupole, but the parallel rods are replaced by two 
electrodes which face each other as well as a ring electrode halfway between the two electrodes. 
Ions are thus trapped in a circular flight path due to the electric field, but linear electric fields can 
also be generated by changing the configuration of the electrodes. An example of this type of 
analyser is the Orbitrap – this stores ions in a stable flight path (an orbit), and the frequency of an 
ion’s orbit around the electrode is related to its m/z ratio.  
 Database search 
Once the structural information of a protein has been acquired through MS, this information can be 
used for protein identification. Online databases can be searched using MS data to accurately 
identify large numbers of proteins (Quadroni and James, 1999). The most specific online 
databases use amino acid sequences of peptides to identify the proteins from which the peptides 
were derived. Numerous databases are available, and these allow the identification of proteins 
from raw MS data, examples of which include SEQUEST, Mascot and SONAR (Eng, McCormack 




 Choice of proteomics method for this study 
The most commonly used MS to obtain amino acid sequences is the triple quadrupole (Graves and 
Haystead, 2002). This version of the quadrupole uses two stages of the analysis: i) Once all the 
proteins and peptides have been ionized, the instrument scans all ions above a certain m/z ratio 
and transmits these ions to its third quadrupole; ii) The instrument undergoes a second MS scan 
(therefore called MS/MS mode or Tandem mass spectrophotometry) where the selected ions are 
channelled into a collision chamber and strike one another, breaking into fragments. This 
fragmentation allows peptide bonds to be broken. The fragments are then determined based on 
their m/z ratio by the third quadrupole, and the amino acid sequence of each of the fragments can 
be determined (as each amino acid has a unique mass). 
2.9. Purpose of research  
The last decade has provided numerous studies investigating the link between obesity and male 
fertility. Numerous mechanisms have been elucidated and information has been provided about 
the various pathways which become dysfunctional.  
Even with all of this knowledge, there is a great deal that is unknown about both obesity and 
infertility, and how these pathologies interchangeably affect each other. Moreover, non-consensus 
on some of the disease causing mechanisms and resulting pathological changes leaves a lot 
unanswered regarding the true consequences of both of these disorders. Could it be that the 
individuals that show pathological changes are merely the ones that have succumb to the 
onslaught of damage that ensues when an individual becomes obese? To what extent is fertility 
affected and could there be more molecular changes occurring that are undetectable at the gross 
level of functioning? 
New molecular techniques such as genomics, transcriptomics, proteomics and metabolomics that 
have been made possible by the decoding of the human genome through the Human Genome 
Project have provided us with the ability to research biomolecular changes that could be occurring 
within a diseased individual. Moreover, they have been shown to provide insights into disease-
causing mechanisms. Molecular techniques may provide a great avenue to discover the more 
intrinsic changes that obesity may give rise to and, furthermore, aid in the discovery of 
mechanisms through which obesity can act to bring about the observed changes in infertile men.  
2.10. Aims and objectives 




• To examine the effects of obesity on male fertility by observing specific macroscopic, 
microscopic and molecular changes to structure and function in a diet-induced obese 
animal model  
• To examine changes in protein expression within the reproductive tissues of the obese 
subjects, quantify these changes, and identify the affected molecular pathways  
The aims are thus threefold:  
Aim 1: To establish an animal model of obesity by means of an obesogenic diet 
Objectives 
- Measure anthropometric and macroscopic measurements including body weight, 
visceral fat weight and adiposity to ascertain the establishment of the obesity model 
- Monitor other macroscopic changes including testicular weight and haematocrit  
Aim 2: To assess microscopic and molecular changes related to obesity and potential male fertility 
Objectives 
- Measure sperm parameters (viability and morphology), histological sections (testis and 
epididymis), hormone levels (testosterone and estradiol), unfasted glucose and 
oxidative stress parameters 
- Corroborate experimental data with data found in literature  
Aim 3: Perform proteomic analysis on reproductive tissues (testis, epididymis, spermatozoa) in 
order to identify differences in protein expression between obese and control animals 
Objectives 
- Determine proteins over- and under-expressed in obesity 
- Relate changes in protein expression to the observed changes in anthropometric, 
macroscopic, microscopic and molecular parameters 
- Perform enrichment analysis to determine molecular pathways that are up- and down-
regulated in obesity 
- Perform functional network analysis and identify affected protein networks. Visualise the 
protein networks affected by changes in protein expression 
- Correlate changes in protein expression to the macroscopic, microscopic and molecular 




Hypothesis: We hypothesise that the chronic diet-induced obesity model will have a negative 






3. Chapter 3: Materials and Methods 
This chapter will provide a detailed account of the study procedures, the animal model and the 
materials and methods utilized during the course of the study.  
3.1. Ethical Clearance 
Project approval was obtained from the Research Ethics Committee: Animal Care and Use (REC: 
ACU) of the Faculty of Medicine and Health Sciences, Stellenbosch University after the study was 
deemed to comply with the guidelines of the revised South African National Standard for the Care 
and Use of Animals for Scientific Purposes. 
Ethical approval was granted for the parent study titled, “High fat diet and obesity: effects of 
melatonin”. An amendment to the initial protocol to include the harvesting of reproductive organs 
and plasma for the purposes of this study from rat carcasses was approved.  
Ethics Reference Number: SU-ACUM13-00035. 
3.2. Study design 
The figure below (Figure 3.1) provides an overview of the experimental groups used in the study, 
as well as the analyses performed under each type of interrogation that was carried out.  
Figure 3.1 Diagram outlining the experimental design followed, the individual study groups as well as the 
analyses carried out during the course of the study (T = testosterone, E = estradiol). The study used forty male 






Forty male Wistar rats were utilized for this study (breed originating from Charles River, United 
Kingdom, Ltd.). The animals were bred and maintained at the Stellenbosch University Animal 
Facility under conventional environments (22°C, ±40% relative humidity, 12 hour day/night cycle) 
with ad libitum access to food and water until ± 6 weeks of age or until adequate weights (200-220 
g) were obtained. Animals were then randomly and equally divided into control (age-matched) and 
diet-induced obesity (DIO) groups where they received a high caloric diet or standard rat chow for 
54 weeks, respectively.   
The diet used for this model was based on a hyperphagia inducing diet adapted from Pickavance 
and coworkers (Pickavance et al., 1999), successfully implemented by previous studies (Huisamen 
et al., 2012; Salie et al., 2014), where standard commercially available rat chow was supplemented 
with both sucrose and Holsum cooking fat (68% saturated fat, 26% mono-unsaturated fat and 5% 
poly-unsaturated fat) (Sime Darby Plantation, Liberia). Diet compositions are summarized in Table 
3.1 below: 
Table 3.1 Macronutrient composition of diets used in the rat feeding protocol. Analysis of the diets was performed 
by Microchem (Cape Town, South Africa). (DIO, Diet-induced obesity) 
 
Control DIO 
Carbohydrate (%) 34.6 42 
Protein (%) 17.1 8.3 
Total fat (g/100g) 4.8 11.5 
Saturated fat (g/100g) 0.9 7.6 
Cholesterol (mg/100g) 2.2 13 
Sucrose (g/100g) 5.3 25.4 
 
At 60 weeks of age, rats were sacrificed by euthanasia using an overdose of sodium pentobarbital 
(intraperitoneal 100mg/kg). Each animal had their body weight measured and immediately 
examined post-mortem to determine visceral fat weight and non-fasting blood glucose. Blood was 
collected from the thoracic cavity and used for plasma extraction and haematocrit analysis. Testes 




parameter evaluations, histological analysis, protein determination, antioxidant evaluation 
(catalase, superoxide dismutase, glutathione, lipid peroxidation), and proteomic analysis. 
3.3. Anthropometric and macroscopic parameters 
 Body weights and body fat 
The body weights of fully sedated male Wistar rats were recorded using a Mettler (Mettler K5, 
E.Mettler, Zurich) scale. At post-mortem, an incision was made across the abdomen to allow 
access to abdominal fat depots, where retroperitoneal, epididymal and omental fat were removed; 
the combined weight of the three fat deposits were recorded and expressed as the visceral fat 
weight. The Adiposity Index (AI) was determined by substituting the body weight and weights of 





where Total Body Fat = Epididymal fat + Retroperitoneal fat + Omental fat. 
The AI was used as a measure of obesity. This index is a measure of fat storage, demonstrating 
the degree of adipose tissue accumulation in a study animal (Levin et al., 2003; Sinitskaya et al., 
2007; Leopoldo et al., 2016). Animals with an AI of 10-25% above the mean body weight of the 
age-matched controls were considered to be moderately obese, while those with ≥40% increase 
were considered to be morbidly obese (Levin et al., 2003; Woods et al., 2003; Leopoldo et al., 
2016).  
Immediately after collection, the testes were dissected free from associated tissue and weighed 
using a Mettler Toledo Ab204-5 digital scale (Mettler-Toledo, Columbus, Ohio, USA).  
 Haematocrit 
Whole blood from the chest cavity was collected into two non-heparinized capillary tubes for 
haematocrit analysis. The tubes were then sealed using white sealing clay and centrifuged in a 
micro-haematocrit centrifuge (Hawksley, Lancing, UK) at 2500xg for 5 minutes to allow maximum 
packing of red cells. Haematocrit was subsequently determined with a haematocrit tube reader 




3.4. Microscopic parameters  
 Semen analyses 
Rat epididymides harvested from each rat were placed in a petri dish containing a 5ml solution of 
Hams F-12 nutrient media (Sigma Chemicals, St Louis, MO, USA) supplemented with 3% Bovine 
Serum Albumin (BSA) (Roche Diagnostics GmbH Mannheim, Germany) at 37°C. The caudal 
portion of each epididymis was resected by radial section using fine pointed scissors and placed in 
2ml of 3% Hams-BSA solution for 5 minutes, with occasional agitation to facilitate the release of 
sperm into the media.  Morphology and viability analyses were performed on sperm suspensions 
from both groups to determine sperm quality. 
 Morphology and morphometry 
For morphology analysis, 10µl of sperm was pipetted and smeared onto a glass slide. After air 
drying at room temperature, slides were immersed into a staining tray containing SpermBlue® 
(Microptic SL, Barcelona, Spain) fixative for 20 minutes, and stained thereafter using SpermBlue® 
stain for 15 minutes in the same manner. Stained slides were then gently immersed in distilled 
water for 3 seconds to remove excess stain, allowed to air dry, and mounted using DPX mountant 
(Merk Millipore, Modderfontein, Gauteng) and a coverslip. Sperm morphometry was performed by 
means of computer-aided sperm analysis (CASA) using the Sperm Class Analyser version 6 Rat 
Tox (SCA®; Microptic, Barcelona, Spain) software and a Nikon E50i, with bright field optics at 600 
x magnification using a blue filter. Analyser settings were as follows: optics Ph+; contrast 166; 
brightness 465; scale 600x; capture 100 images per slide. The SCA software automatically 
analyses spermatozoa to detect acrosome, head and mid-piece defects, and accurately measures 
these and other variables to determine whether sperm are normal or abnormal. 
 Viability 
Viability determines the integrity of sperm plasma membranes by means of a dye exclusion 
technique. Sperm (10µl) was mixed with eosin (Sigma-Aldrich, South Africa) and nigrosin (Sigma-
Aldrich, South Africa) dyes (1:1:1 ratio) in a 2ml Eppendorf; 10µl was pipetted out onto a glass 
slide and a thin smear was made. Smears were allowed to air dry then mounted using DPX 
mounting medium and a coverslip. 200 cells were counted using a Nikon Eclipse E200 light 
microscope (Tokyo, Japan) at 40x magnification. Live spermatozoa remained unstained as their 
membranes were impermeable to eosin while the dead sperm stained red, indicating permeability 
and a damaged membrane. The number of viable sperm was expressed as a percentage of the 





Tissue collection and fixation 
Immediately after collection, testes and epipidymides were freed from associated tissue and placed 
in specimen containers containing 10% paraformaldehyde (formalin) solution, for a minimum of 48 
hours to allow fixation. This fixation step stops tissue degradation and cytosis and ensures that 
structural integrity is maintained. Tissues were processed for embedding in paraffin wax. This was 
done in a 3-step process which includes dehydration in alcohol, clearing in xylene and infiltration 
with paraffin wax, all done automatically using a Duplex processer (Shandon Elliott). Tissues were 
placed in metal embedding moulds and filled with wax; cassettes were fixed to the moulds and 
placed onto an iced surface to set, creating tissue blocks. Tissue blocks were trimmed and cut into 
uniform 5μm thick sections using a microtome (Ultra- cut UCT, Leica, Vienna, Austria). Sections 
were then placed into a 40⁰C water bath before being mounted onto glass slides and stained using 
haematoxylin and eosin (H&E) stains. Slides were then mounted using DPX mounting medium and 
glass coverslips to complete the histological preparation process. 
Analysis 
Microscopic evaluation of the morphological features of testicular and epididymal tissues were 
performed using a Leica photomicroscope (Leica Microsystems, Wetzlar, Germany), equipped with 
an Olympus C-5060 digital camera (Olympus, Tokyo, Japan) to capture photomicrographs at a 
constant magnification (x 10). Micromorphometric analyses of the tissue samples were performed 
using Quick Photo Micro Image software, version 4 (Olympus, Tokyo, Japan). Qualitative analysis 
of the microscopic structure of the testes and epididymis were assessed at first. Relative volumes 
(%) of the epithelium, lumen and interstitium were then subsequently evaluated, followed by the 
evaluation of metric parameters (μm) - the diameter of the seminiferous and epididymal tubules, 
epithelial height and lumen diameter. 
3.5. Molecular analyses 
 Blood glucose 
Non-fasting blood glucose was measured via collection of blood from a tail prick. A drop of blood 
was then placed onto the absorbent film of a slip that was immediately inserted into a glucometer 




 Hormone analyses 
Hormone analyses were performed using plasma. Blood samples collected from the abdominal 
cavity were placed into EDTA blood tubes using a Pasteur pipette and placed on ice for 30 minutes 
before being centrifuged at 1000 x g (10min, 4⁰C) to yield plasma. 
 Testosterone 
The plasma levels of this hormone were quantified using a commercially available enzyme-linked 
immunosorbent assay (ELISA; Demiditec Diagnostics GmbH, Kiel, Germany) which makes use of 
competitive binding principles to determine unknown testosterone concentrations. Microplate wells 
were pre-coated with testosterone antiserum directed towards antigen sites of testosterone 
molecules. The testosterone present within experimental samples competes with a defined amount 
of testosterone-horseradish peroxidase conjugates to bind to antiserum binding sites. After 
incubation, the unbound conjugates are removed through multiple washing steps. The amount of 
peroxidase conjugates bound inversely corresponds to the testosterone concentration in each 
sample. After a substrate solution is added, the intensity of the colour reaction is inversely 
correlated to the optical density (OD) measured.   
10 µl of each standard (0, 0.1, 0.4, 1.5, 6.0, 25.0 ng/ml), control and samples were pipetted into 
microplate wells in triplicate. 100 µl of incubation buffer was added into each well, followed by 50 µl 
of enzyme conjugate. These solutions were incubated at room temperature for 1 hour on a 
microplate mixer/shaker. The contents of the wells were then expelled and microplates thoroughly 
rinsed with a 4 step wash using 300 µl of diluted wash solution. Wash solution was then completely 
removed by vigorous beating of the microplate on absorbent paper to eliminate any residual 
droplets. 200 µl of substrate solution was then dispensed into each well and incubated in the dark 
for 30 minutes. The enzymatic reaction was then halted with the addition of 50 µl of stop solution. 
Absorbance was measured at 450nm within 15 minutes of the addition of stop solution. 
A standard curve was created by plotting protein standards on the x-axis vs 450nm absorbance 
readings of the standards on the y-axis in Excel. A calibration curve was used to calculate sample 
protein concentrations (ng/ml) using the mean absorbance readings of each sample. 
 Estradiol 
The plasma levels of this hormone were quantified using a commercially available enzyme-linked 
immunosorbent assay (ELISA; DRG Diagnostics GmbH, Marburg, Germany) which makes use of 
competitive binding principles to determine unknown estradiol concentrations. Microplate wells 




estradiol present within experimental samples competes with a defined amount of estradiol-
horseradish peroxidase conjugates to bind to antiserum binding sites. After incubation, the 
unbound conjugates are removed through multiple washing steps. The amount of peroxidase 
conjugates bound inversely corresponds to the estradiol concentration in each sample. After a 
substrate solution is added, the intensity of the colour reaction is inversely correlated to the optical 
OD measured.   
Each standard (0, 25, 100, 250, 500, 1000, 2000 pg/ml), control and samples (25 µl) were pipetted 
into microplate wells in triplicate. Enzyme conjugate (200 µl) was inserted into each well using a 
multi-channel pipette and mixed rigorously for 10 seconds. These solutions were then incubated 
uncovered at room temperature for 2 hours. The contents of the wells were then discarded and 
microplates thoroughly rinsed with a 3 step wash using 400 µl of diluted wash solution. Wash 
solution was then completely removed by vigorous beating of the microplate on absorbent paper to 
eliminate any residual droplets. Substrate solution (100 µl) was then dispensed into each well and 
the microplate incubated at room temperature for 15 minutes. The enzymatic reaction was then 
halted with the addition of 50 µl of stop solution. Absorbance was measured at 450±10nm within 
10 minutes of the addition of stop solution.  
A standard curve was created by plotting protein standards on the x-axis vs 450nm absorbance 
readings of the standards on the y-axis in Excel. Sample protein concentrations (pg/ml) were read 
off the standard curve using the mean absorbance readings of each sample. 
 Protein determination 
The amount of protein present in each tissue sample had to be quantified prior to antioxidant and 
proteomic analysis. This was in order to determine whether adequate protein concentrations were 
present in each sample (for proteomics) and as a variable used to calculate antioxidant 
concentrations (per milligram of protein for catalase and superoxide dismutase assays). Testis and 
epididymis tissue as well as sperm pellets (200mg) were thawed on ice and placed in Sorvall tubes 
after which 2mL of lysis buffer (Table 3.2) was added. The tissue was then homogenized on ice 
using a polytron. Homogenates were transferred to appropriately marked Eppendorf tubes and 
centrifuged at 10000 x g (15 minutes, 4⁰C). Supernatants were pipetted out without agitating the 
pellet, transferred to new marked Eppendorf tubes and kept on ice. Two different protein 
determination procedures were used to determine protein concentrations of the collected tissues; 
bicinchoninic acid (BCA) and Bradford protein determination assays. This is due to the constituents 
of the respective lysis buffers used for the antioxidant and proteomic assays. The presence of SDS 
interrupts the bonding of the coomasie blue dye used in Bradford assays, providing an incorrect 





The BCA protein determination assay is formulated based on bicinchoninic acid (BCA), utilizing 
colorimetry to detect and quantify total protein. It uses the reduction reaction of Cu2+ to Cu+ caused 
by proteins in alkaline media, a chemical reaction called the biuret reaction. A certain reagent 
containing BCA is used to sensitively and selectively detect the colorimetric change that occurs 
when the cuprous anion (Cu+) is emitted by proteins. A purple colour change occurs when two 
BCA molecules chelate with one cuprous anion, allowing a powerful absorbance at 562nm which 
increases with increasing protein concentrations in an almost linear fashion over a 20–2,000 μg/ml 
range.  
Each standard and sample (25μL) were pipetted into microplate wells in triplicate. 200 μL of 
Working Reagent was then added to each well and placed on a plate shaker for 30 minutes to 
ensure thorough mixing. The plate was then covered to prevent dehydration and incubated for 30 
minutes in a CO2 incubator (Heal Force, Shanghai, China). The microplate was then cooled to 
room temperature before absorbance readings were taken. Absorbances were measured at 
~562nm using a plate reader (FLUOstar Omega, BMG Labtech, Offenburg, Germany). A standard 
curve was the plotted using the known concentrations vs 562nm absorbance measurements of the 
standards. This was then used to determine the concentration of each sample. 
 Bradford 
The Bradford protein assay uses spectrophotometric analysis to measure the protein content of a 
solution. It includes several steps, which are outlined below: 
3.5.3.2.1. Setup 
Bradford reagent was formulated by combining 20ml of Bradford stock solution (0.6mM (w/v) 
Coomassie Blue G-250, 95% (v/v) ethanol and 85% (v/v) phosphoric acid) with 80ml of dH2O in a 
1:5 ratio, which was then filtered twice using two filter papers. Bradford standards of known 
concentration were prepared using serial dilutions of bovine serum albumin (BSA). These were 
used to create a standard curve by plotting 595nm absorbance readings of the standards vs their 
known protein concentrations (1-20μg range). Unknown sample protein concentrations were then 
determined using the resultant linear equation of this curve. Tubes were then set out on a rack in 






3.5.3.2.2. Sample dilution 
Two dilution steps were used to prepare samples for analysis. An initial 1:10 dilution (10µl sample 
supernatant + 90µl dH2O) was performed on the experimental samples (row A), after which a 1:20 
dilution was performed where 5μl was taken from samples in row A, placed into corresponding 
tubes (row B) and diluted with 95μl dH2O. This was done to ensure protein concentrations of the 
experimental samples do not exceed that of the highest standard (20μg), allowing the unknown 




 Figure 3.2: Diagram showing a setup example for a Bradford assay of 12 samples. Row A is the first dilution and contains a 
single file of tubes labelled 1-12, one for each sample. Row B is the second dilution step and contains tubes labelled 1-12 in 




Table 3.2: Composition of lysis buffer used to create testis, epididymis and sperm homogenates for antioxidant 
analyses 
Reagent Stock solution Concentration of 
working solution 
Amount used for 
30mL lysis buffer 
Tris-HCl EGTA  
(pH 7.5) 
200mM 20 mM 3 mL 
EDTA 100mM 1 mM 300 µL 
NaCl 1M 150 mM 4.5 mL 
β-glycerolphosphate  1 mM 0.006 g 
Tetra-Na-
Pyrophosphate 




0.018 mg/10mL 1 mM 3 mL 
Leupeptin and 
Aprotinin 
10 µg/mL 10 µg/mL 30 µL 




50 µg/mL 10 µg/mL 90 µL 






The Bradford protein assay uses spectrophotometric analysis to measure the protein content of a 
solution. It includes several steps, which are outlined below: 
Filtered Bradford reagent (900μl) was then added to all standards and samples in row B and 
vortexed. Solutions were allowed to stand for 15 minutes before measurement with a 
spectrophotometer at 595nm. Spectrophotometric readings were performed on the standards 
starting with the blank to set the “zero”, then read from 10 to 80; samples were read from 1 to 12.  
The standard curve was plotted using the known protein concentrations/standards (x-axis) vs 
595nm absorbance (OD) readings of the standards (y-axis) using Chart Wizard in Excel. A 
trendline is then added to the curve, and the resultant straight line equation used to calculate 
sample protein concentrations (µg protein per ml). 
 Oxidative stress parameters 
Mammals have an innate enzymatic antioxidant system which regulates the amount of ROS within 
their bodies, protecting against oxidative stress. The reproductive system, sperm in particular, 
possesses this system, with the quantity of each antioxidant enzyme varying between species. 
Enzyme activity was quantified using enzymatic antioxidant assays, measuring enzyme activities 
between the control and experimental group 
 Catalase 
Catalase is an abundant antioxidant enzyme found in nearly all aerobic organisms. It is responsible 
for catalysing the breakdown of a powerful ROS molecule, hydrogen peroxide (H2O2), into oxygen 
(O2) and water (H2O). H2O2 is a by-product of normal aerobic metabolism and found to be toxic 
when present in large quantities, i.e. in conditions causing pathogenic ROS production. Catalase is 
responsible for the degradation of the majority of H2O2, thereby detoxifying a system. 
3.5.4.1.1. Tissue preparation 
Tissue samples were thawed at room temperature then placed on ice to prevent enzymatic 
reactions from taking place. Each tissue (±200mg) was resected using fine pointed scissors, 
placed in 2ml cold phosphate buffer, and homogenized on ice using a polytron. Homogenates were 
then transferred to appropriately marked Eppendorf tubes and centrifuged at 10000 x g (15 
minutes, 4⁰C). Supernatants were pipetted out without agitating the pellet, transferred to new 




BCA protein determination was performed on all tissue homogenates (testis and epididymis). 
3.5.4.1.2. Assay 
Each standard and sample (20μL) were pipetted into UV microplate wells in triplicate.  Catalase 
assay buffer (150μL) was dispensed into each well using a multi-channel pipette. Catalase’s 
enzyme reaction was activated with the addition of 75 μL of H2O2 and immediately analysed on a 
plate reader (Multiskan spectrum) at 240nm using SkanIt RE for MSS 2.2 (ThermoScientific™ Inc.) 
software. The software recorded the linear absorbance decrease of catalase for 1 minute at 15 
second intervals.  
The average absorbance (ΔA/T) was calculated for each standard and sample. The absorbances 
of the standards were then corrected by subtracting the average absorbance of standard A, then 
plotted as a function of the catalase activity (U/ml). Catalase activity (CAT) of all samples was then 
calculated by substituting corrected absorbance values of all samples into the following equation, 
acquired from the linear regression of the plotted standard curve:  
CAT (U) = [(sample absorbance – y-intercept)/slope x 0.25mL/0.005mL]. 
Catalase activity was expressed as U/mg protein concentration. 
 Superoxide dismutase  
Superoxide dismutase (SOD) is an essential, widely distributed antioxidant enzyme within aerobic 
cells. SOD is responsible for dismutation of the superoxide anion (O2ˉ), an abundant reactive 
oxygen specie (especially within the mammalian reproductive system), into H2O2 and O2. 
Superoxide dismutase is increased in conditions causing pathogenic ROS production to prevent 
tissue damage by O2ˉ and its metabolites. 
SOD was measured using a microplate SOD enzyme assay dependent on the spectrophotometric 
assessment of O2-.  The assay uses two chemicals, 6 hydroxydopamine (6HD) and 
diethylenetriaminepentaacetic acid (DETAPAC), to generate O2- anions, which are reduced in the 
presence of SOD. The reaction yields a colorimetric signal where samples with reduced amounts 
of SOD emit a lesser signal. SOD activity was calculated using a resultant linear regression curve, 
where activity was expressed as U/mg protein concentration.  
3.5.4.2.1. Tissue preparation 
Tissues were prepared in the same procedure outlined in the Catalase tissue preparation protocol, 




Tissue homogenates contained both cytosolic and mitochondrial SOD. Centrifuging the 
supernatant at 1000 x g (15 minutes, 4⁰C) separated the two enzymes, keeping cytosolic SOD in 
the supernatant and containing the mitochondrial SOD within the pellet. The supernatant was used 
to measure cytosolic SOD activity. 
BCA protein determination was performed on all tissue homogenates (testis and epididymis). 
3.5.4.2.2. Assay 
The SOD enzyme assay measures the auto-oxidation of 6-HD. One unit of SOD is defined as the 
amount of SOD required to exhibit 50% dismutation of the O2ˉ radical.  
12μL of each standard and sample were pipetted into microplate wells in triplicate.  170 μL assay 
buffer was dispensed into each well using a multi-channel pipette. SOD’s enzyme reaction was 
activated with the addition of 15 μL of 6-HD and immediately analysed on a plate reader (Multiskan 
spectrum) at 490nm using SkanIt RE for MSS 2.2 (ThermoScientific™ Inc.) software. The software 
recorded linear absorbance decreases of catalase for 4 minutes at 1 minute intervals. 
The average absorbance (ΔA/T) was calculated for each standard and sample. Standard A’s 
absorbance was divided by itself, and the absorbance of the remaining standards and samples 
divided by the average absorbance of standard A to produce a linearized rate (LR), then plotted as 
a function of the final SOD activity (U/ml). SOD activity of all samples was then calculated by 
substituting linearized absorbance values of all samples into the following equation, acquired from 
the linear regression of the plotted standard curve:  
SOD (U/mL) = [(sample LR – y-intercept)/slope] x sample dilution 
SOD activity was expressed as U/mg protein concentration 
 Glutathione 
Widely distributed in both animals and plants, Glutathione (GSH) is a co-factor essential in the 
reduction of lipid hydroperoxides into their corresponding alcohols and H2O2 to H2O, through 
electron donation to glutathione peroxidases (GPx). GSH bears the brunt of ROS attack by 
buffering high levels of H2O2 through its oxidation into a disulphide dimer, oxidised glutathione 
(GSSG). 
This assay quantifies GSH via an enzymatic recycling method which uses glutathione reductase 




reducing the GSH:GSSG ratio. Thus, the GSSG:GSH ratio and the enumeration of GSH are good 
indicators of the oxidative status of cells and tissues.  
GSH’s sulphhydryl group reacts with a colorimetric detector, 5,5,’-dithiobis-2-nitrobenzoic acid 
(DTNB), converting it to 5-thio-2-nitrobenzoic acid (TNB) to produce a yellow colour. The resultant 
mixture of TNB with GSH (GSTNB) is reduced by GR, catalysing the production of more TNB and 
the recycling of GSH. The rate at which TNB is produced directly correlates to this enzyme recycle 
reaction, which in turn, is directly proportional to the amount of GSH within a sample. The 
absorbance of TNB is measured at 405 or 414nm by a fluorometer, providing an accurate 
approximation of the GSH concentration. The use of GR allows both GSH and GSSG to be 
quantified, reflecting total glutathione.  
3.5.4.3.1. Tissue preparation 
Tissues were prepared in the same procedure outlined in the Catalase tissue preparation protocol, 
as shown above. 
3.5.4.3.2. Assay 
Each standard and sample (50μL) were pipetted into microplate wells in triplicate. Assay buffer 
(50μL) was dispensed into each well using a multi-channel pipette. DTNB (50μL) was then added 
to every well followed by 50μL GR. The solution was mixed and incubated for 5 minutes at room 
temperature. The reaction was activated with the addition of 50μL NADPH and immediately 
analysed on a plate reader (Multiskan spectrum) at 412nm using SkanIt RE for MSS 2.2 
(ThermoScientific™ Inc.) software. The software recorded the linear absorbance for 5 minutes at 
1-minute intervals. 
The absorbance values for all standards and samples were plotted as a function of time, creating 
an i-slope. Plotting the i-slope of each standard as a function of the concentration of total GSH then 
created an f-slope. 
Total GSH activity of all samples was then calculated by substituting the absorbance values of all 
standards and samples, calculated from the i- and f-slopes, into the following equation: 
Total GSH or GSSG concentrations (µM GSH) = {(i-slope for sample) – (y-intercept)}/f-slope x 




 Thiobarbituric Acid Reactive Substances (TBARS) 
Oxidative stress results in cellular injury through several mechanisms, lipid peroxidation being a 
prominent one. Malondialdehyde (MDA) is a typical product of lipid peroxidation. Polyunsaturated 
fats yield lipid peroxides, which, due to their instability, disintegrate into several compounds 
including reactive carbonyl compounds, i.e. MDA.  
Biological specimens under oxidative stress contain Thiobarbituric Acid Reactive Substances 
(TBARS) such as aldehydes and hydroperoxides, which increase with increasing oxidative stress. 
MDA forms adducts with TBARS, thiobarbituric acid in particular, with which it forms a 1:2 adduct. 
This MDA-TBA complex, forming under acidic, high temperature (90-100⁰C) conditions, elicits a 
colorimetric reaction measured with a fluorometer at 530-540nm. This assay is therefore a direct 
measure of the amount of MDA present in a sample, indicating the amount of lipid peroxidation 
taking place.  
3.5.4.4.1. Tissue preparation 
Tissues were prepared in the same procedure outlined in the Catalase tissue preparation protocol, 
as shown above, using 10% Trichloroacetic acid (TCA) as the homogenizing media. 
3.5.4.4.2. Assay 
The appropriate number of Eppendorf tubes for all standards and samples were labelled. 100μL of 
each standard and sample were pipetted into their corresponding Eppendorf tubes. 2.5ml 
TBA/buffer solution was forcefully added down the side of each tube. Tubes were then sealed and 
placed in a 100⁰C waterbath for 1 hour. The tubes were then cooled in an ice bath for 10 minutes 
and then allowed to reach room temperature on the bench. The samples and standards were then 
centrifuged at 3000rpm for 15 minutes, and their supernatants used for analysis.  
Each standard and sample (300μL) were pipetted into microplate wells in triplicate and analysed 
on a plate reader (Multiskan spectrum) at with excitation at 530nm and emission at 550nm using 
SkanIt RE for MSS 2.2 (ThermoScientific™ Inc.) software. The software recorded the absorbance 
of TBA.  
The average absorbance (ΔA/T) was calculated for each standard and sample. TBA activity was 
then calculated by plotting the corresponding mean MDA value for each standard on an x-axis 
versus their average absorbance on a y-axis to construct a standard curve. A straight line equation 
was obtained for the standard curve, and MDA concentration calculated by substituting mean MDA 




TBARS are expressed in terms of MDA (nmol/ml). 
 Proteomics 
Proteomic investigation of the testis, epididymis and sperm were carried out to assess changes in 
protein profiles between the control and obese samples. Samples were homogenized and whole 
cell lysates were created. Protein concentrations were measured by means of a Bradford assay, 
after which equal protein concentrations (10µg/μl) of 4 (or 8) samples were each pooled together. 
Eight pools (4 control, 4 obese) of testis and epididymis samples and two pools (8 control, 8 
obese) of sperm samples, resulting in 16 samples of each organ being pooled together and 
analysed as shown in Table 3.3 below: 
 
Table 3.3: Table outlining the epididymis, testis and sperm samples pooled for proteomic analysis 
Sample pools 
Tissue Samples contained within each pool 









































 In-solution digest with trypsin 
Protein digestion was carried out using Trypsin to break down proteins into their respective 
peptides. Briefly, 30µg of each protein pool was dried down within Eppendorf tubes and made up 
to a final volume of 10µl using Triethylammonium bicarbonate (TEAB; 50nM, Sigma 17902). 
Proteins were then reduced using tris (2-carboxyethyl) phosphine (TCEP; Sigma 646547) to a final 




samples to room temperature, alkylation was performed using methylmethanethiosulphonate 
(MMTS; Sigma 208795) where after samples were brought to a final concentration of 10mM 
MMTS. Following incubation at room temperature (15 minutes), a 1µg/µl trypsin solution was 
added to each sample in a 1:20 (trypsin:protein) ratio. The addition of TEAB corrected samples to 
a 50mM concentration before an 18-hour trypsin digest at 37°C. Peptides then underwent vacuum 
centrifugation before resuspension in trifluoroacetic acid (TFA; 0.1%, Sigma T6508). C18 desalting 
was then carried out to conclude the digest. 
 Analysis 
Label-free protein quantitation of samples was performed using a Q-Exactive quadrupole-Orbitrap 
Liquid Chromatography Mass Spectrometer (LC-MS/MS) (Thermo Fischer Scientific, USA). The 
extracted peptides (1.5µg) were resuspended in sample loading buffer and introduced into the C18 
trap column (300μm x 5mm x 5μm) of the Mass Spectrophotometer, followed by chromatographic 
separation by the C18 column (75μm x 20mm x 2μm). Peptide separation was then carried out via 
a multi-step gradient generated by a solvent system composed of solvent A (Water, 0.1% Formic 
Acid) and solvent B (Acetonitrile; 0.1% FA) at 300nl/min. 
Four biological and four technical replicates were assessed to relatively quantify the protein 
expression of each sample pool by means of the Progenesis QI software (Nonlinear, UK). Acquired 
MS-MS spectra were converted from RAW data files into the mzML format using ProteoWizard 3.0 
msConvert with vendor peaklisting before being run through MSGF+ software (July 16, 2014 
version) (Kim et al., 2010) against the RefSeq Rat protein sequence database (updated February 
8, 2016). IDPicker 3.1 software (Ma et al., 2009) was utilized and four-on-four comparisons were 
run to allow protein assembly and filtering. Peptide identification stringency was applied in the 
initial protein assembly to allow for accurate identification of proteins. A peptide-to-spectrum match 
(PSM) false discovery rate (FDR) of 2% was applied where a minimum requirement of 4 spectra 
was applied to remove erroneously identified protein spectra. 
3.6. Statistical analysis 
Biometric, macroscopic, microscopic and molecular data were analyzed using Graphpad Prism 
software (version 5). Normality was tested using the Kolmogorov-Smirnoff test after which unpaired 
t-tests or Mann-Whitney tests were respectively applied. Data is represented as mean ± Standard 
Deviation (SD), and a p value below 0.05 was considered significant. 
Spearman correlation analyses were carried out to analyze the associations between all measured 




Proteomics data was analyzed using Multiple Comparisons performed on R version 3.3.2 (2016-
10-31). Spectral count data was preprocessed to remove sparse proteins with low spectral counts 
(< 12) (Slebos et al., 2014). Statistical analysis was performed on the remaining proteins. In each 
sample type, for a given protein (protein 𝐹𝐹), the following Poisson regression model was applied: 
 
 𝐵𝐵𝑖𝑖𝑖𝑖 = 𝑇𝑇𝑜𝑜𝑜𝑜𝑜𝑜𝑊𝑊𝑇𝑇𝑖𝑖 + 𝛽𝛽0 + 𝛽𝛽1 ⋅ 𝑇𝑇𝑇𝑇𝑊𝑊𝑇𝑇𝑇𝑇𝑇𝑇𝑊𝑊𝐹𝐹𝑇𝑇 
𝐵𝐵𝑖𝑖𝑖𝑖 represents the spectral count of the 𝐹𝐹𝑡𝑡ℎ protein in the 𝑗𝑗𝑡𝑡ℎ replicate, where , 𝐹𝐹 =
1, … , # 𝑢𝑢𝑜𝑜𝑊𝑊𝐵𝐵 𝑝𝑝𝑇𝑇𝑇𝑇𝑇𝑇𝑊𝑊𝐹𝐹𝐹𝐹𝑜𝑜, and 𝑗𝑗 = 1, … , 8,   𝑇𝑇𝐹𝐹𝐵𝐵 𝑇𝑇𝑇𝑇𝑊𝑊𝑇𝑇𝑇𝑇𝑇𝑇𝑊𝑊𝐹𝐹𝑇𝑇 = 1 if the replicate is for diet-induced obesity 
and =0 if from control samples.   
Differences in sensitivity (abundance) were adjusted, where total spectral counts in each replicate 
were used as the offset. The two-sided hypothesis tested was  𝐻𝐻0: 𝛽𝛽1 = 0 versus 𝐻𝐻1: β1 ≠  0.  
Raw p values were obtained for each protein and adjusted to allow for multiple comparisons. “BH” 





4. Chapter 4: Results 
The results obtained during this study are presented in this chapter, with data represented in tables 
and figures to visually depict and summarize the findings. Statistically significant results will be 
described herein and will inform the subsequent discussion. 
4.1. Anthropometric and macroscopic parameters 
Anthropometric measurement of the study animals (Figure 4.1) showed the diet-induced obesity 
(DIO) animals to exhibit a significantly higher body weight, visceral fat mass and a higher AI 
compared to the control group. Haematocrit was observed to be lower in the DIO group compared 
to controls. Using the mean body weight of the control group as a threshold, 3 (15%) of the control 
animals demonstrated a ≥ 10% increase in body weight compared to the mean control body weight 
and can be classified as moderately obese and/or obesity prone, while 13 (65%) of the DIO 
animals showed a similar increase and categorization. Two (10%) of the DIO animals showed a 
reduction in body weight compared to controls and were thus observed to have low (relative) body 
weights and classified as obesity resistant. All the animals were included in the statistical analysis 
and analysed within their study groups. No animals were excluded from analysis based on their 
proclivity towards obesity as their removal did not change the statistical significance of the 
measured parameters.  
Testicular weight measurements did not show differences in absolute testis weight between DIO 
and control groups (Figure 4.1). However, when these weights were expressed as a ratio of body 
weight (Testis: Body Weight ratio; Testis:BW), (Bailey et al., 2004; Sellers et al., 2007), known as 
the relative testis weights, we observed the relative weights of the DIO testes to be significantly 


























































































Figure 4.1: Histograms depicting anthropometric and macroscopic parameters of control (n = 20) and DIO  




4.2. Microscopic parameters 
 Sperm analyses 
Semen analysis of the DIO and control groups revealed changes in several sperm parameters of 
the DIO animals as a result of the treatment. The results are summarized in Table 4.1, with 
examples of the observed changes in sperm morphology and viability illustrated in the 
accompanying figures, Figure 4.2 and 4.3, respectively. The percentage of morphologically normal 
sperm was significantly lower in DIO subjects compared to controls. Sperm from the DIO group 
exhibited a higher proportion of head defects, with a significant number observed to have a 
reduced head area when compared to controls. Sperm viability of the DIO animals were also 
significantly lower compared to controls. 
Table 4.1: Summary of sperm viability, sperm morphology and morphometry data in the control and DIO 
groups. (# = statistically significant result) 
 Groups  
 Control DIO p-value 
Normal Sperm Morphology (%) 74.27 ± 2.2240 60.53 ± 2.8720 0.0008# 
- Head defects (%) 23.93 ± 2.1550 37.47 ± 2.9050 0.0004# 
- Midpiece defects (%) 2.80 ± 0.0470 3.07 ± 0.8016 0.8412 
Sperm Morphometry    
Head     
-  Length = Arc (μm) 21.32 ± 0.0901 21.11 ± 0.1564 0.2546 
- Width (μm) 1.48 ± 0.0205 1.47 ± 0.0241 0.8674 
- Area (μm2) 19.06 ± 0.2498  18.13 ± 0.3091 0.0266# 
- Perimeter (μm) 45.73 ± 0.2060 45.39 ± 0.3380 0.3968 
- Linearity (%) 50.52 ± 0.3714 50.09 ± 0.5333 0.5181 
- Angle (degrees) 59.37 ± 1.1510 57.82 ± 1.1880 0.3589 
- Roughness 0.11 ± 0.0016 0.11 ± 0.0009 0.1646 
- Chord (μm) 10.80 ± 0.0596 10.60 ± 0.1007 0.0964 
Midpiece    
- Width (μm) 0.71 ± 0.0104 0.68 ± 0.0159 0.1032 
- Area (μm2) 2.23 ± 0.1648 2.05 ± 0.1490 0.4315 
- Angle (degrees) 10.77 ± 0.3925 10.25 ± 0.6506 0.5027 
Sperm viability (% live sperm) 58.80 ± 5.4120 43.20 ± 2.3470 0.0030# 
Teratozoospermic Index (TZI) 1.02 ± 0.0110 1.02 ± 0.0113 0.6162 
Sperm deformity index 0.26 ± 0.0244 0.41 ± 0.0317 0.0013# 








Figure 4.2: Representative images of morphometrically normal and abnormal spermatozoa. Analyses were performed 
using The Sperm Class Analyser (SCA) © Computer Assisted Sperm Analysis (CASA). Images are shown with and without 
thresholding (left vs. right), with green boxes around spermatozoa denoting normal sperm, and red boxes denoting 
abnormal sperm. 
Figure 4.3: Images showing a viability analysis performed using the Cell Counter module of the SCA© CASA program, 





Analysis of the testicular and epididymal histology revealed several changes in reproductive 
organs between the two study groups. The results of these will be subdivided into quantitative and 
qualitative sections and presented accordingly. 
 Quantitative analysis 
Significant reductions in the epithelial height of the seminiferous tubules were observed in the DIO 
testes compared to controls (Table 4.2, Figure 4.4). Similarly, the relative volumes of the 
seminiferous tubules were also lower in the DIO testes compared to controls (Table 4.2, Figure 
4.6). Luminal diameters and relative luminal volumes were significantly smaller in the DIO group, 
compared to controls. Seminiferous tubular diameters were significantly decreased in the obese 
animals. The relative interstitial volume was increased in the obese testes compared to controls 
(Table 4.2, Figure 4.6). The seminiferous epithelia of the DIO epididymis showed no changes in 
epithelial height and relative epithelial volume compared to controls (Table 4.3, Figure 4.5). 
Luminal diameters and relative luminal volumes were reduced in the DIO group compared to 
controls. Epididymal tubular diameters and relative tubular volumes were reduced in the obese 
epididymides while the relative interstitial volume significantly increased compared to the age-
matched controls (Table 4.3, Figure 4.6). 
Table 4.2: Summary of the observed differences in testicular histomorphometric parameters between the 
control and DIO groups. Illustrations of these measurements can be observed in Fig. 4.4 and 4.6.  
 
 Seminiferous tubules Interstitium 















 Control DIO Control DIO Control DIO Control DIO Control DIO Control DIO 
Mean 48.51 38.66 72.32 61.16 157.9 137.3 29.15 22.73 206.40 176.00 4.49 10.29 
SD 9.38 2.37 3.83 6.32 16.85 9.85 3.29 5.07 23.41 11.26 1.16 1.49 
CV 19.35 6.14 5.29 10.42 10.67 7.18 14.45 17.39 11.34 6.40 28.80 14.49 
P 
value 





Table 4.3: Summary of the observed differences in epididymal histomorphometric parameters between the 











 Epidydimal ducts Interstitium 

















 Control DIO Control DIO Control DIO Control DIO Control DIO Control DIO 
Mean 23.27 22.74 9.56 9.09 356.40 241.50 80.91 73.65 382.70 264.20 9.53 17.32 
SD 2.12 1.55 3.60 2.00 86.10 41.19 7.09 4.01 67.98 41.44 2.56 11.26 
CV 9.15 6.85 28.50 22.02 23.96 17.06 8.76 5.45 15.99 15.69 11.34 6.40 
P 
value 
0.6686 0.7240 0.0246 0.0018 0.0261 0.0007 
 
Figure 4.2: Photomicrograph of testicular tissue (H&E staining, 40x objective) illustrating the quantitative 


















Figure 4.3: Photomicrograph of epididymal tissue (H&E staining, 40x objective) illustrating the quantitative 












Figure 4.4: Photomicrograph (H&E staining, 10x objective) depicting the histological analysis of 
relative luminal volume (blue crosses), relative epithelial volume (orange crosses) and relative 
interstitial volume (green grosses) using testicular tissue as an example. The same analysis was 
carried out on epididymal tissue to assess relative volumes, which were expressed as a percentage 
(%) of the total testicular or epididymal volume. A grid is overlaid to appropriately divide the tissue 
into different tissue regions, after which crosses are respectively inserted to demarcate cubes of 
the grid which contain ≥60% of the relevant tissue. The number of cubes were then quantified and 
expressed as a % of the total number of cubes (per field). Two seminiferous tubules and all relevant 




 Qualitative alaysis 
The most frequently observed histological pattern in the DIO testes is a mosaic distribution of 
normal and affected tubules. This means that within the microscopic fields analysed, there is a 
“pattern” or distribution of damaged seminiferous tubules interspersed with normal, intact tubules. 
The normal tubules (Figure 4.6A) show intact seminiferous epithelium, with many groups of 
developing sperm attached to Sertoli cells and spermatids released into the lumen. The damaged 
tubules (Figure 4.6B) exhibit a shortening of the pseudostratified seminiferous epithelia (evidenced 
by significantly reduced epithelial heights (Table 4.2)), a degeneration of the epithelial layer and a 
disruption of the cell-to-cell connections between the epithelia. Large vacuoles may also be seen 
between the germ cells. Less sperm can be observed within the lumen. Spermatogonia and Sertoli 
cells are seen to detach from the basement membrane. In the epididymis (Figure 4.7), a similar 
mosaic distribution is observed. Control epididymides show columnar and basal epithelia that is 
tightly adherent to the basement membrane, with well-organized steriocilia. In the DIO group 
(Figure 4.7B), epithelia is seen breaking away from the basement membrane (with a portion of 
epithelia observed in the lumen, possibly from an “upstream” section of the duct) and steriocilia are 




Figure 4.5: Photomicrographs of sections of testicular tissue (H&E staining, 60x objective) showing 
(A) control and (B) DIO testes. The pseudostratified (germinal) epithelium consisting of 
spermatogenic cells can be visualized, along with the supportive Sertoli cells (pink arrows). The 
lumens of control and DIO testes can also be observed (green arrows), with DIO tubules 
containing less sperm within the lumen. Numerous vacuoles (yellow arrows) can be seen in the 









Figure 4.6: Photomicrographs of sections of epididymal tissue (H&E staining, 60x objective) showing control 
(A) and DIO (B) epididymides. The columnar and basal epithelia (red arrows) lie on basement membranes 
(yellow arrows) which separate the epididymal ducts from the interstitium below. The stereocilia of the 
control epididymis is well developed and pronounced, stretching into the lumen of the duct whereas the 
steriocilia in the DIO epididymis appear disrupted in places and less defined. The DIO epididymis is seen to 
have less sperm (purple arrows). Epididymal columnar epithelia is seen in the lumen of the DIO epididymis 




4.3. Molecular analyses 
The following table summarizes the results obtained from the molecular analyses performed during 
experimentation: Each of the significant results will be elaborated in the text below. 
Table 4.4: Table outlining the changes in molecular parameters between control and diet-induced obesity 
(DIO) animals. Results are presented as mean ± standard deviation (SD) with p values provided to show the 
significance of each parameter change  
 Control DIO p value 
Blood glucose (mmol/l) 6.57 ± 0.117 6.78 ± 0.1806 0.335 
Haematocrit (%) 42.97 ± 0.711 41.11 ± 0.4792 0.037 
Testosterone (ng/ml) 5.64 ± 1.125 5.36 ± 1.064 0.708 
Estradiol (pg/ml) 34.51 ± 4.058 37.09 ± 4.732 0.207 
Testosterone:Estradiol ratio 0.166 ± 0.033 0.148 ± 0.036 0.248 
Testosterone:BW ratio 0.008 ± 0.002 0.007 ± 0.002 0.076 
Catalase (U/mg)    
Testis 2373 ± 112.600 2109 ± 63.44 0.048 
Epididymis 1550 ± 71.910 1532 ± 49.89 0.402 
Superoxide dismutase (U/µg)    
Testis 26.60 ± 0.4854 24.78 ± 0.5123 0.014 
Epididymis 22.78 ± 0.5030 22.92 ± 0.6916 0.871 
GSH    
Testis (total GSH; tGSH) 338.00 ± 17.940 275.90 ± 13.87 0.009 
TBARS (umol/g MDA)    
Testis 0.151 ± 0.0139 0.148 ± 0.0139 0.878 
Epididymis 0.102 ± 0.0131 0.098 ± 0.0125 0.474 
 
 Blood glucose 
Despite a slight elevation, unfasted blood glucose levels were not different between control and 
DIO groups and remained within normal ranges (3.3 – 7.2 millimoles/litre (mmol/L)) for both lean 
and DIO groups (Kohn and Clifford, 2002; Ringler and Dabich, 2013) (Table 4.4). 
 Hormone analyses 
The obese phenotype showed no difference in the measured steroid hormones, as 
spectrophotometric quantification of total testosterone and estradiol yielded lower (-5%) and higher 
(7%) hormone concentrations respectively when compared to controls, but not to statistically 
significant levels (Table 4.4). Estradiol levels of DIO rats did, however, exceed the normal 
physiological range (10 – 36 nanograms/millilitre (ng/ml)) (DRG Diagnostics, 2014) (Table 4.4). A 
calculated Testosterone:Estradiol (T:E) ratio showed no differences in T:E ratios between control 




 Oxidative stress parameters 
CAT activity (U) was lower in the testes of DIO animals (2109 ± 283.7 U/mg protein vs. 2373 ± 
503.4 U/mg protein; p = 0.048) but unchanged in the epididymis (1532 ± 211.7 U/mg protein vs. 
1550 ± 305.1 U/mg protein; p = 0.402) in comparison to control animals (Table 4.4). SOD activity 
was significantly lower in the DIO testes (24.78 ± 2.291 U/µg protein vs. 26.60 ± 2.171 U/µg 
protein; p = 0.014) but not altered in the epididymides (22.92 ± 3.093 U/µg protein vs. 22.78 ± 
2.193 U/µg protein; p = 0.871) compared to controls. LPO was not significantly changed between 
the two groups in both the testes (0.148 ± 0.0624 umol/g MDA vs. 0.151 ± 0.0622umol/g MDA; p = 
0.8778) and epididymides (0.098 ± 0.0545 umol/g MDA vs. 0.102 ± 0.0571 umol/g MDA; p = 
0.4743). Total GSH concentration in the testes of DIO animals was lower than in the controls 
(275.9 ± 62.05 tGSH vs. 338.0 ± 80.24 tGSH; p = 0.009). 
 Correlations 
Correlations between biometric, haematocrit, sperm, histomorphological, blood glucose, hormone 
and antioxidant enzyme data revealed several relationships between the measured variables 
(Figure 4.9).  
Animals with larger body weights showed higher blood glucose levels (r = 0.3899; p = 0.048). 
Similarly, greater visceral fat weights yielded higher blood glucose levels (r = 0.4795; p = 0.002) 
and were associated with lower Testis:BW ratios (r = -0.5686; p < 0.001). Haematocrit positively 
correlated with testicular weight (r = 0.4563, p = 0.004). Reduced T:E ratios were found in animals 
with greater adiposity indexes (r = -0.2988; p = 0.029). Lower percentages of morphologically 
normal sperm were found in animals with higher body weights (r = 0.4795; p = 0.002) as well as in 
those with higher visceral fat weights (r = -0.3780; p= 0.002). Furthermore, reduced sperm head 
area correlated with high visceral fat weight (r = -0.4588; p = 0.011) and high estradiol (r = -0.4655; 
p = 0.042). Animals with higher testicular weight had higher percentages of viable spermatozoa (r 
= 0.5004, p = 0.025). 
Antioxidant and peroxidation measurements showed significant relationships with molecular and 
microscopic parameters. Catalase activity in the testis correlated with changes in sperm 
morphometry through a positive correlation between catalase and sperm head chord (r = 0.3703, p 
= 0.044). Epididymal catalase activity was higher in animals with higher estradiol levels (r = 0.4208, 
p = 0.0456), and similarly correlated with sperm morphometry via correlations with sperm head 
width (r = -0.5018, p = 0.006), head linearity (r = 0.4074, p = 0.028), head chord (r = 0.3974, p = 
0.033) and midpiece angle (r = 0.4821, p = 0.008). Epididymal catalase activity furthermore 




0.037), luminal diameter (r = -0.7167, p = 0.037), relative luminal volume (r = -0.9333, p < 0.001) 
and relative interstitial volume (r = 0.9167, p = 0.001). SOD activity in the testes showed a 
significant relationship to the changes observed in several sperm morphometry parameters, 
including head area (r = 0.4389, p = 0.015), head roughness (r = 0.5382, p = 0.002) and midpiece 
defects (r = 0.3949, p = 0.031). SOD activity further showed a negative relationship with the 
relative epithelial volume (r = -0.685, p = 0.035) and the relative luminal volume of the testes (r = -
0.8061, p = 0.007). SOD activity in the epididymis similarly correlated positively with midpiece 
defects observed in the sperm (r = 0.4232, p = 0.022). Total GSH in the testes correlated 
negatively with all 3 body weight and fatness measurements, where lower tGSH levels were 
observed in animals with higher body weight (r = -0.3421, p = 0.031), visceral fat weight (r = -
0.3371, p = 0.033) and higher AI (r = -0.3318, p = 0.0365). Lower tGSH levels were found in 
animals with higher percentages of morphologically normal sperm (r = 0.4882, p = 006), and lower 
sperm head defects (r = -0.5205, p = 0.003). Testicular histology measurements significantly 
correlated with tGSH, with reduced tGSH levels observed in testes with higher tubular diameters (r 
= 0.7212, p = 0.023) and luminal diameters (r = 0.7576, p = 0.015).  
Histological measurements of the testes and epididymis showed several relationships with 
measured molecular and microscopic parameters. Testicular epithelial height was negatively 
associated with blood glucose (r = -0.6160, p = 0.031), as well as positively related to sperm head 
area (r = 0.7820, p = 0.011). Luminal diameters of the seminiferous tubules demonstrated a 
positive association with relative testicular weight (r = 0.6610; p =0.044), although a negative 
correlation was observed with testosterone (r = -0.7580; p = 0.015). Relative testicular interstitial 
volume exhibited a negative relationship with the Tesits:BW ratio (r = -0.7090; p = 0.027) and 
sperm head roughness (r = -0.6460, p = 0.049). Epididymal histomorphological changes also 
correlated with various measured parameters. Relative epithelial volume correlated positively with 
sperm head roughness (r = 0.7218; p = 0.023). Relative interstitial volume further correlated with 




























































































































































































































































































































































































































































































































































































































































































































































































































































































A total of 3754 proteins were identified within the testes, epididymis and spermatozoa by proteomic 
analysis. After removal of sparse proteins and the application of identification stringency, 246 
epididymal and 61 sperm proteins tested as significantly different between the control and DIO 
groups, whilst no testicular proteins were significantly expressed (change in expression reaching 
statistical significance).  
Of the epididymal proteins, 199 were successfully mapped and assigned functions using the 
Uniprot database. Forty-four proteins had identified sequences with no known functions. The 
remainder of the epididymal proteins were unidentified. Of the sperm proteins that showed 
significance, 37 were successfully mapped and identified by the Uniprot database, while 20 were 
mapped but had no further information or assigned functions. 
After ascertaining protein functions, all epididymal and sperm proteins were divided into 6 
categories: metabolic, structural, reproduction-specific, antioxidant/pro-oxidant, regulatory and 
immune-related proteins. Several proteins had multiple functions and were classified as 
multifunctional. Due to the long list of significant proteins, only the top 6 (where appropriate) most 
abundant proteins in each category will be displayed in this section (Table 4.5 and Table 4.6), with 
the full list of proteins displayed in the addendum. Schematic diagrams showing protein-protein 
interactions of the abundantly expressed proteins grouped according to function are shown in 












Table 4.5: Annotation of the most abundant significantly expressed Epididymal proteins of each functional category performed using Uniprot 
Accession 
number 










Q5XIV1 Phosphoglycerate  
kinase  
Pgk2  100 118 0.017 Carbohydrate degradation; glycolysis; conversion of pyruvate  





97 113 0.023 Multifunctional enzyme involved in glycolysis. 
Has a role in various processes including growth control,  
hypoxia tolerance and allergic responses. Serves as a receptor 
and activator of plasminogen on the cell surface of several 











61 79 0.004 Essential role in amino acid metabolism. Important for 
metabolite exchange between mitochondria and cytosol. A fatty acid-
binding protein which facilitates cellular uptake of long-chain free fatty 
acids  
P01026 Complement C3  C3 66 45 0.008 Activation of the complement system. Activated to become  
C3b and C3a (an anaphylatoxin and mediator of local  
inflammation). Induces smooth muscle contraction, increases  
vascular permeability and causes histamine release from mast  
cells and basophilic leukocytes. In chronic inflammation, acts as  
a chemoattractant for neutrophils. Adipogenic hormone  
stimulating triglyceride (TG) synthesis and glucose transport  




TG removal. Appears to stimulate TG synthesis via activation of  
the PLC, MAPK and AKT signalling pathways 
P16290 Phosphoglycerate  
mutase 2 
Pgam2 32 52 <0.001 Gluconeogenesis, glycolytic process, regulation of pentose-phosphate 
shunt. Interconversion of 3- and 2-phosphoglycerate with 2,3-








Dbi 27 49 <0.001 Binds medium- and long-chain acyl-CoA esters with very high affinity and 
may function as an intracellular carrier of acyl-CoA esters. Able to 
displace diazepam from the benzodiazepine (BZD) recognition site 












171 215 <0.001 Cell motility. Ubiquitously expressed in all eukaryotic cells. 
P60711 Actin, cytoplasmic 
1 (Beta-actin) 
Actb 153 190 <0.001 Cell motility. Ubiquitously expressed in all eukaryotic cells. 
P68136 Alpha-actin-1 Acta1 158 203 <0.001 Cell motility. Ubiquitously expressed in all eukaryotic cells. 





77 93 0.020 The major component of microtubules. 
P31000 Vimentin Vim 37 58 <0.001 Vimentins are class-III intermediate filaments found in  
numerous non-epithelial cells, more especially mesenchymal  
cells. Attached to the nucleus, endoplasmic reticulum, and  
mitochondria. Is involved in the stabilization of type I collagen  
mRNAs. 
P58775 Tropomyosin beta 
chain (Beta-
Tpm2 26 69 <0.001 Binds to actin filaments in muscle and non-muscle cells. Plays a central 






contraction is regulated by interaction with caldesmon. In non-muscle 
cells is implicated in stabilizing cytoskeleton actin filaments. The non-





Pgk2  100 118 0.017 Flagellated sperm motility, glycolytic process  
P12020 Cysteine-rich 
secretory protein 







100 151 <0.001 Supposedly helps spermatozoa undergo functional maturation while they 
move from the testis to the ductus deferens. 
P0DP29 Calmodulin-1 Cam1, 
Cam2, 
Cam3 
37 48 0.027 Mediates the control of a large number of enzymes, ion channels, 
aquaporins and other proteins through calcium-binding. Stimulate 
protein kinases and phosphatases in a calcium-dependant mechanism. 
Together with centrin, is involved in a genetic pathway that regulates the 
centrosome cycle and progression through cytokinesis. Positively 







Oat 32 44 0.012 Expressed in the head and flagellum of epididymal sperm but not in 
testicular sperm (at protein level) .Amino-acid biosynthesis; L-proline 
biosynthesis; L-glutamate 5-semialdehyde from L-ornithine. 







17 25 0.049 An anticoagulant protein which acts as an indirect inhibitor of a 














protein porin 2) 
Vdac2 14 6 0.020 Expressed in the head region of epididymal sperm. Forms a channel 
through the mitochondrial outer membrane that allows diffusion of small 










60 83 <0.001 Conjugates reduced glutathione (GSH) to exogenous and endogenous 











36 50 0.006 Plays a role in cell protection against oxidative stress by detoxifying 
peroxides and in phospholipid homeostasis. Catalyzes the reduction of 
hydrogen peroxide and organic hydroperoxides to water and alcohols, 
respectively. Can reduce H2O2 and short chain organic, fatty acid, and 
phospholipid hydroperoxides. Also has phospholipase activity. 
P07632 Superoxide 
dismutase [Cu-Zn]  
Sod1 13 29 <0.001 Destroys radicals which are normally produced within the cells and which 
are toxic to biological systems. 
Q63716 Peroxiredoxin-1 
(HBP23) (Heme-
binding 23 kDa 
protein) 
(Thioredoxin 
peroxidase 2)  
Prdx1 
Tdpx2 
22 32 0.015 Thiol-specific peroxidase that catalyzes the reduction of hydrogen 
peroxide and organic hydroperoxides to water and alcohols, respectively. 
Plays a role in cell protection against oxidative stress by detoxifying 
peroxides and as sensor of hydrogen peroxide-mediated signaling events. 



















22 12 0.019 Protects cells from oxidative stress by metabolizing a number of lipid 
peroxidation-derived aldehydes. Involved in lysine catabolism 













12 19 0.041 Involved in redox regulation of the cell. Acts as an antioxidant. Inhibits 
macrophage production of inflammatory cytokines, probably through 
suppression of the MAPK signaling pathway. Expressed by the principal 
cells of the epididymis. Detected in the head region of epididymal sperm 
(at protein level) 
Regulatory 
P02770 Serum albumin Alb 449 536 <0.001 A protein with a binding capacity for water, plams ions, fatty acids, 








264 311 <0.001 Binds ATP, opioids and phosphatidylethanolamine. Serine protease 
inhibitor which inhibits thrombin, neuropsin and chymotrypsin. Inhibits 
the kinase activity of RAF1 by inhibiting its activation and dissociating the 








Tf 113 132 0.013 Iron binding transport proteins which bind two Fe(3+) ions in association 
with an anion, usually bicarbonate. Transports iron atoms from sites of 
absorption and heme degradation to sites of storage and utilization. 




shock protein 90 





72 89 0.012 Molecular chaperone - processes and transports secreted proteins. 














protein family A 
member 5)  
Hspa5 
Grp78 
84 111 <0.001 Endoplasmic reticulum chaperone. Necessary for correct folding of 
proteins and degradation of misfolded proteins.  
 
Cellular response to glucose starvation, cellular response to interleukin-4 
F7FJQ3 NPC intracellular 
cholesterol 
transporter 2  









9 3 0.004 Cell surface glycoprotein receptor involved in costimulation signal 
essential for T-cell receptor (TCR)-mediated T-cell activation. Acts as a 
positive regulator of T-cell coactivation. Induces T-cell proliferation and 





antigen CD26)  
Regulates lymphocyte-epithelial cell adhesion. May be involved in the 
promotion of lymphatic endothelial cells adhesion, migration and tube 
formation. When overexpressed, enhances cell proliferation. Also 
regulates various physiological processes by cleaving peptides in the 
circulation, including many chemokines, mitogenic growth factors, 
neuropeptides and peptide hormones. 
 
Detected in the serum and the seminal fluid 




binding protein 2) 
(Guanylate-
binding protein 1) 
Gbp2  4 1 0.049 Hydrolyzes GTP to GMP in 2 consecutive cleavage reactions, but the 
major reaction product is GDP. Promotes oxidative killing and deliver 
antimicrobial peptides to autophagolysosomes, providing broad host 
protection against different pathogen classes  
Q63663 Guanylate-
binding protein 1  
(GTP-binding 




protein 2) (p67) 








Calr 61 74 0.03557251
7069555 
Calcium-binding chaperone that promotes folding, oligomeric assembly 






calreticulin/calnexin cycle. This lectin interacts transiently with almost all 
of the monoglucosylated glycoproteins that are synthesized in the ER.        
Involved in maternal gene expression regulation. May participate in 








Vcp 53 74 <0.001 Fragmentation and reassembly of Golgi stacks during and after mitosis. Is 
part of a complex (UFD1, VCP and NPLOC4) that binds ubiquitinated 
proteins and exports misfolded proteins from the ER to the cytoplasm to 
be degraded by the proteasome. The complex also regulates disassembly 
of spindles at the end of mitosis and is essential for the formation of a 
closed nuclear envelope. Involved in a stress-induced mechanism that 
selectively regulates the translocation of stressed/damaged 
mitochondrial outer-membrane proteins to be degraded by 
proteasomes. Essential for the clearance of ubiquitinated proteins via 
autophagy. May play a role in the ubiquitin-dependent sorting of 
membrane proteins to lysosomes where they undergo degradation. Key 
role in caveolin sorting within cells.  
Involved in the DNA damage response and is recruitment to double-
strand breaks 










37 72 <0.001 Catalyzes the formation, breakage and rearrangement of disulfide bonds. 
At the cell surface, seems to cleave disulfide bonds of proteins attached 
to the cell. May therefore cause structural modifications of proteins. 
Inside the cell, seems to form/rearrange disulfide bonds of new proteins. 
At high concentrations, functions as a chaperone that inhibits 
aggregation of misfolded proteins. At low concentrations, facilitates 
aggregation (anti-chaperone activity). Shows receptor activity, where  
activation increases disulfide reductase activity at the plasma membrane, 
altering the plasma membrane redox state and enhancing cell migration. 
May be involved with other chaperones in the structural modification of 
the TG precursor in hormone biogenesis. 
 Also acts on structural subunits of various enzymes such as prolyl 4-















31 57 <0.001 Functions as a protein deglycase that glycated proteins, releasing 
repaired proteins, lactate or glycolate, respectively. Deglycates cysteine, 
arginine and lysine residues in proteins, and thus reactivates these 
proteins by reversing glycation by glyoxals. Acts on early glycation 
intermediates (hemithioacetals and aminocarbinols), preventing the 
formation of advanced glycation endproducts (AGE) that cause 
irreversible damage. Also functions as a nucleotide deglycase able to 
repair glycated guanine in the free nucleotide pool (GTP, GDP, GMP, 
dGTP) and in DNA and RNA. Is thus involved in a major nucleotide repair 
system named guanine glycation repair (GG repair), dedicated to 
reversing methylglyoxal and glyoxal damage via nucleotide sanitization 
and direct nucleic acid repair.       
Plays an important role in cell protection against oxidative stress and cell 
death acting as an oxidative stress sensor and redox-sensitive chaperone 
and protease       















Part of a large chaperone multiprotein complex. Involved in cell redox 
homeostasis; chaperone-mediated protein folding; response to 





Table 4.6: Annotation of the most abundant significantly expressed spermatozoal proteins of each functional category performed using Uniprot 
Accession 
number 









Metabolic       
P18163 Acyl CoA 
Synthase (Long-
chain-fatty-acid--





87 79 0.049 Initiates fatty acid utilization by producing acyl CoA synthase from fatty 
acids. Results in the production of free fatty acids. Activation of long-
chain fatty acids for both synthesis of cellular lipids, and degradation via 
beta-oxidation. Activated by Adiponectin. 











Uqcrc1 16 33 0.005 This is a component of the ubiquinol-cytochrome c reductase complex, 
which is part of the mitochondrial respiratory chain. This protein may 




75 kDa subunit, 
mitochondrial 
Ndufs1 8 19 0.004 Core subunit of the mitochondrial membrane respiratory chain NADH 
dehydrogenase (Complex I) that is believed to belong to the minimal 
assembly required for catalysis. Complex I s in the transfer of electrons 
from NADH to the respiratory chain. The immediate electron acceptor 
for the enzyme is believed to be ubiquinone (By similarity). This is the 
largest subunit of complex I and it is a component of the iron-sulfur (IP) 
fragment of the enzyme. It may form part of the active site crevice 











(PDHE1-A type II) 
Pdha2 6 18 0.001 The pyruvate dehydrogenase complex catalyzes the overall conversion of 
pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic 
pathway to the tricarboxylic cycle.  
 












Idh3a 6 15 0.013 Catalytic subunit of the enzyme which catalyzes the decarboxylation of 
isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of 
the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer 
composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have 
considerable basal activity but the full activity of the heterotetramer 
(containing two subunits of IDH3A, one of IDH3B and one of IDH3G) 
requires the assembly and cooperative  of both heterodimers.  
P29410 Adenylate kinase 
2, mitochondrial 
(AK 2) (ATP-AMP 
transphosphoryla





Ak2 5 12 0.037 Catalyzes the reversible transfer of the terminal phosphate group 
between ATP and AMP. Plays an important role in cellular energy 
homeostasis and in adenine nucleotide metabolism. Adenylate kinase 
activity is critical for regulation of the phosphate utilization and the AMP 





M0R8B6 Tubulin beta 
chain 
Tubb1 38 26 0.003 Tubulin is the major constituent of microtubules. It binds two moles of 
GTP, one at an exchangeable site on the beta chain and one at a non-
exchangeable site on the alpha chain. 
P08733 Myosin 
regulatory light 
chain 2 (MLC-2) 
(MLC-2v) (Myosin 
light chain 2) 
Myl2 
Mlc2 
5 22 <0.001 Contractile protein that plays a role in heart development. Following 
phosphorylation, plays a role in cross-bridge cycling kinetics and cardiac 
muscle contraction by increasing myosin lever arm stiffness and 
promoting myosin head diffusion; as a consequence of the increase in 
maximum contraction force and calcium sensitivity of contraction force. 
These events altogether slow down myosin kinetics and prolong duty 
cycle resulting in accumulated myosins being cooperatively recruited to 
actin binding sites to sustain thin filament activation as a means to fine-
tune myofilament calcium sensitivity to force. During cardiogenesis plays 
an early role in cardiac contractility by promoting cardiac myofibril 
assembly. 
D4A0A0 Dynein light chain 
roadblock 
Dynlrb2 16 10 0.044 Acts as one of several non-catalytic accessory components of the 
cytoplasmic dynein 1 complex that are thought to be involved in linking 
dynein to cargos and to adapter proteins that regulate dynein . 
Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde 
motility of vesicles and organelles along microtubules.  
Q6AXV2 Tektin-4 Tekt4 
Tek4 
4 12 0.020 Structural component of ciliary and flagellar microtubules. Forms 
filamentous polymers in the walls of ciliary and flagellar microtubules. 
Reproduction specific 






Capza3 1 5 0.011 F-actin-capping proteins bind in a Ca(2+)-independent manner to the fast 
growing ends of actin filaments (barbed end) thereby blocking the 
exchange of subunits at these ends. Unlike other capping proteins (such 
















Hbb 70 62 0.049 Involved in oxygen transport from the lung to the various peripheral 
tissues. 










16 29 0.050 Chaperonin implicated in mitochondrial protein import and 
macromolecular assembly. Together with Hsp10, facilitates the correct 
folding of imported proteins. May also prevent misfolding and promote 
the refolding and proper assembly of unfolded polypeptides generated 
under stress conditions in the mitochondrial matrix.  
Q6PDU6 Hbb-b1 
MGC72973 





3) (LAP-3)  
Lap3 3 14 <0.001 Presumably involved in the processing and regular turnover of 
intracellular proteins. Catalyzes the removal of unsubstituted N-terminal 
amino acids from various peptides 

















6 2 0.008 May regulate the activity of kinases such as PKC and SRC via binding to 
integrin beta-1 (ITB1) and the receptor of activated protein C kinase 1 


















Figure 4.8: Pie charts representing the percentage of overexpression in each functional category for (A) epididymal and (B) sperm proteins. Regulatory proteins as 
a category are seen to have consistently high abundance in both the epididymis and sperm. Metabolic proteins are the most abudant in the control groups, with 





Figure 4.9: Bar charts visually illustrating and comparing the overexpression of proteins in the epididymis and sperm based on cellular location. Proteins from the 








Figure 4.10: A schematic diagram showing protein-protein interactions of epididymal proteins grouped according to function. The pathways in yellow are the ones in 
which the abundantly expressed proteins are involved. Expression profile image created in Reactome (Jassal et al., 2019). Several pathways are affected including 






Figure 4.12: A schematic diagram showing protein-protein interactions of sperm proteins grouped according to function. The pathways in yellow are the ones in which 
the abundantly expressed proteins are involved. Expression profile image created in Reactome (Jassal et al., 2019). An emphasis on metabolic, transport and 




5. Chapter 5: Discussion 
This chapter is divided into three sections in order to discuss the various study objectives 
respectively. The first section describes the study model and the attainment of obesity by the study 
animals. In the second section, the results from study will be discussed. The implications of these 
results will be assessed and compared to findings and interactions obtained by other models of 
DIO. The results of the current study will thereafter be discussed in combination with the 
proteomics data obtained in order to assess the contribution of the significant proteins to the 
observed anthropometric, macroscopic, microscopic and molecular results. The third section will 
summarize the proteomics results and discuss the functional networks affected by the DIO model, 
especially in the context of male fertility. The associations and interactions between the study 
variables are summarised in Figures 5.1 and 5.5 – 5.9. 
5.1. Achievement of obesity 
Obesity is a multifaceted disorder with numerous factors contributing towards its manifestation. 
Despite this, its current rate of incidence suggests that behavioural and environmental factors have 
been significant contributors to the current epidemic, as genetic factors can only account for a 
limited number of cases (Marques et al., 2016). Polygenetic, and not monogenetic, animal models 
of obesity are therefore preferred as DIO represents the predominant mode of obesity 
development in humans (Rosini, Ramos da Silva and de Moraes, 2012). The presence of multiple 
genetic mutations in individuals does not necessarily lead to the onset of obesity but confers a 
predisposition to the disorder which can be brought to the fore by lifestyle habits and the 
environment. The environment alone contributes to the inherent ability of an individual to develop 
obesity (de Castro, 2004; Karnehed et al., 2006). Furthermore, the induction of obesity via diet and 
a sedentary lifestyle provides similar metabolic responses in animals as those observed in 
humans. Therefore, diet-induced obesity animal models are useful in mimicking the 
pathophysiology of vascular and metabolic complications, which have been shown to manifest 
during obesity (Rosini, Ramos da Silva and de Moraes, 2012).  
Maintaining laboratory rats on a modified ad libitum diet is a widely applied approach to inducing 
weight gain in these animals. The consumption of large portions of high calorie-containing foods as 
well as frequent feeding due to its greater availability replicates the predominant mechanism of 
obesity development in humans. Keeping animals in cages with no exercise for the duration of the 
experiment promotes sedentary behaviour, and also mimics the two predominant causes of obesity 
in humans (Hill et al., 1984). Altering the palatability and/or calories of food with the addition of 
sugars, polysaccharides, fats and calorie-rich foods causes hyperphagia and thus increases the 




1980; N. J. Rothwell, Saville and Stock, 1982). In the current study, supplementation of the DIO 
diet with condensed milk and lard (Holsum cooking fat) increased the palatability and caloric 
content of the food to further stimulate the induction of obesity. Furthermore, longer diets have 
been shown to be more representative of the long-term development of obesity and are more 
effective in inducing obesity in animals. A long-term diet was therefore used in the current study, 
where a control or hyperphagic (DIO) diet was provided to ± 6 week old rats for 54 weeks to obtain 
significant increases in body weight and a higher likelihood of obese animals in the DIO group.  
The chronic diet elevated body and visceral fat weights for both control and DIO rats, with DIO rats 
having significantly higher body and visceral fat weights compared to controls. In comparison to 
shorter feeding protocols used to induce obesity (I. M. Faust et al., 1978; Farley et al., 2003; 
Nascimento et al., 2008; Olivares et al., 2010; Bakos et al., 2011b; Saravanan et al., 2014), the 
control rats in this study were considerably larger. This is due to the diet duration and the age of 
the animals at the end of the experimental protocol. Although not a measured variable in this study, 
age is associated with changes in adiposity as it leads to alterations in body composition. These 
include reductions in muscle mass, increased visceral fat and decreased fat free mass 
(Wannamethee et al., 2007). This is a generally observed phenomenon in humans, as older males 
tend to have higher body weights compared to younger males. The resultant body weights are an 
advantage for the current study as they better represent the body composition of adult males. 
Nonetheless, the DIO rats had a significantly higher body weight and visceral fat weight compared 
to controls.  
The AI was used in this study as a measure of obesity. Several studies have correlated the AI with 
the Lee index (Lee, 1929), a reliable measure of body fat content (Bernardis and Patterson, 1968; 
Bernardis, 1970; Kanarek and Marks-Kaufman, 1979; Rogers and Webb, 1980). In the current 
study, the AI increased to ranges well above normal (Leopoldo et al., 2016), with the obese group 
exhibiting significantly higher adiposity compared to controls. 
Unfasted blood glucose remained within normal ranges (3.3-7.2 mmol/l) (Kohn and Clifford, 2002; 
Ringler and Dabich, 2013) for both the control and obese animals, which is consistent with the 
hyperphagia inducing diet described by our colleagues (Salie, Huisamen and Lochner, 2014), 
where the diet caused a small, but insignificant increase in blood glucose concentrations. The rats 
were, similarly, only pre-diabetic and did not develop diabetes. The model used in this study is 
therefore a model of obesity and does not test the effects of hyperglycaemia. The current study 
found unfasted blood glucose to correlate with visceral fat weight, as animals with higher visceral 
fat weights possessed higher blood glucose levels, an observation corroborated by Du Toit et al. 




The glycaemic status of this study’s animals is in agreement with (and therefore reinforces) the 
results from experiments carried out by Westermark and colleagues which showed that dietary 
intervention in rats does not lead to type II diabetes and therefore hyperglycaemia (Westermark et 
al., 1986, 1987). This has been attributed to a lack of amyloid deposition in rat pancreatic β-cells 
by the amyloid producing peptide, islet amyloid polypeptide (IAAP), a deposition normally observed 
to occur in type II diabetes.  
IAAP is a peptide located within β-cells, specifically within the islets of Langerhans (Westermark et 
al., 1987). It is co-stored with insulin within the secretory granules of β-cells (Lukinius et al., 1989) 
in humans and other mammals, including the rat (Asai et al., 1990). This peptide is secreted 
together with insulin upon glucose stimulation (Mitsukawa et al., 1990). IAAP is similar to calcitonin 
gene related peptide (CGRP), a known inhibitor of insulin secretion (Cooper et al., 1987). It 
therefore has the ability to inhibit insulin-stimulated glucose uptake while also suppressing glucose 
output from the liver (Molina et al., 1990), thereby causing hyperglycaemia (Molina et al., 1990). In 
humans, IAAP is secreted in obese individuals and amyloid is deposited into pancreatic β-cells. 
This causes insulin secretion to be inhibited in moments when insulin is required (i.e. after a meal, 
when glucose levels typically rise), which hampers insulin-stimulated glucose uptake. This results 
in glucose not being absorbed from the blood stream, leading to hyperglycaemia. Due to species 
variation, the human IAAP amino acid contains an amyloidogenic sequence whereas rat IAAP 
does not. As a result, rat IAAP cannot cause the deposition of amyloid into pancreatic β-cells (Asai 
et al., 1989; Betsholtz, Christmansson, et al., 1989; Betsholtz, Svensson, et al., 1989; Stridsberg 
and Wilander, 1991). Glucose uptake is therefore not hampered in rats as it is in humans. The 
current study was partly able to show that this phenomenon is also evident in long-term obesity as 
a longer dietary intervention did not lead to hyperglycaemia and therefore type II diabetes in our 
model. 
5.2. Effect of the long-term diet on male fertility 
 The effect of diet on testosterone, estrogen and other hormones 
One of the interesting observations of this study is that chronic obesity did not affect testosterone 
concentrations, but rather caused supraphysiological estradiol concentrations. In addition, the diet 
led to higher visceral fat which, together with supraphysiological estradiol, correlated significantly 
with changes in sperm morphology, specifically a reduction in sperm head sizes. A correlation 
between serum estradiol levels and sperm morphology was also observed in a study by Müller et 
al. (2012) where increased estradiol concentrations were associated with a lower percentage of 
normal sperm. Likewise, Marchiani et al. (2015) provided a high fat diet to study animals and 




morphology. In most cases, an increase in estradiol in human and animal models is linked to the 
aromatization of peripheral androgens into estrogens due to an increase in aromatase precipitated 
by increased body fat (Du Plessis et al., 2010). As estrogen receptors are present in the testis, 
epididymis and sperm (Hess, 2003), and take part in spermatogenesis, sperm maturation, motility, 
capacitation, acrosome reaction and sperm fertilizing capacity (O’Donnell et al., 2001; Guido et al., 
2011), changes in estrogen concentrations are likely to have an effect on sperm structure and 
function. The effect of estradiol on male physiology are further elaborated later in the text. 
Regarding sperm parameters, smaller testes were significantly associated with reduced sperm 
viability irrespective of the DIO testis weight not being significantly lower compared to controls. 
Furthermore, the observed increase in visceral fat significantly lowered sperm morphology.  
The haematocrit of the DIO animals was significantly reduced compared to controls, indicating a 
decreased percentage of circulating erythrocytes. Other studies have reported similar findings, 
where significant reductions in haematocrit were found in overweight and obese subjects 
(Tungtrongchitr et al., 2001; Ferreira et al., 2013) and in rats placed on diets high in fat (Fitzgerald 
et al., 2001; Bertinato et al., 2014). The current study found haematocrit (%) to be positively 
associated with testis size (g), a change also observed in an experiment by Hamilton and his co-
investigators (1964). Studies have linked larger testes to higher production of testosterone 
(Berndtson and Jones, 1989; Kaplan and Mead, 1993; Garamszegi et al., 2005; Preston et al., 
2012). Testosterone is a known stimulator of erythropoietin (Shahidi, 1973; Shahani et al., 2009), a 
glycoprotein hormone produced by the kidneys. Erythropoietin stimulates erythrocyte precursors in 
the bone marrow, resulting in the increased production of red blood cells (Takeuchi and Kobata, 
1991). As haematocrit is quantified as the percentage of red blood cells within the blood, the 
number of red blood cells stimulated by production of erythropoietin will have an effect on the 
haematocrit measurement. This mechanism explains the observed association.  
The testosterone results observed in this study were contrary to those found in shorter term diets 
(Cattaneo et al., 1996; Wang et al., 2005; Vigueras-Villaseñor et al., 2011) but similar to that of a 
long-term diet study by Fernandez et al. (2011), possibly as an adaptive response to chronically 
low testosterone concentrations which are compensated over time. Similar to compensated 
hypogonadism, normal testosterone concentrations can be observed despite reductions in testis 
size (Tajar et al., 2010; Giannetta et al., 2012). This is attributed to possible readjustments to the 
HPG axis set-point to counteract deficits in testicular function or defects in the testosterone 
feedback mechanism at the hypothalamic-pituitary level (Liu et al., 2006). While the levels of 
testosterone in this study did not differ significantly compared to controls, a downward trend was 
observed in the obese animals. The testosterone concentrations correlated negatively with the AI. 




lower haematocrit percentages and relatively smaller testis sizes. The importance of these findings 
is the consequence of a higher visceral fat mass on gonad size and hormone concentrations. 
Hormone concentrations are essential for gonad size and spermatogenesis, and a reduction in 
hormones such as testosterone can affect the volume of the seminiferous tubules, testicular 
interstitium and the number and structure of Leydig and Sertoli cells within the testes, all of which 
are necessary for proper spermatogenesis and reproductive function (Mendis‐Handagama, Zirkin 
and Ewing, 1988; Berndtson and Jones, 1989). Furthermore, despite there not being a significant 
decrease in the testosterone concentrations of the current study, the slight reduction in 
testosterone combined with the increase in estradiol can impact spermatogenesis to some 
magnitude.  
There was a tendency towards increased estradiol levels in DIO rats but these were not statistically 
significant. The concentrations found in the obese group were, however, higher than normal 
reference values, implying that chronic obesity can result in a hyperestrogenic state (Hemsell et al., 
1974; Schneider et al., 1979, 1983). Similarly, several other studies have been able to correlate 
male obesity with elevated estrogen levels (Schneider et al., 1979; Cohen, 1999; C. D. Fernandez 
et al., 2011; Fan et al., 2015). As these were short term diets, our study has shown that this 
change persists long-term. An increase in visceral fat stimulates estrogen production (Corona et 
al., 2015), thereby disturbing the body’s natural T:E ratio which is required for normal 
spermatogenesis (Bray, 1997; Pavlovich et al., 2001; Raman and Schlegel, 2002) and optimal 
reproductive function. This is due to the release of aromatase. Aromatase is amplified by an 
increase in visceral fat, leading to an increased conversion of testosterone (aromatization) to 
estrogen (Cohen, 1999). High estrogen concentrations affect the hypothalamic-pituitary-gonadal 
(HPG) axis, thereby down-regulating the production of testosterone via a negative-feedback 
system (Wozniak et al., 2009). The result is a reduction in testosterone, with even small changes in 
estrogen leading to low concentrations of this hormone. Male estrogen is vital for the regulation of 
several physiological functions including bone maturation and resorption, numerous brain functions 
and lipid metabolism (Vermeulen et al., 2002). As estrogen receptors are highly expressed in the 
testes, changes in the level of this hormone could have a modulatory effect on the spermatogenic 
process (Heikinheimo et al., 1995; Blanco-Rodríguez and Martínez-García, 1997). 
 The effect of diet on sperm morphology and histology of the testis and 
epididymis 
Significantly lower percentages of morphologically normal sperm were observed in the DIO 
animals compared to controls. Sperm morphology is affected by testicular spermatogenic activity, 
which is directly linked to testicular size (Holstein, Schulze and Davidoff, 2003). With the high 




reflection of negative stressors occurring within the body (Menkveld et al., 2011). Obesity can, 
therefore, affect sperm morphology severely due to the high susceptibility of testicular tissue to 
damage. In the present study, morphometric examination showed DIO spermatozoa to have 
significantly more head defects compared to controls. A high number of these sperm were 
borderline micro in size as characterised by van der Horst et al. (2018), a change found to 
negatively correlate with visceral fat weights and estradiol. Since the biological activity of estrogen 
is more potent than that of testosterone (Akingbemi et al., 2005), supraphysiological concentrations 
of estrogens are directly detrimental to spermatogenesis (Hammoud et al., 2006; du Plessis et al., 
2010). Morphologically abnormal sperm are furthermore associated with DNA fragmentation, 
immature chromatin and abnormal number of chromosomes (Dadoune et al., 1988; Lee et al., 
1996; Gandini et al., 2000; Devillard et al., 2002; Martin et al., 2003). Morphologically abnormal 
spermatozoa have a lower fertilizing capacity, leading to lower fertility rates and longer time to 
pregnancy. 
The chronic hyperphagic diet reduced sperm viability significantly compared to controls. Sperm 
viability correlated positively with testicular weight, suggesting that the animals with larger testes 
produced more viable sperm.  
As the absolute size of the testes was not significantly different between the two study groups, 
histological analysis of this organ was necessary to provide information on the microanatomical 
changes which may have been occurring within the testes of the obese subjects. The first 
observation is that the testes that are relatively smaller in size are likely to have smaller luminal 
diameters and higher relative interstitial volumes, according to the significant relationships 
observed in the current study. Second, the histopathological changes observed in the testes 
occurred to varying degrees. The most frequently observed histological pattern within the testicular 
tissue is a mosaic distribution of damage, where assessment of testicular histology at low 
magnification shows an array of damaged and normal seminiferous tubules (Figure 4.3). Damaged 
seminiferous tubules within the testes demonstrated significantly reduced tubular diameters. This 
tubular contraction could be the consequence of germ cell loss or a decline in tubular fluid 
secretion by the Sertoli cells, an androgen dependant process (Paniagua et al., 1991; Stewart and 
Kim, 2011) . Seminiferous tubular fluid also maintains the size of tubular lumens (Sharpe et al., 
1994), which are significantly reduced in the diet group. Seminiferous epithelium was reduced in 
height; seminiferous tubules with a lower epithelial height were associated with higher levels of 
sperm head defects and the production of sperm with smaller heads. The damaged tubules 
showed degeneration of the pseudostratified epithelial layer (germ cell layer) evidenced by the 
significant decline in both the epithelial height and relative volume occupied by seminiferous 
epithelia. This compromises the testes’ ability to adequately produce spermatozoa. The reduction 




glucose levels, where a higher blood glucose was related to reductions in the epithelial height. 
Hyperglycaemia affects adenylate energy which is required for spermatogenesis (Amaral et al., 
2006). Moreover, glucose is required by the Sertoli cells to produce lactate, the primary substrate 
for ATP production in germ cells (Erkkilä et al., 2002). Hyperglycaemia has been shown by 
previous studies to increase glycolysis, which in turn increases the NADH/NAD+ ratio, instigating a 
redox imbalance which increases the oxidation of tissue structures such as proteins and lipids 
(Ahmed, 2005). This can damage tissue structures and the correlation with glucose offers a 
mechanism for the observed reduction in testicular epithelia. Large vacuoles are evident between 
the germ cells at various depths of the seminiferous epithelium. Literature relates this to dilatations 
caused by degenerating germ cells being phagocytosed by Sertoli cells, giving rise to lipid droplets 
in Sertoli cell cytoplasm (Paniagua et al., 1991). These are now visualized as patent spaces 
(Figure 4.3), as the fat droplets have been dissolved by the xylene during tissue fixation. Tubular 
vacuolation is also an early indicator of Sertoli cell injury (Creasy, 2002). The volume occupied by 
the testicular interstitium increased in the DIO group compared to controls. This is due to 
reductions in the seminiferous tubular diameters, giving a relative increase in interstitial tissue. 
Interstitial volume was negatively associated with relative testicular weights, implying that relatively 
smaller testes are likely to have a larger interstitial volume. 
Microanatomic analysis of the epididymis showed no change in epithelial height and relative 
epithelial volume between the control and DIO group. Tubular diameter is reduced within the 
epididymides of DIO animals compared to controls, which points towards contraction of the 
epididymal tubules. Luminal diameter and relative luminal volume were expanded in the diet group 
compared to controls. This could be the result of reduced spermatogenesis and germ cell loss 
occurring within the testes. A greater luminal diameter and relative luminal volume is correlated 
with lower catalase activity in the epididymis. The resultant spermatozoa produced by the 
damaged tubules is likely to be morphologically abnormal and have reduced viability. This is 
correlated to high estradiol levels induced by the chronic diet. Furthermore, the male gonads are 
highly reactive to physiological stress, therefore the increased production of abnormal sperm is a 
reflection of negative stress factors within the body (Menkveld, Holleboom and Rhemrev, 2011). 
The relative interstitial volume of DIO epididymides was enlarged in relation to the control 
epididymides. Literature points towards a possible edematous state that could exist within the 
interstitium as a result of an inflammatory process (Creasy, 2002) or an apparent increase in 
interstitium due to contraction of tubules. The current study has correlated the larger interstitial 




 Effect of diet on antioxidant capacity 
Antioxidant activity was analysed to assess the capacity of the testes and epididymis to remove 
excess free radicals. The partial reduction of oxygen during metabolic processes gives rise to the 
production of radicals including O2-, H2O2, and the hydroxyl radical (OH•) which in excess, may 
result in OS. This is a state where pro-oxidants (caused by ROS) overcome antioxidants’ ability to 
reduce them, and has been implicated as a mechanism of damage in numerous conditions 
including obesity. Obesity produces OS via several mechanisms including mitochondrial and 
peroxisomal oxidation of fatty acids and the overconsumption of oxygen, resulting in ROS 
production via oxidation reactions and the generation of free radicals by the mitochondrial 
respiratory chain (Fernández-Sánchez et al., 2011b). The current study measured the possible 
occurrence of OS within the study animals and assessed the possibility of oxidative damage within 
the reproductive organs. Assessment of the oxidative status of a system through the analysis of 
enzymatic antioxidant activity and the quantitation of cellular damage via the assessment of lipid 
peroxidation, etc., is necessary for the investigation of oxidative damage. As adipose tissue 
releases adipokines and cytokines, these can directly stimulate the production of free radicals 
(Fernández-Sánchez et al., 2011b). These can also indirectly fuel ROS production by stimulating a 
low grade inflammatory state within obese individuals which, in turn, stimulates more ROS (Xu et 
al., 2003).  
The antioxidants typically analysed to assess antioxidant activity include CAT, SOD and 
glutathione. These are first line (CAT and SOD) and second line (GSH) antioxidants which 
neutralize and scavenge free radicals, respectively (Ighodaro and Akinloye, 2018). The current 
study monitored these antioxidants to assess the clearance of free radicals during the obese 
condition. CAT activity was lower in the testes of the obese animals, suggesting an inability to 
adequately remove H2O2 radicals from the system (Luck, 1965). An inability to reduce testicular 
H2O2 could imply an overabundance of this free radical, which can be attributed to the 
overproduction of ROS.  
SOD is the most powerful enzymatic antioxidant (Ighodaro and Akinloye, 2018). As SOD is a 
metalloenzyme, a metal co-factor is required for its activity. Several metals are utilized by different 
forms of SOD, including iron (Fe), manganese (Mn), zinc (Zn) and copper (Cu). This therefore 
creates 3 different isoforms which have different cellular locations. These are Fe-SOD which is 
predominant in prokaryotes and plant chloroplasts, Mn-SOD in prokaryotes and eukaryotic 
mitochondria, and Cu/Zn-SOD which is localized in the cytosol of eukaryotes as well as 
peroxisomes and chloroplasts. These are all encoded by different genes. (Fridovich, 1995; 
Dringen, Pawlowski and Hirrlinger, 2004; Gill and Tuteja, 2010; Karuppanapandian et al., 2011). 




consume O2- radicals. The significantly lowered CAT and SOD activities observed in the DIO testes 
are an indication of this tissue’s reduced ability to remove access hydrogen peroxide (H2O2) and 
O2- radicals, respectively. Lower antioxidant activity is a significant cause of cell injury and can 
cause damage to intracellular structures, which can ultimately lead to reduced cell function 
(Wiernsperger, 2003; King and Loeken, 2004; Suanarunsawat et al., 2014).  
GSH, an antioxidant highly abundant in aerobic cells, bodily fluids and tissue, protects cells and 
subcellular components from endogenous and exogenous ROS and reactive nitrogen species 
(RNS) (Rauhala, Andoh and Chiueh, 2005; Jozefczak et al., 2012). GSH bears the brunt of an 
ROS attack by buffering high levels of free radicals (Meyer et al., 2007) through its oxidation into a 
disulphide dimer, oxidised glutathione (GSSG) (Aquilano, Baldelli and Ciriolo, 2014). The loss of 
GSH via oxidative processes has been related to the pathophysiology of numerous disease 
processes (Ballatori et al., 2009), including obesity (Cabler et al., 2010; Du Plessis et al., 2010). 
The lower concentrations of reduced glutathione (GSH) within the DIO testes implies the increased 
use of GSH to scavenge free radicals within this tissue. This may be related to obesity as an 
instigator of ROS production (Matsuda and Shimomura, 2013), a mechanism confirmed in the 
current study due to increased antioxidant activity and the increased oxidation of GSH. 
The antioxidant activities of the reproductive organs have been correlated to changes in sperm, 
histological and molecular parameters. Lower antioxidant activity is a significant cause of cell injury 
and can cause damage to intracellular structures including sperm, which can ultimately lead to 
reduced cell function (Wiernsperger, 2003; King and Loeken, 2004; Suanarunsawat et al., 2014). 
The negative association between relative epithelial volume in the testes and SOD offers a 
mechanism of damage. Lower SOD activity implies less clearance of superoxide ions by the 
testes, and a higher likelihood of damage to surrounding cellular structures and germ cells. The 
current study has associated smaller seminiferous tubular diameters with lower amounts of GSH. 
As more GSH has been oxidised by ROS, there is less available to buffer any changes in ROS 
levels within damaged seminiferous tubules, increasing damage to tubular structures and the 
developing germ cells. The reduced luminal diameters also correlated with reduced testosterone 
concentrations. Less testosterone produced by Leydig cells leads to reduced germ cell production 
as this hormone is necessary to stimulate and maintain spermatogenesis (Cheng and Mruk, 2010; 
Preston et al., 2012). Reduced germ cell production could thus be the result of reduced 
testosterone production and increased damage from an overproduction of ROS. Although analysis 
of the epididymis showed no change in epithelial height and relative epithelial volume between the 
control and DIO group, the current study observed the relative epithelial volume to be negatively 
associated with lipid peroxidation, as reduced epithelial volume was related to higher levels of 
MDA. Increased lipid peroxidation could result in reduced cell viability due to destruction of sperm 




polyunsaturated fatty acids in their membranes. DNA damage, damage to sperm nuclei and loss of 
germ cells are additional consequences of lipid peroxidation (Sergio Oehninger et al., 1995; Sikka, 
2001; Aitken and Sawyer, 2003). The tubular diameters of the epididymides, which were reduced 
and therefore contracted in the DIO animals compared to controls, was associated with lower 
catalase activity. As previously mentioned, lower catalase activity indicates increased oxidation 









Figure 5.1: Summary of the study results and the associations between significantly different variables, as well as associations between variables that are significantly 
correlated. The chronic DIO diet is shown to affect anthropometric, macroscopic, microscopic and molecular variables directly or via a significant increase in visceral 
fat and the adiposity index. (MDA – malondialdehyde ; GSH – reduced glutathione).  



















































5.3. The proteomics of diet-induced male infertility 
The potential damaging effects of obesity can be further expanded using additional molecular 
assessments. The current study has analysed the reproductive organs and sperm of control and 
DIO animals using proteomics in an attempt to offer more insights into the broader underlying 
mechanisms through which obesity may be affecting sperm and body processes and thus male 
fertility. The findings of this section are illustrated in Figure 5.2 – 5.4, and thereafter summarised at 
the end of each subheading in Figures 5.5 – 5.9. 
 Proteins associated with glycolysis and oxidative phosphorylation 
Proteomic analysis in the current study has shown a large number of the differentially expressed 
proteins between the DIO and control groups to be involved in metabolic processes (summarised 
in Figure 5.5). Spermatozoa have a high, fluctuating demand for energy (Wallimann, Wyss, 
Brdiczka, Nicolay & Eppenberger, 1992) which is attained via two key metabolic pathways, 
glycolysis and oxidative phosphorylation (Du Plessis et al., 2015). Glycolysis predominantly takes 
place in the sperm head and principle piece of the flagella while oxidative phosphorylation is 
performed within the mitochondria. These two metabolic processes provide the sperm with 
adenosine triphosphate (ATP) which the cell specifically uses for numerous sperm functions 
including motility, capacitation, hyperactivation and the acrosome reaction (Miki, 2007; Mannowetz, 
Wandernoth and Wennemuth, 2012; Mukai and Travis, 2012). This ATP needs to be made 
available to the entire length of the sperm flagellum which requires the cell to utilize a variety of 
mechanisms and sources in order to generate it.  
Glycolysis (Figure 5.2), the breakdown of monosaccharides from six to three carbon structures 
through a series of reactions catalysed by metabolic enzymes, results in the production of ATP 
(Villar-Palasi and Larner, 1970; Xu et al., 2015). The 6-carbon monosaccharide predominantly 
metabolized is glucose, which is broken down into two 3-carbon pyruvate molecules. This process 
yields two ATP molecules for each glucose molecule metabolized. Pyruvate is then further oxidized 
into acetyl coenzyme A (acetyl-CoA), which can feed into the tricarboxylic acid (TCA) cycle to 
stimulate oxidative phosphorylation. Glycolytic energy substrates utilized by the sperm include 
glucose, fructose, mannose and sorbitol (Visconti, 2012). Fructose can be used directly for 
glycolysis or be converted into glyceraldehyde 3-phosphate via the Hers pathway before re-
entering glycolysis.  
Glycolysis and the TCA cycle (as well as fatty acid oxidation) create high-energy electron donors 
with a large electron transfer potential, namely nicotinamide adenine dinucleotide (NADH) and 
flavin adenine dinucleotide (FADH2), which donate electrons to oxygen and TCA cycle proteins to 




Oxidative phosphorylation uses this donation of electrons by NADH and FADH2 to create an 
accumulation of electrons between the inner and outer membranes of the mitochondria to generate 
an electron gradient that drives the movement of electrons from the mitochondrial matrix across 
the inner mitochondrial membrane. The movement of electrons across the inner mitochondrial 
membrane forms the electron transport chain, which allows electrons to move through complexes 
on the inner membrane. Electrons eventually return into the mitochondrial matrix through the final 
complex, complex IV, creating ATP with the assistance of ATP synthase (Erecińska and Wilson, 
1977; Berg, Tymoczko and Stryer, 2002). Oxygen accepts electrons at the end of the electron 
transport chain as electrons return back into the mitochondrial matrix, and ATP synthase converts 
adenosine diphosphate (ADP) into ATP. Energy substrates used for oxidative phosphorylation 
include pyruvate, lactate and acetyl-CoA which are generated from glycolysis and beta (β) 
oxidation (Berg, Tymoczko and Stryer, 2002; Amaral et al., 2013). Citrate is not permeable to 
mitochondria and is therefore not used as a primary energy source; it needs conversion by malate 









The process of glycolysis was significantly affected in the current study, with numerous glycolytic 
proteins including phosphoglycerate kinase, enolase and hexokinase and pyruvate dehydrogenase 
within the epididymis (Krisfalusi et al., 2006) showing differential expression between the control 
and DIO groups. These specific proteins have been found by previous studies to be expressed in 
the principle piece of spermatozoa in order to provide sufficient energy to cytoskeletal proteins, 
which bestow motility to sperm cells (Mukai and Okuno, 2004). Their position here aids in the 
provision of ATP to distal regions of the sperm tail. Furthermore, these proteins are not only 
concentrated in the principle piece but are also bound to the cytoskeletal proteins of the fibrous 
sheath. Their binding to cytoskeletal proteins allows them to provide the energy required for the 
active sliding of flagellar filaments during sperm movement (VandeBerg, Cooper and Close, 1973; 
Boer et al., 1987). Phosphoglycerate kinase 2 (PGK2), a key enzyme in the glycolytic pathway, is 
expressed exclusively in male germ cells (Boer et al., 1987). It is expressed by sperm cells which 
have undergone meiosis and the continued survival of these sperm appears to require glycolysis 
mediated by PGK2 (VandeBerg, Cooper and Close, 1973). The gene for this protein is located on 
the X chromosome and continues to be expressed after any possible inactivation of the X-
chromosome during spermatogenesis (Monesi, 1971; VandeBerg, Cooper and Close, 1973). PGK 
catalyzes the first ATP generating step of glycolysis by converting 1,3-bisphosphoglycerate to 3-
phosphoglycerate (Figure 5.2) and thus converting ADP to ATP (Danshina et al., 2010). PGK2 is 
expressed exclusively during spermatogenesis; its transcription is triggered at the onset of meiosis 
by mRNA transcripts of PGK2 which are first expressed in preleptotene spermatocytes, increasing 
in pachytene spermatocytes and spermatids (McCarrey et al., 1992). The PGK2 protein itself is 
only found in spermatids (Danshina et al., 2010). A study by Danshina and colleagues (2010) 
which compared mice with an intact PGK2 gene (wild type, WT) with mice lacking the PGK2 gene 
(pgk2-/-) observed pgk2-/- mice to have similar sperm motility to WT mice, although progressive 
motility was significantly reduced in the pgk2-/- group. ATP levels were also measured by 
incubating sperm under capacitating conditions and the ATP concentrations of the pgk2-/- sperm 
were observed to be < 10% of the WT levels within 30 minutes of incubation. In addition, the sperm 
from pgk2-/- and WT mice displayed similar levels of oxygen consumption during incubation in 
glucose-free medium containing pyruvate and lactate. Further incubation in media which contained 
substrates of the mitochondrial respiratory chain (i.e. succinate), showed that the reduction in 
progressive motility and ATP observed in the pgk2-/- mice were not due to a reduced activity of the 
mitochondrial respiratory chain as this process continued unabated. The stable total motility seen 
in pgk2-/- mice was postulated to be due the availability of other glycolytic enzymes such as 
acylphosphatase to catalyse the conversion of 1,3-bisphosphoglycerate to 3-phosphoglycerate, 
bypassing the need for PGK2. The pgk2-/- mice also did not have altered testicular histology, 
sperm ultrastructure or sperm counts, which indicated that the loss of PGK2 is compensated for by 




spermatogenesis. As both the DIO and control rats of the current study had high expression of 
PGK2, it can be deduced that sperm motility and ATP levels would be relatively conserved in both 
groups, although the DIO group showed higher expression of the PGK2 protein compared to 
controls. This is likely to be the result of the higher glucose levels present in the DIO plasma 
compared to controls. Glucose can act as a substrate for glycolysis and an excess amount can 
produce higher ATP concentrations. According to Danshina et al. (2010), higher ATP 
concentrations can result in higher progressive motility. This is plausible as mammalian sperm 
preferentially produce ATP from carbohydrate (fructose and glucose) fermentation during aerobic 
metabolism as opposed to gaining energy from sources such as lactate (Mann et al., 1981). Higher 
sperm motility could also be a sign of sperm hyperactivation, which is an adverse event it if occurs 
prematurely. This is a high velocity, whiplash-like movement of sperm which is used by 
spermatozoa to burrow through cumulus cells that surround an oocyte just prior to fertilization (de 
Lamirande and Cagnon, 1993). Premature hyperactivation of sperm causes a reduction in fertility 
as this mechanism only happens once and cannot be initiated again should a sperm come into 
contact with an oocyte. Sperm motility was unfortunately not measured in the current study as the 
epididymides were placed directly on ice after extraction to preserve enzyme activity for 
subsequent antioxidant analyses, thus exposing sperm to low temperatures which lowered sperm 
motility. Comparisons between total and progressive motility as well as hyperactivation between 
the study animals could thus not be analysed to confirm this association, but the current higher 
expression of PGK2 seems to suggest a high amount of glycolysis occurring to make energy 
available for sperm cells, with DIO sperm possibly having higher motility. The postulation that 
hyperactivation is a possible reason for the increased motility is supported by the overexpression 
of PDHA (see later) in DIO sperm, a protein that has been shown to be active in sperm 
capacitation and hyperactivation (Lee, 2014). 
 Other glycolytic and mitochondrial enzymes 
Phosphoglycerate mutase 2 (PGAM2) and Enolase 1 (ENO-1), also glycolysis enzymes (Figure 
5.2), similarly showed a higher expression in the epididymis of the DIO group, supporting the 
evidence for a higher rate of glycolysis in the DIO epididymis and epididymal sperm Figure 5.5). 
Hexokinase 2 (HK2) and Pyruvate dehydrogenase (PDHA), were, however, more abundantly 
expressed in the epididymis of the control animals. Hexokinases catalyse the first step of the 
glycolytic pathway by phosphorylating hexose sugars such as glucose and fructose (Wilson, 1997) 
to initiate their metabolism. The typical action of hexokinases is to convert glucose into glucose-6-
phosphate (G-6-PO4) (Figure 5.1). There are several hexokinase isoenzymes, namely hexokinase 
I-IV (Ureta, 1982). HK2 is the more insulin-sensitive isotype and is capable of metabolizing 
fructose, glucose and other hexose sugars such as mannose (Ureta, 1982) for use as energy 




a better insulin sensitivity in the control animals and the use of other substrates including fructose 
and mannose for energy. HK2 has also been shown to be active in the synthesis of glycogen from 
G-6-PO4 and in providing G-6-PO4 for use by the pentose phosphate pathway (Wilson, 1985). The 
pentose phosphate pathway converts G-6-PO4 into ribulose-5-phospate to generate NADPH for 
biosynthetic reactions, where NADPH is used for the biosynthesis of fatty acids, cholesterol, 
steroid hormones and nucleotides (Bhagavan, 2002; Bhagavan and Ha, 2015). Hexokinase IV, 
also known as Glucokinase (GK), is likewise more abundant in the epididymis of the control 
animals of the current study. This enzyme has been shown in pancreatic beta cells (β-cells) to 
sense and respond to fluctuations in plasma glucose concentrations and its phosphorylation of 
glucose is essential to the control of glycolytic flux in β-cells (Postic, Shiota and Magnuson, 2001). 
Other glucose responsive cells have been found to display functional changes in glucose 
metabolism based on GK activity. In the liver, GK has been shown to exert a strong influence on 
the utilization of glucose by hepatocytes and in glycogen synthesis (Ferre et al., 1996; Hariharan et 
al., 1997; Niswender et al., 1997). Hariharan et al. (1997) were able to show in an experiment 
using transgenic mice expressing the human hepatic GK gene that increased GK activity results in 
the reduction of glucose plasma levels and in a lower BMI compared to control mice. The higher 
glucokinase (GK2 and GYKL1) expression in the epididymis of control animals of the current study 
also corresponds to the results observed by Hariharan et al. (1997) as the control rats had lower 
body weights compared to the DIO group. This implies better glucose uptake by cells, reducing 
plasma glucose and a better maintenance of body weight by the control animals. While the plasma 
glucose levels did not show significant changes between the control and DIO groups, the 
proteomic assessment of the epididymis points to higher glucokinase levels in the control animals, 
which according to the cited literature, points towards better glucose uptake in this tissue. The high 
rate of glycolysis in the DIO animals is therefore likely to be due to the use of other energy 
substrates which can feed into the pathway at the point after the hexokinase and GK dependant 
steps (see later). GK expression is also dependent on the presence of insulin and has been shown 
to regulate genes involved in fatty acid metabolism and lipogenesis (Girard, Ferré and Foufelle, 
1997).  
PDHA is localized in the mitochondrial matrix and stimulates the conversion of glucose to acetyl-
CoA (Lissens et al., 2000). It is the rate-limiting enzyme connecting glycolysis with the TCA cycle 
(Figure 5.1). Mammalian PDHA is present in two forms; somatic (PDHA1) and testis-specific 
(PDHA2) (Dahl et al., 1990). PDHA is under regulation by metabolic, nutritional, developmental 
and hormonal control, and its expression can be down-regulated in stress conditions such as 
insulin-dependent diabetes and by high levels of free-fatty acids and ketone bodies (Wieland et al., 
1971). Succinyl-CoA:3-ketoacid coenzyme A transferase 1 (SCOT1), a key enzyme in the 




SCOT catalyzes the conversion of acetoacetate, a major ketone body, into acetoacetyl-CoA which 
is further metabolized by the TCA cycle for energy production (Cong et al., 2013). The use of 
ketone bodies for energy occurs when fat-derived energy is used by tissues other than the liver, 
which can result in ketoacidosis, the increased presence of ketones within plasma (Fukao et al., 
1997). The increased expression of SCOT1 observed in the DIO epididymis thus implies a possible 
increase in ketone bodies within the epididymis and plasma of the DIO group, which is a likely 
contributor to the reduced expression of PDHA1 in the DIO epididymis. The implications of the 
implied increase in ketones within the plasma of the DIO animals will be expanded on later in this 
discussion. 
 Role of PDHA2 differential expression in energy production in testis 
compared to epididymis  
The expression of PDHA2, the testis-specific form of PDHA, coincides with the onset of 
spermatogenesis, with significant expression being observed with the appearance of pachytene 
spermatocytes (Iannello, Young and Kola, 1994). This is similar to the expression of PGK, which is 
similarly observed in preleptotene spermatocytes at first before increasing within the more mature 
forms. PDHA1 is also present in the reproductive tissue, with expression noted in spermatogonia, 
Sertoli cells and Leydig cells, but it is limited to these regions. In white adipose tissue, the action of 
PDHA results in the provision of carbon from glucose, which becomes available for lipid synthesis 
(Maury et al., 1995). The PDHA-stimulated increase in acetyl-CoA is also essential in the 
production of glycerol, fatty acids and amino acids (Lee, 2014). This bodes well for developing 
sperm as these products are necessary for the production of sperm membranes, in sperm 
energetics and in the attainment of cell fluidity that is necessary for processes such as capacitation 
and the acrosome reaction in mature sperm. PDHA2 expression differed between the epididymis 
and sperm homogenates in the current study. Its expression was less abundant in the DIO 
epididymides, which implies a lower availability of PDHA2 for sperm maturation within the 
epididymis of the DIO animals. This could compromise DIO sperm maturation and result in the 
creation of more immature sperm. PDHA2 expression was higher in the sperm homogenates of the 
DIO animals compared to controls. As these sperm have already gone through the maturation 
process, the actions of PDHA2 here are more likely for the purposes of sperm energy production. 
As most of the other glycolytic proteins have been observed to have higher expression in the DIO 
animals, it is logical that the expression of PDHA2 is also higher here. This increase in PDHA2, as 
the rate-limiting enzyme connecting glycolysis with the TCA cycle, implies a higher stimulation of 
the TCA cycle and therefore oxidative phosphorylation in the DIO sperm. Mannose also seems to 
be another energy substrate being used by the epididymis of the current study’s animals due to the 
presence of beta-mannosidase (MANBA) in the epididymal homogenates of control and DIO 




mannose residues from non-reducing ends of all N-linked glycoprotein oligosaccharides. The DIO 
animals therefore seem to be less able to use this sugar as a metabolic substrate. 
 Proteins involved in oxidative phosphorylation 
Although sperm can essentially survive on glycolysis alone in terms of its energy requirements, it 
does require oxidative phosphorylation for differentiation and maturation (Barroso et al., 1993; 
Spiropoulos, 2002; Nakada et al., 2006; Du Plessis et al., 2015). This is, however, species specific 
and mammals prefer differing metabolic pathways as sources of energy; glycolysis is essential for 
fertilization in human, hamster, mice and rat spermatozoa, but not for bovine sperm (Galantino-
Homer et al., 2004; Miki et al., 2004). The mitochondria of spermatozoa, which are the site of 
oxidative phosphorylation, are tightly wrapped around the axoneme of the flagella at the principle 
piece. The binding of mitochondria to the axoneme is facilitated by selenoprotein and disulphide 
bridges which provide stability to the mitochondrial sheath (Ho and Suarez, 2003; Storey, 2008). 
These mitochondria, the source of ATP generation, are not located along the entire length of the 
sperm. This is due to their “bulky” nature which has the potential to negatively affect sperm motility 
at such locations. The ATP that they generate therefore has to be able to diffuse down the length 
of the entire flagellum in order to support the energy requirements of the tail (Serohijos et al., 2006; 
Kamp et al., 2007). Therefore, aberrations in the activities of mitochondrial respiratory enzymes 
can affect sperm motility (Luft, 1995).  
Oxidative phosphorylation seems to be a highly used metabolic pathway in the animals of the 
current study (Figure 5.5), although several enzymes that are involved in this pathway differ in 
expression between the epididymis and sperm homogenates. In the epididymis, ubiquinol-
cytochrome-c reductase complex core protein 2 (UQCRC2), succinate dehydrogenase (SDHA), 
Isocitrate dehydrogenase (IDH3B) and mitochondrial 2-oxoglutarate/malate carrier protein 
(SLC25A11) were significantly expressed in the epididymis, with lower expression observed in the 
DIO animals. On the other hand, oxidative phosphorylation enzymes UQCRC1, IDH3A, SDHA, 
NADH-ubiquinone oxidoreductase (NDUFS1), NADH dehydrogenase [ubiquinone] flavoprotein 1 
(NDUFV1) and malic enzyme (ME2) showed higher expression in the DIO spermatozoa. These 
results point to a higher rate of oxidative phosphorylation used by the mature DIO spermatozoa 
than the epididymis itself. 
 Lipids and Fatty acids as an energy source in spermatozoa and the 
reproductive system 
Spermatozoa have been shown to utilize fatty acid metabolites as another source of fuel. In a 
study by Amara et al. (2013), which performed proteomic analysis on human sperm tails, it was 




involved in lipid metabolism, as well as those involved in β-oxidation. They also observed 
peroxisome proteins known to participate in the oxidation of very long chain fatty acids, proving 
that the use of fatty acids as metabolic substrates may be more pronounced than previously 
believed. Their data was able to suggest that mitochondria within spermatozoa are able to oxidize 
saturated as well as unsaturated fatty acids, similar to other somatic cells. Furthermore, incubation 
of sperm in the absence of exogenous sugars did not reduce sperm motility; sperm were able to 
survive in this media for several days, implying that endogenous substrates of metabolism were 
made available by the sperm, although the nature of these were unknown. Due to the presence of 
enzymes of fatty acid metabolism, it was strongly postulated that sperm could possibly oxidize 
endogenous phospholipids to yield fatty acid substrates for use as energy substrates. Their data 
showed, possibly for the first time, that sperm may be able to metabolize very long chain fatty acids 
using peroxisomal enzymes.  
Peroxisomes, which are single membrane organelles with a granular matrix, are known to 
contribute to the maintenance of cellular homeostasis (Islinger, Cardoso and Schrader, 2010). Very 
long chain fatty acids can only be degraded by peroxisomes, with evidence showing all 
peroxisomes to be capable of β-oxidation (Wanders and Waterham, 2006). Peroxisomes were 
initially believed to not be present in rodent reproductive tissue, but evidence has disproved this 
notion as these cells have been located in epididymal cells and were later also found to be present 
in Leydig cells and in spermatocytes themselves (Reisse et al., 2001; Lüers et al., 2006). 
Mitochondria and peroxisomes have been shown to be interconnected, with evidence of cross-
linking between these organelles being found (Schrader and Fahimi, 2008). In addition, active 
vesicular transport occurs between mitochondria and peroxisomes. Somatic cells shorten very long 
chain fatty acids by metabolizing them via peroxisomal enzymes, and the resultant fatty acids can 
then be completely metabolized by mitochondria or become substrates for the synthesis of lipids 
and cholesterol. Based on the observed presence of peroxisome proteins, mitochondria and fatty 
acid oxidation enzymes, this process is also suggested to occur in the testis, epididymis and 
spermatozoa (Schrader and Fahimi, 2008).  
The presence of several proteins involved in lipid metabolism have been observed in the present 
study which suggests a use of lipids as metabolic substrates in the study animals (summarised in 
Figure 5.5). These proteins include coatomer subunit beta (COPB1), long-chain-fatty-acid-CoA 
ligase (ACSBG1), tripeptidyl-peptidase 2 (TPP-2), acyl-CoA synthetase 2 (ACSF2), acyl-CoA-
binding protein (ACBP) and hydroxyacyl-coenzyme A dehydrogenase (HADH) which stimulate or 
mediate lipolysis, lipid oxidation or adipogenesis. The presence of these proteins in our study 
corroborates the findings made by Amaral et al. (2013) that lipid metabolism is active within the 
reproductive system. Furthermore, peroxisomal proteins such as ATP-binding cassette sub-family 




isomerase 1 (IDI1) have been found to be significantly expressed in the epididymides of the 
present study, further pointing towards the presence of peroxisomes in the reproductive system, 
which was believed to not be the case for a significant amount of time.  
COPB1, an enzyme involved in the control of adipocyte growth, was underexpressed in the DIO 
epididymis of the current study. It limits lipid storage within lipid droplets by promoting the 
association of the enzyme adipocyte triglyceride lipase (PNPLA2) with lipid droplet surfaces to 
mediate lipolysis. On the other hand, redox-regulatory protein FAM213A, an antioxidant, is a 
protein secreted by adipocytes and is located on the principle cells of the epididymis. Its increased 
expression in the epididymis of the DIO rats, together with the reduced expression of COPB1, 
implies a greater number and/or size of adipocytes within the DIO epididymides and a 
compensatory increase in antioxidant ability to assist in the adverse increase in ROS that can 
result from this higher abundance of adipocytes. 
ACSBG1, a protein which mediates the synthesis of cellular lipids by activating long chain fatty 
acids as well as their degradation via β-oxidation, is significantly expressed in the epididymis of 
both the control and DIO rats, with a reduced expression in the DIO epididymis. Similarly, ACSF2, 
an acyl-CoA synthase, is less expressed in the DIO epididymis. This enzyme can catalyse the 
initial reaction of fatty acid metabolism, by forming a thioester with CoA. It has a preference for 
medium-chain fatty acids as energy substrates and plays a role in adipocyte differentiation. ACBP 
binds long and medium chain acyl-CoA esters and is active in β-oxidation; its expression, however, 
was higher in the DIO epididymis. HADH, a mitochondrial protein, plays an important role in the β-
oxidation of short chain fatty acids, exerting its highest activity toward 3-hydroxybutyryl-CoA. This 
protein is also reduced in expression in the DIO epididymis. ABCD3, a peroxisomal membrane 
protein, is a transporter which has been postulated to be involved in the transport of branched-
chain fatty acids and also shows a reduced expression in the epididymis of the DIO rats. This data 
points towards a lower amount of fatty acid catabolism in the DIO epididymis compared to controls. 
These fatty acids are possibly being metabolized in the controls to increase their availability as 
energy substrates for somatic cells and as well as the maturing of stored spermatozoa within the 
epididymis. They are also utilized for the synthesis of membrane lipids and cholesterol, which can 
be made available for sperm membranes and as hormone precursors. The apparently lower fatty 
acid metabolism in the DIO group implies a reduced usage of fatty acids as energy substrates of 
metabolism and for sperm maturation and hormone production within the epididymis. In the 
spermatozoa, acyl-CoA synthase 1 (ACSL1) is highly abundant in both the control and DIO sperm, 
although expression is lower in the DIO sperm. ACSL1 is a long-chain-fatty-acid-CoA ligase that 
stimulates fatty acid utilization through the metabolism of fatty acids into acyl-CoA and is activated 
by adiponectin. Its reduced expression by the DIO sperm suggests a lower availability of fatty acids 




binding proteins carnitine O-palmitoyltransferase 2 (CPT 2), electron transfer flavoprotein subunit 
alpha (Alpha-ETF) and fatty acid-binding protein 3 (FABPH) (also known as aspartate 
aminotransferase) in the DIO sperm compared to controls implies a higher ability of DIO sperm to 
bind and transport the fatty acids that are available for use as energy and membrane substrates.  
Furthermore, the spermatozoa of the DIO group having a higher expression of the ketone enzyme 
SCOT1 implies an additional mechanism through which DIO can make more energy substrates 
available when substrates from glycolysis and fatty acid oxidation are inadequate. Amaral et al. 
(2013) found the human homologue SCOT-t, a ketone catabolism enzyme, to be present in the 
sperm proteins that they quantified in their study, which literature suggests might be used to 
support sperm motility (Tanaka et al., 2004). Ketones are normal metabolites produced by the liver 
for use by extrahepatic tissues (Cohen, 1937). They are created to replace glucose in times of 
cellular glucose deficiency such as starvation, insulin deprivation and insulin-insensitivity (Cahill et 
al., 1966; Veech et al., 2001; Cahill and Veech, 2003; Cahill, 2006). They are efficiently used by 
the mitochondria to produce ATP and may also protect glucose dependent cells from free radical 
damage (VanItallie and Nufert, 2003). Ketone utilization increases as their concentration rises in 
the blood (Mirsky and Broh-Kahn, 1937). In humans, the turnover time for ketone bodies in 
circulation is approximately two minutes (Wastney, Hall and Berman, 1984). The rate of ketone 
production is higher in obese individuals, and extrahepatic tissues absorb this metabolite for 
energy production but at a lower clearance rate than normal individuals (Hall et al., 1984). This can 
result in high plasma ketone levels in obesity.  
Based on the presence of proteins involved in ketone production and β-oxidation in the 
reproductive tissues of the current study (Figure 5.5), these mechanisms are implied to be 
extensively utilized by the control and DIO animals to produce metabolic substrates for ATP 
synthesis. A reduction in  the availability or utilization of insulin in insulin-resistant states such as 
starvation, obesity and diabetes, stimulates a compensatory acceleration in the hepatic conversion 
of free fatty acids to ketones for use as energy substrates (Cahill, 1970). Ketones are produced 
from fatty acids which are mobilized from adipose tissue stores; these fatty acids enter the liver 
and are metabolized by acyl-CoA synthetases and will be further metabolized depending on the 
length of their fatty acid chains. Short and medium chain acyl-CoAs are permeable to the inner and 
outer mitochondrial membranes, and enter the mitochondria to undergo β-oxidation into 
acetoacetate and acetyl-CoA. Long chain fatty acyl-CoAs are permeable to the outer mitochondrial 
membrane, where they enter the mitochondria to be metabolized further into long chain acyl-
carnitine before passing through the inner mitochondrial membrane to undergo β-oxidation. Very 
long chain acyl-CoAs and unsaturated fatty acids (as well as long and medium chain acyl-CoAs) 




oxidation does not proceed to completion, peroxisomes transport medium chain and acylcarnitine 
compounds to the mitochondria for final β-oxidation (VanItallie and Nufert, 2003).  
Mitochondrial β-oxidation (Figure 5.3) results in acetyl-CoA which enters the TCA cycle to be 
utilized for ATP generation (Abcam, 2019). When excess acetyl-CoA from β-oxidation cannot be 
metabolized, two acetyl-CoA molecules dimerize to form acetoacetyl-CoA, which begins 
ketogenesis (Figure 5.3 and 5.4). The result is two ketones, acetoacetate and β-hydroxybutyrate, 
being released by the mitochondria into circulation. From circulation, ketones can be taken up by 
extrahepatic tissues to use for energy production. Acetoacetate and β-hydroxybutyrate enter the 
mitochondria of extrahepatic tissues; β-hydroxybutyrate is further metabolized to acetoacetate by 
β-hydroxybutyrate dehydrogenase. Acetoacetate molecules are then broken down into two acetyl-
CoAs which subsequently undergo oxidative phosphorylation within the TCA cycle (Figure 5.4). In 
the TCA cycle, NADH and FADH2 are formed by the reduction of NAD+ and FAD to NADH and 
FADH2 (Figure 5.3). Electrons are then donated to complex I and II of the mitochondrial respiratory 
chain by NADH and FADH2 which initiates the flow of electrons down the electron transport chain 
to oxygen. This allows complexes I, II and IV to pump H+ out of the mitochondrial matrix into the 
intermembrane space. The movement of H+ back into the mitochondrial matrix through complex V 
produces ATP (with the assistance of ATP synthase) (VanItallie and Nufert, 2003) (Figure 5.3). 
The implied lower rate of β-oxidation and higher expression of SCOT1 suggest ketones to be a 
source of acetyl-CoA for ATP generation within the DIO animals. 
In an experiment by Lardy and Phillips (1945), which compared metabolic substrates utilized by 
mammalian spermatozoa, the two ketones acetoacetate and β-hydroxybutyrate were found to 
increase sperm motility at a lower oxygen consumption than the other metabolic substrates tested 
by these investigators. The mechanism of this result was not understood until studies by 
Kashiwaya et al. (1994; 1997) and Veech et al. (2001) were carried out on working heart 
perfusions. They compared the physiological effects of insulin versus those of ketones via the 
addition of glucose, ketones, insulin or a combination of these substrates to the heart perfusate. 
The efficiency of the hydraulic work performed by the heart to pump was increased by 28% after 
the addition of insulin and equally after the addition of ketones (Kashiwaya, King and Veech, 
1997). The addition of ketones to the perfusate decreased the rate of conversion of glucose to 
pyruvate as ketones were used as an alternate fuel instead of glucose, but it did increase the 
concentration of G-6-PO4. In addition, the activity of hexokinase was increased, but to a lesser 
degree than with the addition of insulin, which can explain the increase in G-6-PO4. Acetyl-CoA 
was increased 15 fold compared to 9 fold when insulin was added. The insulin-mediated increase 
in acetyl-CoA was mediated by an increase in pyruvate dehydrogenase, whereas the ketone-
stimulated increase was more likely due to the conversion of ketones themselves to acetyl-CoA 




reduction of free mitochondrial NAD+ to NADH and increased ATP production, as seen with the 
addition of insulin. The first 3 metabolites of the TCA cycle therefore increased, but succinate 
content was decreased while fumarate remained the same. Sato et al. (1995), who performed a 
similar experiment, noted a decrease in aspartate and oxaloacetate, and Kashiwaya et al. (1994) 
observed an increase in the action of glycerate mutase with the addition of ketones. The change in 
the succinate:fumarate content is interpreted as the oxidation of the mitochondrial coenzyme Q to 
co-enzyme QH2; the combination of NAD/NADH and Q/QH2 conversion results in an increase in 
electrons being ejected from the mitochondrial matrix, increasing the electron gradient to result in 
an elevated ATP production. These experiments can explain the results noted in the current study. 
The expression of hexokinase and pyruvate dehydrogenase being less abundant in the DIO 
epididymis compared to controls points to an insulin-stimulated increase in glycolysis in the control 
animals, which was not stimulated to the same extent in the DIO epididymis due to a higher 
dependence on ketones. The decreased succinate in the Sato et al. (1995) experiment is likely due 
to an increase in succinate dehydrogenase (SDHA), which has been observed in the DIO sperm of 
the current study, suggesting an alteration in the succinate:fumurate ratio as was seen with the 
addition of ketones in the aforementioned studies. The observed increase in acetyl-CoA in the 
hearts perfused with ketones is also a possible occurrence in the current study as the increase in 
ketone catabolism stimulated by SCOT1 can yield the breakdown of each molecule of 
acetoacetate into 2 molecules of acetyl-CoA. The change in the ratios of NAD+/NADH and co-
enzyme Q/co-enzyme QH2 observed in the studies by Kashiwaya (1994; 1997) can be coupled to 
the respective increase in NDUFS1 and UQCRC1 expression observed in the DIO sperm, which 
increase the action of the electron transport chain to increase ATP. Thus the lower glycolysis noted 
in the DIO animals is likely to be compensated by an increase in ketone usage by the epididymis 
and sperm, which then increased the expression of TCA cycle enzymes and substrates to possibly 













Figure 5.3: Image illustrating fatty acid metabolism, visualizing the collaboration between β-oxidation, the TCA 
cycle and the electron transport chain in the conversion of fatty acids into energy substrates and ATP. (FACS 
– Fatty-acyl-CoA synthase, CPT – carnitine palmitoyltransferase, CT – carnitine/acylcanitine translocase, 























 The role of creatinine kinase 
Creatine kinase (CK) is an enzyme that is active in the transfer of ATP from mitochondria to sites 
of energy usage in cells such as sperm, muscles and neurons (Ford, 2006). It participates in what 
is known as the phospho-creatine (PCr) shuttle where it catalyses the transfer of an N-phosphoryl 
group from PCr to ADP, thereby regenerating ATP (Kaldis et al., 1997). It is found in cells that have 
a high, fluctuating demand for energy (Wallimann et al., 1992). This enzyme has been found in the 
current study to be less abundant in the epididymides of the DIO group (summarised in Figure 5.6). 
Carbonic anhydrase (Ca5b), on the other hand, is necessary to shuttle ATP substrates back to the 
mitochondria from the sites of ATP usage in order for more ATP to be produced for subsequent 
energy production (Ford, 2006). This protein was found in the current study to have a higher 
expression in the DIO groups compared to controls (Figure 5.6). The lower expression of CK and 
higher expression of Ca5b in the DIO animals implies that a lot of energy (ATP) is being used up in 
the DIO epididymides but this energy is replenished at a lesser rate than that of the controls. Thus 
the ratio of energy utilization vs. production could be compromised in the DIO animals. Energy 
transfer, especially in the sperm tails, could thus also compromised. The high rate of energy 
created by the TCA cycle therefore does not seem to be adequately transferred to the cells by the 
CK system or the increased Ca5b is a compensatory mechanism that allows the creation of more 
ATP via the TCA cycle due to a less than optimal ATP replenishment shunt that is likely to be 
present as a result of the lowered expression of CK. 
CK has five isotypes, three are cytosolic namely brain-type (CK-BB), muscle-type (CK-MM), and a 
combination isotype (CK-MB) which occurs in dimers (Huszar, Vigue and Morshedi, 1992) and two 
are mitochondrial isotypes which are located in the intermembrane space, namely ubiquitous (CK-
Mia) and sarcomeric (CK-Mib) mitochondrial CK (Wyss et al., 1992). The CK-BB is localized in the 
sperm tail whilst the mitochondrial isotypes are localized in mitochondria within the sperm mid-
piece (Kaldis et al., 1997). Mitochondrial CK is, in all instances, co-expressed with at least one of 
the cytosolic CK enzymes. In this study, the epididymis appears to show co-expression with CK-
MM (protein Ckm), which has a lower expression in the DIO epididymis. Inhibition of CK impedes 
sperm In view of this it can be inferred that the reduced CK indicates that ATP replenishment and 
transfer by the PCr shunt to sperm and high energy cells in the epididymis is inefficient and is likely 
compensated for by an increase in ATP via glycolysis.  
The CK-MM protein levels in sperm of the current study’s animals are, however, significantly more 
abundant in the DIO sperm compared to controls, the opposite of what was observed in the 
epididymis (Figure 5.6). According to Huszar and colleagues (1990; 1992), because CK-MM is a 
cytosolic protein, its concentrations are meant to decrease as sperm mature and reduce their 
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Figure 5.6: Summary of proteins involved in associated with creatinine kinases that were found to be 
differentially expressed in the current study, including the functions and possible interactions postulated 




 The role of reactive oxygen species (ROS) 
As oxidative phosphorylation uses large amounts of oxygen to create ATP, its consumption results 
in the production of large amounts of ROS. The partial reduction of oxygen during metabolism 
gives rise to the production of free radicals including O2-, H2O2, and the hydroxyl radical (OH•). 
While ROS molecules are necessary for normal sperm functions, an increased production of these 
highly reactive oxygen metabolites leads to OS, which can damage many cellular components 
including proteins, lipids and DNA (Francis and Stevenson, 2019). The products of ATP hydrolysis 
(ADP, inorganic phosphate and H+) and ROS need to be efficiently removed in order to avoid 
cellular stress (Oberholzer et al., 2007). 
The passing of electrons from one mitochondrial complex to another within the ETC of the inner 
mitochondrial membrane is central to the production of ATP (Saraste, 1999). The main entry point 
for electrons into the ETC is Complex I, which stimulates the transfer of 2 electrons from NADH to 
ubiquinone (Wirth et al., 2016; Leipnitz et al., 2018). Proteins NDUFS1, SDHA and ETFA in 
spermatozoa as well as CDGSH iron-sulfur domain-containing protein 1 (CISD1) and ubiquinol-
cytochrome-c-reductase complex core protein 2 (UQCRC2) in the epididymis are similarly involved 
in the ETC within mitochondria. The NDUFS1 gene codes for a major subunit in complex I (Bénit et 
al., 2001) and CISD1 is an iron-containing protein located in the outer mitochondrial membrane 
that plays an essential role in complex I-driven respiration (Wiley et al., 2007). These proteins 
being overexpressed in the DIO group of the current study implies an increase in electron 
translocation through complex I. SDHA codes for complex II, and is active in the TCA cycle (Brière 
et al., 2005). It is overexpressed in the sperm of DIO animals, which reveals an increased activity 
of Complex II and an amplified ETC activity. ETFA transfers electrons to the mitochondrial 
respiratory chain via ETF dehydrogenase (ETF-ubiquinone oxidoreductase). UQCRC2 encodes 
Complex III, the most well-characterized complex of the ETC (Saraste, 1999) (summarised in 
Figure 5.7). Complex III transfers electrons from ubiquinol to cytochrome c, with this oxidation 
resulting in the transport of hydrogen ions (H+) across the mitochondrial membrane (Sánchez et 
al., 2013). Complex I and III have been identified as sites of H2O2 and O2- radical formation 
(Boveris and Chance, 1973). As these free radicals attack nearby molecules to stabilize 
themselves, the proximity of these newly produced molecules to the mitochondria make these 
organelles susceptible to damage by free radicals (Petrosillo et al., 2009). Free radicals attack 
mitochondrial complexes and mitochondrial membranes by virtue of their unsaturated fatty acid 
components. This can ultimately result in reduced mitochondrial ETC in the long term, thereby 
decreasing energy production. The result is a potential reduction in sperm function and motility, 
which are all dependent on mitochondria and ATP. The enzymes pyruvate dehydrogenase 
(PDHA2) and malate (malic acid, ME2) are molecules shown to drive flux (the rate of flow of 




of the DIO group in the current study implicates an additional mechanism of ETC stimulation in 
obesity. The upregulation of PDHA2, through its activity in glycolysis and the TCA cycle, can 
further stimulate free radical production in DIO sperm. The increased release of NADPH produced 
via the conversion of malate to pyruvate by ME2 (Jiang et al., 2013) is an additional source of 
stimulation of the TCA cycle and ETC, further driving the ability of these metabolic processes to 
increase free radical production. 
Iron-containing proteins, such as CISD1, contain iron (Fe) and cysteinate sulfur (S) atoms in 2 to 4 
iron-sulfur clusters (Lovenberg, 1973). In other words, they contain iron-sulfur (Fe-S) clusters of 2 
to 4 atoms of iron and sulfur each (2Fe-2S to 4Fe-4S), that are bound to cysteine (Cys) protein 
residues (Rouault, 2012). They are used for numerous cellular functions including electron 
transport in the ETC, the regulation of enzymatic activity, DNA repair, transcription, cellular 
bioenergetics (Fontecave et al., 2008) and in the synthesis of heme and iron–sulfur clusters 
(Crane, Siegel and Getzoff, 1995). Iron-containing proteins are redox-sensitive molecules and are 
readily converted into either [4Fe-4S] or [2Fe-2S] upon reduction or oxidation to accept or donate 
electrons accordingly (Karmi et al., 2018). Fe-S clusters can thus bind to electron-rich enzyme 
substrates and accept or donate electrons to stabilize the protein conformations of numerous 
metabolic proteins as necessary for their activity (Beinert, Holm and Münck, 1997; Rouault, 2012).  
Mitochondria can also synthesize Fe-S clusters and incorporate them into the TCA cycle (e.g. into 
aconitase and succinate dehydrogenase) and into mitochondrial complex I-III. CISD1, as an iron-
containing protein, can therefore regulate the maximal capacity of electron transport and oxidative 
phosphorylation, thereby assisting to control maximal mitochondrial respiratory rates. CISD1 has 
also been postulated to take part in iron metabolism. In an experiment using the plant analogue, 
AtNEET, which is found in plant mitochondria and chloroplasts, AtNEET was shown to transfer Fe 
via an Fe-S/Fe cluster to mitochondria or an acceptor protein (Nechushtai et al., 2012) leading to 
an accumulation of Fe within the plant. This result was also coupled to an increase in ROS 
production. Furthermore, the expression of AtNEET has been found to increase in response to an 
accumulation of the dioxygen molecule O2- (Op Den Camp et al., 2003), a function similarly 
observed in the mammalian equivalent (Beinert, Holm and Münck, 1997). The AtNEET protein has 
a common protein structure to the human analogue and its functions are thus transferrable to their 
human equivalent.  
In the current study, CISD1 was overexpressed in the DIO epididymis compared to controls (Figure 
5.7). In an experiment examining the effects of the overexpression of CISD1 (also known as 
MitoNEET) on adipocyte mitochondrial activity in mice, Kusminski et al. (2012) observed CISD1 
overexpression to increase lipid uptake and storage, resulting in the expansion of adipose tissue 




oxidation rates due to the reduction of mitochondrial Fe transport into the matrix via direct inhibition 
of Fe transport by CISD1; this is a step which is a rate-limiting component of the β-oxidation 
pathway. This result is in agreement with the current study where a reduction in proteins involved 
in the β-oxidation pathway in the epididymis of DIO animals was observed. Furthermore, 
individuals suffering from obesity and type 2 diabetes are known to exhibit lower β –oxidation rates 
(Kelley et al., 2002; Ritov et al., 2005). The enhanced lipid uptake and lower β-oxidation rates 
stimulated by CISD1 suggests that it can contribute to the adjustment of energy stored vs. energy 
burnt by altering energy bioenergetics (Kusminski et al., 2012). CISD1 was also found by 
Kusminski and co-investigators (2012) to lower the NAD+/NADH ratio, resulting in a build-up of 
NADH. As NADH and FADH2 are re-oxidized by the ETC into NAD+ and FAD, the build-up of 
NADH caused by the overexpression of CISD1 could imply that a) high rates of glycolysis, which 
occur in compensation to a reduction in β-oxidation, generate surplus NADH, b) ETC activity 
during CISD1 overexpression is inefficient to re-oxidize NADH, c) CISD1 has an impact on the 
NAD+/NADH ratio and d) the alteration of NAD shuttle, salvage and degradation by CISD1 
compromises mitochondria performance which is further affected by the increased concentrations 
of NADH (Muoio and Newgard, 2006). A decrease in the ability of mitochondria to reduce the 
NAD+/NADH ratio thereby disrupts the energy bioenergetics of mitochondria and their redox 
capabilities. An increased storage vs. usage of fat is also observed in the DIO animals based on 
the implied decrease in β-oxidation and increase in proteins necessary for energy storage. 
Increased oxidative phosphorylation, the subsequent release of ROS by mitochondria and the 
possible damage incurred by mitochondria due to the ROS that they produce, instigates a vicious 
cycle which potentiates mitochondrial damage. This damage can alter mitochondrial dynamics 
(Kim and Song, 2016) and induce the mitochondrial permeability transition pore (MPTP) (Ellerby 
and Bredesen, 2000) at contact sites between the mitochondrial inner and outer membranes 
(Crompton, 1999). This increase in mitochondrial permeability could result in the release of 
cytochrome c which can stimulate the intrinsic apoptotic cascade via the activation of caspase 4, 8 
and 9 (Pan, O’Rourke and Dixit, 1998; Osellame, Blacker and Duchen, 2012).  
Pyruvate dehydrogenase, oxoglutarate dehydrogenase as well as isocitrate dehydrogenase are 
Ca2+-sensitive enzymes. An increase in these enzymes is observed in the current study through 
the overexpression of PDHA2, SDHA and IDH3A in DIO sperm (Figure 5.7). Their increase can be 
linked to possible increases in Ca2+ concentrations within mitochondria. OS and increased ETC 
cycling have been shown to induce a slow incremental rise in resting Ca2+ concentrations within 
mitochondria (Crompton, 1978, 1976), which may result in Ca2+ overload. This is due the release of 
hydrogen ions (H+) from the respiratory chain, which leave mitochondria through transport systems 
on the inner mitochondrial membrane. The exit of H+ from the mitochondrial matrix is exchanged 




the mitochondria in exchange for an influx of Ca2+ into the matrix by means of a Na+/Ca2+ 
exchanger (Crompton, Capano and Carafoli, 1976; Crompton, Künzi and Carafoli, 1977). This 
exchange sets up a gradient which can drive Ca2+ influx into the matrix via a Ca2+ uniporter 
(Crompton et al., 1978). This allows Ca2+ to be distributed into the mitochondrial matrix until a Ca2+ 
overload occurs (Nichols and Crompton, 1980; Crompton, 1990). This is an important mechanism 
of cellular injury. Mitochondrial Ca2+ overload can itself be harmless, but in combination with OS 
and a reduction in ATP due to mitochondrial damage, can lead to MPTP formation and cell death 
(Crompton, 1990). The intermembrane space between the inner and outer mitochondrial 
membranes is filled with apoptogenic proteins, thus a loss of the outer mitochondrial membrane 
due to damage by oxidants and Ca2+ overload can lead to the release of these proteins and in 
accidental apoptosis (Crompton, 1990). Alterations in cytosolic Ca2+ and thereby Ca2+ cycling into 
mitochondrial matrix can increase the activity of PDHA2, SDHA and IDH3A (McCormack, 
Halestrap and Denton, 1990). Their increase, in response to increased mitochondrial Ca2+, can 
serve as an additional stimulus for the ETC and further free radical production.  
MPTP opening in the face of Ca2+ overload and OS can also result in necrosis (Crompton, Costi 
and Hayat, 1987; Crompton, Ellinger and Costi, 1988). MPTP opening does not cause ATP 
synthesis but rather ATP hydrolysis, which impairs energy metabolism. This causes additional Ca2+ 
dysregulation and further MPTP opening, creating a continuous vicious cycle which culminates in 
cell death (Crompton, Ellinger and Costi, 1988). Furthermore, the overexpression of the PDIA1 
protein suggests a mechanism of protection against OS-induced apoptosis signaling. This protein 
is an abundant redox enzyme which may act as an anti-inflammatory via its downregulation of 
inflammatory mediators such as nuclear factor-kappa B (NF-κB) (Zhou et al., 2008). Catalase can 
partially block MPTP formation in mitochondria (Kowaltowski, 1996), but the lower activity of this 
enzyme suggests the loss of this protective mechanism. 
Heat shock proteins (HSP) are well conserved molecular chaperones which can be upregulated by 
stress conditions such as OS (Georgopoulos and Welch, 1993; Welch, 1993). They may be 
released by necrotic or stressed cells, or moved from the cytosol to cell surfaces where they can 
stimulate immune reactions (Vendetti et al., 2000; Pfister et al., 2005; Sapozhnikov et al., 2007; 
Pockley, Muthana and Calderwood, 2008). HSP60, a prominent HSP isotype, is released from 
cells following metabolic and cellular stress, making it available for interaction with immune cells 
(Habich and Burkart, 2007; Pockley, Muthana and Calderwood, 2008). It is a chemoattractant for 
neutrophils, which degranulate upon stimulation to promote an inflammatory state (Osterloh et al., 
2009). It is also implicated as a stimulator of cytokine release from pre-adipocytes and adipocytes 
in obesity (Macaulay and Larkins, 1988; Gülden et al., 2008, 2009). In so doing, it mediates 
adipocyte dysfunction and potentiates a low grade inflammatory state (Märker et al., 2010). The 




state during obesity, which is a stimulator of OS. Furthermore, the manganese isoform of SOD 
(MnSOD) seems to require HSP60 for proper protein folding, which could moreover explain the 
increase in HSP60 as it is required for MnSOD synthesis (Magnoni et al., 2014). 
Taken together, the changes in expression of the aforementioned proteins point to an increased 
rate of cellular metabolism and inflammation in the obese condition, which can increase the 
production of free radicals. These need to be detoxified by endogenous antioxidants. 
The current study found an increase in the cytosolic SOD protein expression (SOD1) in the 
epididymis of DIO animals. This is contrary to the spectrophotometric measurement of SOD activity 
which evaluated the ability of SOD to inhibit the auto-oxidation of 6HD by the removal of 
superoxide radicals produced during the assay (Heikkila, 1985). SOD activity was lower in the DIO 
group compared to controls, implying a decreased ability to consume O2- radicals. At the protein 
level, higher expression of SOD was observed, which seems to imply increased production of SOD 
in an attempt to cope with the increased demand. Chronic OS has been shown to deplete 
antioxidant enzyme, including SOD (Fernández-Sánchez et al., 2011b). Due to the long-term 
nature of obesity and its persistent stimulation of OS, antioxidant sources become depleted, 
thereby reducing the activity of enzymes such as CAT and SOD (Amirkhizi et al., 2010). 
Furthermore, SOD activity has also been previously found to be reduced in obese subjects 
compared to healthy controls (Ozata et al., 2002; Fernández-Sánchez et al., 2011b). In the event 
that SOD is depleted due to chronic OS or excessive ROS, de novo synthesis of SOD can be 
stimulated, resulting in increased production of the SOD protein (Miguel, Augusto and Gurgueira, 
2009; Liu et al., 2013; Nair et al., 2015; Steinbacher and Eckl, 2015), as seen in the current study. 
Glutathione-S-Transferases (GST) are a family of enzymes that stimulate the conjugation of GSH 
to electron-deficient molecules (electrophiles) (Strange, Jones and Fryer, 2000; Odbayar et al., 
2009). Cytosolic GSTs are found in all cellular life forms. In addition to their ability to assist in free 
radical detoxification, these enzymes are able to bind products of lipid peroxidation (Board and 
Menon, 2013). The most abundant in the cytosol is GSTM5, which has been under-expressed in 
the present study (Figure 5.7). This is a sperm specific isoform, the levels of which show rapid 
increases at weeks 6-7 of sperm development within the rat and are related to increased 
spermatogenesis (Rowe, Patskovsky, et al., 1998). This isoform is easily broken down during OS 
(Rowe, Nieves and Listowsky, 1997), which explains the observed reduction of this protein in the 
current study. Furthermore, its decline implies a decrease in spermatogenesis due to the removal 
of this enzyme as a co-stimulant. Rats that have undergone hypohysectomy were demonstrated to 
have significantly lower GSTM5 expression after 5 weeks suggesting that the expression of this 
GST isoform is necessary for sperm production and maturation (Rowe, Tchaikovskaya, et al., 




kinase, to sperm flagella (Krisfalusi et al., 2006; Nakamura, Mori and Eddy, 2010). Its under-
expression in this study implies an interruption in localization of glycolytic enzymes to sperm tails 
with a probable reduction in sperm motility in the long term due to reduced local delivery of ATP to 
distal regions of sperm flagella.  
Membrane bound GSTs have also been located within mitochondrial membranes (Hayes and 
Pulford, 1995). The testes are rich with multiple forms of GSTs to afford the developing germ cells 
protection against free radical production (Hipler et al., 2000). Testicular germ cells possess 
multiple isoforms of GST on their plasma membranes and their presence here is postulated to be 
beneficial to the removal of LPO intermediates (Hayes and Pulford, 1995) and harmful oxidants. 
The abundance of membrane-bound GSTs in haploid germ cells is necessary for the removal of 
surrounding toxins (Rao and Shaha, 2001) to which sperm are inherently vulnerable due to the 
abundance of polyunsaturated fatty acids (PUFAs) in sperm membranes (Kothari et al., 2010). 
Their presence on cell membranes have also been linked to steroid binding which is necessary for 
cell function (Mukherjee et al., 1999). Furthermore, their presence is confined to regions of the 
plasma membrane overlying the acrosome region in normal non-permeabilized germs cells at 
varying levels of maturity (Rao and Shaha, 2001). GSTA3, an isoform present on sperm plasma 
membranes, has been found to be overexpressed in the DIO epididymis of the current study. This 
implies an increased protection of DIO germ cells from membrane damage, possibly as a result of 
the implied increase in ROS molecules in the DIO animals. GSTM6L has not been well 
characterized, but shows glutathione transferase activity, and is under-expressed in the DIO 
epididymides.   
Lipid peroxidation in both the testes and epididymides of the DIO animals was not significantly 
different to the amount occurring within the control animals. The reason for this could be the 
upregulation of proteins protecting the epididymis and sperm from peroxidation by free radicals 
including ALDH7A1, GSTA3, PRDX1 and PRDX6 (Figure 5.7). ALDH7A1, is a multifunctional 
enzyme which mediates protection against lipid peroxidation by metabolizing betaine aldehyde to 
betaine, an important cellular osmolyte and methyl donor (Brocker et al., 2010). By doing so, it 
protects cells from OS by metabolizing a number of lipid peroxidation-derived aldehydes.  
Vitamin D is a signaling molecule predominantly involved in the metabolism of calcium and 
phosphorus. It has multiple functions in reproduction including testosterone transport, the 
regulation of aromatase activity, calcium and phosphate transportation into spermatozoa, Leydig 
cells and the epididymis, and cholesterol homeostasis in Sertoli cells (Jensen, 2014). The vitamin 
D receptor (VDR) is present in male accessory glands and reproductive organs including the 
testes, epididymis, prostate and seminal vesicles. It is also present on Leydig cells, spermatozoa 




Foresta et al., 2011). The presence of the VDR and enzymes associated with vitamin D 
metabolism in the male reproductive system implies a local modulation of a response to vitamin D 
(Kidroni et al., 1983). The testis and epididymis have a high binding affinity for the active form of 
vitamin D. Furthermore, vitamin D possesses antioxidant capabilities by decreasing lipid 
hydroperoxide levels and increasing total antioxidant capacity (Garcion et al., 2002). Vitamin D-
binding protein showed higher expression in the epididymis of DIO animals compared to controls 
(Figure 5.7). This implies a heightened use of vitamin D in protection by the body to help to 
increase antioxidant capacity.  
Proteomic analysis of the control and obese tissues has revealed increased expression of 
additional antioxidant proteins during obesity, seemingly in order to increase antioxidant capacity of 
the reproductive organs. These include PDIA4, PARK7, PRDX1, PRDX6 and FAM213A (Figure 
5.7).  
Park 7 (Parkinson disease autosomal recessive, early onset 7) is an essential protein as it takes 
part in several cellular processes including autophagy and in the protection against oxidative stress 
and the maintenance of mitochondrial homeostasis (Wilson et al., 2003; Kahle, Waak and Gasser, 
2009). Upregulation of PARK7 is a protective mechanism to preserve mitochondrial and cell 
survival (McCoy and Cookson, 2011; Miller-Fleming et al., 2014). This protein was observed to 
have increased expression in the epididymis of DIO animals compared to controls, implying an 
additional process through which the body may be attempting to reduce OS and increase cell 
survival.  
The protein IMPACT is a regulator of protein translation and is used as a quick mechanism of 
adaptation to stress conditions (Roffé et al., 2013). This protein was under-expressed in the 
epididymis of the DIO animals implying that the obese animals were not able to upregulate this 
protein in order to confer it’s the protection. Furthermore, the downregulation of thioredoxin (TRX) 
in the DIO epididymis, which provides protection against nitric oxide (NO) insensitivity during 
periods of high NO exposure (Huang et al., 2017) such as OS. This implies that the epididymis is 
insensitive to NO which can have downstream effects on NO in the DIO animals. 
The data above implies that OS and inflammation are stimulated in the DIO animals, with a 
compensatory increase in antioxidant capacity via the increased expression of several antioxidant 
proteins in an attempt to reduce the possible damage that can be incurred by the potentiation of 
these processes. OS is a central mechanism through which many damage-inducing processes act 
and has been associated with obesity (Marseglia et al., 2015). The implied existence of OS and 
inflammatory processes within the DIO animals could be a possible mechanism for cell damage as 
these have been implicated as significant causes of cellular injury which can result in damage to 
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 Role of cytoskeletal proteins 
Cytoskeletal proteins were variably affected by the OS and inflammation that appears to be 
present within the DIO animals. Actin proteins (ACTA1, ACTA2, ACTG2, ACTB), tubulins 
(TUBB4B, TUBB5), desmin (DES), vimentin (VIM), thymosin (TMSB4X), tropomyosin alpha-3 
chain (TPM3) and microtubule-associated protein RP/EB family member 1 (MAPRE1) all showed 
higher expression in the DIO epididymis compared to controls (summarised in Figure 5.8). The 
proteins observed to be underexpressed in the DIO epididymis include plastin 3 (PLS3), fibrous 
sheath CABYR-binding protein (FSCB), lumican (LUM), catenin (CTNNA1), echinoderm 
microtubule-associated protein-like 2 (EML2), profilin-2 (PFN2), regulator of microtubule dynamics 
protein 1 (RMDN1) and surfeit 4 (SURF4) (Figure 5.8). Plastins are actinins that have been found 
in stereocillia and are responsible for the spatial arrangement of actin filaments within these 
structures (Daudet and Lebart, 2002). FSCB may be involved in the later stages of fibrous sheath 
generation. It binds calcium and has been localized to fibrous sheaths and the surface of 
longitudinal columns and ribs of the principal piece of sperm flagella. LUM is a proteoglycan 
protein, specifically a small leucine-rich proteoglycan, and has been reported to have an essential 
role in cell migration and proliferation during tissue growth, tissue repair and embryogenesis, and 
assists in the regulation of tissue hydration as well as collagen fibrillogenesis (Baba et al., 2001; 
Onda et al., 2002). It is also located in vascular smooth muscle cells, e.g. in the intima of blood 
vessels (Talusan et al., 2005). CTNNA1 has been implicated in several important biological 
processes including ovarian follicle development, male gonad development and actin filament 
organisation. This protein is a catenin, which are cell adhesion proteins that combine with 
cadherins to form adherens junctions. Catenins are cytoplasmic anchoring (connecting) proteins 
that mediate the signalling of extracellular events to the interior of the cell. Additionally, catenins 
influence the architecture of differentiated tissue, as well as cell polarity, proliferation and in linking 
the cell surface to cytoplasmic and nuclear events through signal transduction (Aaltomaa et al., 
2005). Cadherins are plasma membrane proteins that participate in calcium-dependant cell 
adhesion. These proteins are essential for tissue development and differentiation in many organs 
and are important for tissue integrity and barrier functions (Sundfeldt et al., 2000). The cytoplasmic 
portion of Epithelial cadherin (E-cadherin) binds to cytoplasmic anchoring proteins such as 
catenins to form adherens junctions (Piedra et al., 2003). Beta catenins bind directly to E-catenin 
while alpha (α) catenins like CTNNA1 link E-cadherin bound β-catenins to the actin network of the 
cytoskeleton (Aaltomaa et al., 2005). Cells that lack α-catenin expression are not able to form 
stable contacts even if β-catenins and E-cadherins are present (Hirano et al., 1992). A study by 
Byers et al. (1994) which looked at the distribution of cadherins and catenins in rat testes found α- 
and β-catenins to be expressed in the seminiferous epithelium and prominently in Leydig cells, as 




al., 2006) located α-catenins in the acrosome of spermatids and in the cytoplasm of Leydig cells. 
Zhang et al. (2006) withdrew testosterone from adult rat testes with the use of testosterone 
undecanoate (TU) and assessed the expression of α-catenins. They found that α-catenins 
expression was reduced or absent in the TU-treated rat testes, resulting in Leydig cell atrophy. Ha 
et al. (2011) found ROS to significantly affect the expression of E-cadherin and α-catenin. 
The expression of sperm proteins was predominantly not reduced in the sperm of the DIO group, 
with the exception of dynein light chain roadblock (DYNLRB2) and tubulin beta (TUBB1), which 
were under-expressed in the DIO sperm. Dyneins are motor proteins which aid in the movement of 
cilia and flagella (axonemes) and in driving movement of discrete structures along microtubules 
(Allan, 2011). They drive the sliding of microtubules and, if fixed to a cell structure, are able to pull 
on microtubules to reorganize the cell during migration and mitosis. Importantly, cells without 
dynein cannot divide properly (Allan, 2011). Tubulins are part of the microtubule family. 
Microtubules are filamentous structures that are responsible for directing the movement of 
vesicles, in organizing the endoplasmic reticulum (ER) and Golgi apparatus in the cytoplasm and in 
equally partitioning chromosomes before cell division (Bhattacharya and Cabral, 2004). EML2 is 
part of the echinoderm microtubule-associated protein (EMAP) family, a group of proteins involved 
in protein-protein interactions and active in cytoskeletal dynamics and signal transduction (Ly et al., 
2002). Furthermore, these proteins have been postulated to be an important link between signal 
transduction events and changes in the organization of microtubular structures during the cell cycle 
(Li and Suprenant, 1994). EMAPs are widely expressed in all peripheral tissues including the 
testes. They are also abundant in mitotic and interphase microtubule arrays (Li and Roberts, 2001) 
and are integral components of microtubules (Sloboda, Rosenbaum and Dentler, 1976). EML2 
expression was reduced in the epididymis of DIO animals compared to controls  
Taken together, this data suggests that while the expression of most cytoskeletal and structural 
proteins within the sperm and epididymis were predominantly unaffected in the DIO group, the 
functional proteins that are responsible for regulating their orientation and function were affected. 
The under-expression of essential proteins such as α-catenin, lumican and dynein have possibly 
comprised cell structure and function. Bearing in mind the histological changes observed in the 
tissue sections of the DIO and control epididymides, the reduced expression of plastin can be 
linked to the observed loss of definition within the stereocilia as this protein is necessary for the 
spatial arrangement of actin filaments within these structures. The reduction in α-catenin could be 
linked to the observed loss of adherence between the basement membrane and the epididymal 
epithelia, as the epithelia were seen to be less adherent to one another and to break away from the 
basement membrane. Furthermore, cell signalling between these structures could be altered as 
the loss of α-catenin has been shown to disrupt communication between cells and incoming 




also lead to cell atrophy and a disruption in cellular architecture. Lastly, the loss of α-catenin has 
been linked to acrosomal membranes. The reduction in this protein suggests either a loss of 
acrosomal membranes, implying an increased rate of acrosome reactions, or a loss of adhesion 
within the acrosomal membranes which could predispose spermatozoa and spermatids to 
premature acrosome reactions. This result can be coupled to the observed change in expression of 
an acrosomal protein named F-actin capping protein (CAPZA3) which is more abundantly 
expressed in the DIO sperm compared to controls. This protein belongs to a group of actin-capping 
proteins which are ubiquitously expressed components of mammalian cells (Hurst et al., 1998). 
They are actin binding proteins which enable the actin cytoskeleton to rapidly respond to local or 
external signals and thereby promote changes in cell shape (Theriot, 1994). Capping proteins are 
co-localized with actin at the base of the acrosome in developing spermatocytes, almost as though 
to stabilize the position of the acrosome in relation to the nucleus (Fouquet and Kann, 1992). 
Furthermore, F-actin has been shown to break down during the acrosome reaction (Brener et al., 
2003). The increased expression of this protein in relation to the controls suggests that the 
acrosome is likely to be intact, therefore supporting that a decrease in α-catenin will likely affect the 
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 Reproductive proteins 
Several proteins specific to reproductive functions have been differentially expressed between the 
animals of the current study (summarised in Figure 5.9).  
Slc25a11 is a mitochondrial oxidative phosphorylation protein that has also been shown to take 
part in spermatogenesis, and has been underexpressed in epididymis of the DIO group. Valosin-
containing protein) (VCP) is a ubiquitous clathrin-binding protein that is involved in receptor-
mediated endocytosis and Golgi sorting (Yeo and Yu, 2016). It has also been shown to have a 
catalytic similarity to chaperone proteins which indicates that it may modulate protein-protein 
interactions via membrane transport processes (Pleasure, Black and Keen, 1993). It recognises 
and co-localizes with ubiquitin-positive protein aggregates, thereby participating in the clearance of 
aggregates as part of its role in quality control of cellular proteins (Kobayashi et al., 2002; Pécheur 
et al., 2002). This function also pertains to abnormal protein aggregates (Kobayashi, Manno and 
Kakizuka, 2007). In addition to the removal of aggregates, the accumulation of misfolded proteins 
in the cytoplasm induces VCP to translocate to the nucleus and suppress the transcription of more 
misfolded proteins. This allows the cell to degrade and remove the existing misfolded proteins via 
cellular mechanisms such as autophagy, chaperones and proteasomes (Koike et al., 2010) 
Importantly, it has also been implicated in the repair mechanism for double-stranded breaks within 
DNA (Panier and Boulton, 2014). VCP expression has been upregulated in the DIO epididymis of 
the current study, suggesting an increase in the repair of DNA strand breaks as well as the 
removal of misfolded proteins which could be resulting due to the observed increases in damage-
inducing processes such as OS and inflammation induced by the obese phenotype. Its removal of 
misfolded proteins seems to be supported by other proteins including protein disulfide-isomerase 
(PDI), small ubiquitin-related modifier 2 (SUMO-2), HSP70 family protein 5 (HSPA5), 26S 
proteasome non-ATPase regulatory subunit 1 and 13 (PSMD1 and PSMD13) as well as 
proteasome subunit beta type-7 (PSMB7), which are all upregulated in the DIO epididymis.  
Other sperm proteins affected by the DIO phenotype include sperm surface protein Sp17 (SPA17) 
and voltage-dependent anion-selective channel protein 2 (VDAC2). These proteins are necessary 
for the binding of sperm to the zona pellucida (ZP) and have been under-expressed in the 
epididymis of the DIO animals. Fertilization in mammals involves interactions by molecules present 
in both the egg and the sperm (Busso et al., 2007). Cell-cell interactions between sperm and the 
oocyte’s plasma membrane as well as cell-matrix interactions between the sperm and the 
cumulous cells surrounding oocyte, occur respectively during fertilization. SPA17 is a mannose-
binding protein that is localized to the sperm head and flagella (Chiriva-Internati et al., 2009). It has 
been shown to function upon acrosome reaction as a ZP binding protein, a function that has been 




matrix. SPA17 is therefore involved in a cell-matrix interaction during fertilization by binding to the 
carbohydrates in the extracellular matrix surrounding the oocyte (the ZP); the carbohydrates act as 
a receptor to allow cell recognition and attachment, thereby allowing SPA17 to bind sperm to the 
ZP with high affinity (Richardson, Yamasaki and O’rand, 1994). The binding of SPA17 within the 
flagella to AKAP (A-kinase anchoring protein), a scaffold protein which binds to protein kinase 
(PKA) and other components of signal transduction pathways, is postulated to involve this protein 
in the control of sperm motility (Lea, Widgren and O’Rand, 2004). VDAC2 is located at the flagella, 
in the head region overlying the acrosome and in the post-acrosomal region (Petit et al., 2013). 
VDAC2 has been shown to interact with ZP proteins within the head region via its binding to zona 
pellucida proteins ZP2 and ZP3 in an experiment by Petite et al. (2013). Additionally, VDAC2 is a 
voltage-gated channel; at the head of the acrosome, it is postulated to be involved in the transport 
of ATP and calcium between the acrosome and the cytoplasm while on the flagella it is located on 
the outer mitochondrial membrane where it transports calcium, adenine nucleotides and other 
metabolites into the outer mitochondria, thereby participating in energy production (Petit et al., 
2013). Through these transport processes, VDAC has been implicated in capacitation, the 
acrosome reaction and in sperm motility (Liu, Zhang and Wang, 2010). The under-expression of 
these proteins suggests a reduced ability of the DIO sperm to capacitate and therefore undergo a 
timeous acrosome reaction as well as sperm-oocyte fusion. This reduce the ability of DIO sperm to 
fertilize an oocyte, thereby impacting on the fertility of the male.  
COP9 signalosome subunit 3 (Cops3) is a protein which has been shown to have protein kinase 
activity and the control of ubiquitin ligases, a function through which it controls the degradation of 
several proteins involved in the cell cycle such as p53 and cyclin E as a controlling measure for the 
timeous expression of these proteins (Yan et al., 2003). Disruptions in the function of this protein 
results in the accumulation of these proteins and cell cycle arrest, resulting in deficient cell 
proliferation and the death of early embryos (Lykke-Andersen et al., 2003). COP9 is under-
expressed in the DIO epididymis, suggesting that the DIO sperm have a reduced ability to undergo 
the appropriate cell cycle progression that is necessary for embryogenesis, which can predispose 






Figure 5.9: Summary of proteins involved in reproductive processes that were found to be differentially 
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5.4. Summary of protein networks affected by the DIO diet 
Several protein networks were affected by the diet and the subsequent weight gain observed in the 
DIO animals. The predominant pathways affected were related to metabolism, specifically 
influencing proteins involved in glycolysis, β-oxidation and oxidative phosphorylation. Structural 
proteins involved in cell-to-cell communication, extracellular matrix organization, chromatin 
organization, protein localization, signal transduction, muscle contraction and cell motility showed 
differential expression after the introduction of the chronic obesogenic diet. These changes were 
possibly brought on by increases in stress proteins including redox, inflammatory and heat shock 
proteins. Regulatory pathways essential for cell transport, signal transduction, the immune system, 
organelle biogenesis and maintenance, homeostasis and the removal of aberrant cellular 
structures such as autophagy and programmed cell death, were dysregulated. In many cases the 
proteins involved in these pathways were overexpressed, possibly as a compensatory mechanism 
to stimulate the removal of misfolded proteins and detrimental cellular structures which can hinder 
the survival and well-being of DIO tissues. Cell cycle as well as DNA repair and replication 
proteins, which are essential for cell viability and the production of functional proteins, were 
affected by the diet. This influences the capacity of DIO organs to induce these multi-pathway, 
multi-enzyme systems which are necessary for the integrity of the cellular genome. Proper 
regulation of these pathways is essential for the survival of cells after cellular damage from 
metabolic by-products and environmental insults, by stimulating a variety of repair mechanisms 
including the repair of single- and double-stranded breaks prior to replication. Proteins essential for 
proper reproductive function were differentially expressed between the study groups. Reproduction 
includes sperm and oocyte production, fertilization as well as the early stages of embryonic 
development; the expression of proteins involved in the proper functioning of these pathways were 
negatively affected. Proteins necessary for the capacitation and acrosome reaction of sperm were 
underexpressed as well as those necessary for the facilitation of sperm-egg fusion. These are 






6. Chapter 6: Conclusion 
The induction of obesity via diet and a sedentary lifestyle provides similar metabolic responses in 
animals to those observed in humans, therefore diet-induced obesity animal models are effective in 
mimicking the pathophysiology of vascular and metabolic complications which have been shown to 
arise during obesity. This study found a chronic diet to be more effective in inducing obesity, and 
offers new data on the effects of a long-term obesogenic diet. 
The increase in the adiposity of the diet treated animals brought along various physiological 
changes within the DIO group. Lower percentages of normal sperm morphology and viable sperm 
as well as supra-physiological levels of estradiol were observed. These changes show various 
relationships with each other and the other parameters that were measured within this study. This 
can assist in drawing links between the changes in sperm functions and reproductive parameters 
with other underlying physiological mechanisms. 
Sperm morphology was seen in the current study to be associated with aberrant changes in 
testicular histology. Although the weights of the testes were not significantly different between the 
two study groups, adverse microscopic changes occurred within the DIO animals. These 
histological changes were related to lowered relative testicular weights, higher blood glucose 
levels, and changes in testosterone concentrations and antioxidant capacity. The changes in 
testicular histology were linked to alterations in sperm morphology and morphometry. Furthermore, 
while numerous seminiferous tubules displayed altered histology, some tubules with normal 
histology and qualitative and quantitative parameters were present. This implies that while damage 
can occur within the testicular tissue, unaffected seminiferous tubules could still produce normal 
spermatozoa. This can explain why obese humans and animals are still able to reproduce, as their 
fertility is lowered but not necessarily lost. The changes in epididymal histology of the DIO animals 
were linked to alterations in the redox state, where lowered catalase activity and higher lipid 
peroxidation were related to changes in epididymal diameters and relative volumes. These 
changes are more likely to reduce sperm viability and sperm morphometry. This study also found 
estradiol and not testosterone to be affected by chronic obesity. This crucial hormone has 
widespread effects on the male reproductive system and a case has now been made for its levels 
to be as closely monitored as testosterone in obese males.  
Proteomic analysis in the current study has shown a large number of differentially expressed 
proteins to be involved in glycolysis, oxidative phosphorylation and in lipid metabolism. In the 
epididymis, glycolytic proteins essential in sensing and responding to fluctuations in glucose 
concentrations, in initiating an insulin-sensitive response to the presence of glucose, and in the 




epididymis appeared to compensate for these disturbances by increasing the expression of 
proteins that upregulate glycolysis but were not dependent on glucose as an energy substrate. 
Moreover, insulin sensitivity seems to be lowered in the DIO reproductive system, which can lower 
glucose uptake by cells and lead to an increase plasma glucose. Reductions in the proteins 
necessary for the metabolism of glycerol, fatty acids and amino acids for use in sperm membrane 
production and in the attainment of membrane fluidity, leads to a postulation that sperm 
maturation, function and viability have been compromised.  
The presence of several proteins involved in lipid metabolism have been observed in the present 
study which suggests the use of lipids as metabolic substrates in the study animals. These proteins 
stimulate or mediate lipolysis, lipid oxidation, adipogenesis, adipocyte differentiation and β-
oxidation. Furthermore, several key proteins involved in fatty acid metabolism were under 
expressed in the epididymis. This includes proteins which are involved in the control of adipocyte 
growth and in limiting lipid storage within lipid droplets. It also includes those that mediate the 
synthesis and degradation of cellular lipids, and catalyse the first step of fatty acid metabolism. On 
the other hand, peroxisomal proteins have been reduced in expression. This data points towards a 
lower amount of fatty acid catabolism in the DIO epididymis compared to controls. The DIO 
animals seem to have a lower ability to metabolize fatty acids for their use as energy substrates for 
somatic cells as well as the maturation of stored spermatozoa within the epididymis. The 
apparently lower fatty acid metabolism in the DIO epididymis therefore implies a reduced usage of 
fatty acids as energy substrates of metabolism and for sperm maturation and hormone production.  
The reduction in the ability of the epididymis to limit adipocyte growth and lipid storage suggests 
the reduced ability to limit adipocyte growth, which implies a greater number and/or size of 
adipocytes within the DIO epididymides. On the other hand, antioxidant proteins secreted by 
adipocytes and located on the principle cells of the epididymis, were increased. This suggests a 
compensatory increase in antioxidant ability to assist in the adverse increase in ROS that can 
result from this higher abundance of adipocytes. 
The spermatozoa of the DIO group having a higher expression of the ketone enzyme SCOT1 
implies an additional mechanism through which diet-induced obesity can make more energy 
substrates available when substrates from glycolysis and fatty acid oxidation are inadequate. Thus 
the lower glycolysis noted in the DIO animals is likely to be compensated by an increase in ketone 
usage by the epididymis and sperm, which can then increase the expression of TCA cycle 
enzymes and substrates to possibly yield an increase ATP production. 
Taken together, the changes in expression of the aforementioned proteins point to an increased 




production of free radicals. These changes seem to have an effect on numerous structural proteins 
within the epididymis and sperm of the DIO animals. Cytoskeletal proteins including actins, 
tubulins, cadherins and plastins were variably affected. These proteins are essential for cellular 
structure and function, as well as in cell motility. Our study data suggests that while the expression 
of most cytoskeletal and structural proteins within the sperm and epididymis were predominantly 
unaffected in the DIO group, the functional proteins that are responsible for regulating their 
orientation and function were influenced. In addition, the under-expression of essential proteins 
such as α-catenin, lumican and dynein have possibly comprised cell structure and function. 
Bearing in mind the histological changes observed in the tissue sections of the DIO and control 
epididymides, the reduced expression of these proteins can be linked to the observed loss of 
adherence between the basement membrane and the epididymal epithelia as well as the loss of 
definition within the stereocilia. The loss of cell adhesion could also lead to cell atrophy and a 
disruption in cellular architecture. Lastly, the loss of α-catenin has been linked to acrosomal 
membranes. The reduction in this protein suggests either a loss of acrosomal membranes, 
implying an increased rate of acrosome reactions, or a loss of adhesion within the acrosomal 
membranes which could predispose spermatozoa and spermatids to premature acrosome 
reactions.  
Several reproductive parameters have been affected by the diet and the subsequent weight gain 
observed in the DIO animals. This includes those responsible for sperm production, fertilization as 
well as the early stages of embryonic development. It is therefore evident that long term obesity 
can impair male reproductive parameters and could be a contributing factor to the decline in male 
infertility by affecting sperm and reproductive parameters. This information allows us to accept our 
hypothesis, as the chronic diet-induced obesity model had a negative effect on sperm parameters, 
and on reproductive proteins that are responsible for normal reproductive function(s). Obesity in 
males is therefore a matter that needs continuing intervention as it may lead to changes in 
fertilizing capacity. Lifestyle changes are thus encouraged to reduce its incidence and prevalence. 
In addition, intervention strategies aiming to treat and/or prevent the anomalies caused by diet-
induced obesity needs to target metabolic, inflammatory and ROS-generating pathways to prevent 
subsequent cellular damage in obese patients. Targeting some of the aforementioned proteins by 
means of targeted therapy, antioxidant therapy or anti-inflammatory mechanisms is worth 
exploration. This can help to alleviate some of the effects of obesity on body systems including the 
reproductive system. 
6.1. Project limitations and future recommendations 
There are several limitations in this study that need to be addressed by future studies. The 




classification of animal obesity, which includes body length as a parameter to determine obesity. 
Fasted blood glucose can be used to reduce the interference of food consumption in the 
measurement of blood glucose concentrations. Sperm motility should be measured in subsequent 
studies. As the epididymides also had to be collected in the current study for antioxidant assays, 
organs were placed on ice to prevent metabolic reactions that can increase the production of free 
radicals after organ extraction. This, therefore, prevented the examination of sperm motility. Other 
hormone concentrations will need to be assessed, including but not limited to Gonadotropin 
Releasing Hormone (GnRH), Luteinizing Hormone and Follicle Stimulating Hormone (FSH) to 
better assess hormone alterations and to classify hypogonadism. Additional hormines to be 
assessed include leptin, ghrelin and steroidogenic hormones. Since metabolic and inflammatory 
mechanisms seem to have a role as underlying mechanisms affected by obesity, more extensive 
metabolic and inflammatory profiles need to be established in future experiments. Plasma or serum 
insulin, adipokines and metabolic substrates need to be measured to provide more information 
regarding underlying metabolic processes. Oral glucose tolerance tests also need to be performed 
throughout the experiment to determine insulin sensitivity. The measurement of metabolic proteins 
in urine and blood, including creatinine, ketones, glucose, nitrites and amino acids need to be 
assessed. This can allow for the comparison of molecular and proteomic data, and allow for more 
definite conclusions regarding causation to be ascertained. Inflammatory proteins can also be 
analysed via the assessment of e.g. multiplex assays that can give a better profile of the 
inflammatory mediators that are affected by obesity. A mating study can also be carried out to 
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Q5XIV1 Phosphoglycerate  
kinase  
Pgk2  100 118 0.017 Carbohydrate degradation; glycolysis; conversion of pyruvate  





97 113 0.023 Involved in glycolysis. Has a role in several processes e.g. 
growth control and allergic responses. Is a plasminogen receptor 












61 79 0.004 Amino acid metabolism. Essential for metabolite exchange 
between mitochondria and then cytosol. A fatty acid-binding 




P16290 Phosphoglycerate  
mutase 2 
Pgam2 32 52 <0.001 Gluconeogenesis, glycolytic process, regulation of pentose-
phosphate shunt. Interconversion of 3- and 2-phosphoglycerate 







Dbi 27 49 <0.001 High-affinity binding to medium- and long-chain acyl-CoA esters 
and possibly functions as an intracellular carrier of acyl-CoA 
esters. Displaces diazepam from the recognition site on GABA 
type A receptors 
P01026 Complement C3  C3 66 45 0.008 Activation of the complement system. Stimulates histamine 
release from basophilic leukocytes and mast cells. In chronic 
inflammation, it is a chemoattractant for neutrophils. Adipogenic 
hormone which participates in stimulation of triglyceride 
synthesis and glucose transport in adipocytes. Therefore 
regulates fat storage and postprandial TG removal. Appears to 
stimulate triglyceride synthesis 
P27881 Hexokinase-2 (EC 
2.7.1.1) 
(Hexokinase type 
II) (HK II) 
Hk2 27 17 0.029 Hexokinases stimulate the glycolytic (e.g. glucose and fructose) 
thereby initiating their metabolism. HK2 is the insulin-sensitive 












Manba 38 16 <0.001 Exoglycosidase. Involved in the hydrolysis of beta-D-mannose 









Ggh 24 13 0.006 Possibly plays a role in the bioavailability of dietary 
pteroylpolyglutamates (derivatives of folic acid) as well as the 
metabolism of pteroylpolyglutamates and antifolates. Has either 
endo- or exopeptidase activity depending on its tissue of origin. 
When secreted, it primarily exhiits endopeptidase activity 






21 11 0.015 Necessary for the limiting of lipid storage within lipid droplets. 
Involved in lipid homeostasis and promoting the association of 
adipocyte triglyceride lipase with the lipid droplet surface in order 
to mediate lipolysis. Retrograde Golgi-to-ER transport of 
proteins. Involved in Golgi disassembly and reassembly 
processes during the cell cycle. Takes part in autophagy via 
early endosome function/development. Has a role in organellar 






like 2 (EC 3.1.1.-) 
(LAMA-like 
























16 6 0.001 Facilitates the activation of long-chain fatty acids for the 
synthesis and degradation of cellular lipids, via beta-oxidation. 
Can activate long-chain fatty acids. Able to activate a range of 












Tpp2 15 5 <0.001 Stimulates adipogenesis 
P32551 (Complex III 







Uqcrc2 10 4 0.049 Part of the mitochondrial respiratory chain. Is required for the 













10 4 0.026 Implicated in the first step of the subpathway that synthesizes 






family D member 







11 3 <0.001 Probable transporter involved in the transport of branched-chain 
fatty acids and bile acids (C27) into the peroxisome; which is 












8 3 0.015 A pyruvate dehydrogenase complex which catalyzes the overall 









Sdha 7 2 0.003 A subunit of succinate dehydrogenase (SDH) that is takes part 
in mitochondrial electron transport chain via complex II by 












Acsf2 6 2 0.025 Part of a group of enzymes which catalyze the first reaction in 
fatty acid metabolism, via the formation of a thioester with CoA. 


















6 2 0.018 Plays an important role in the mitochondrial beta-oxidation of 













A type II) 
Pdha2 6 1 0.005 Stimulates the overall conversion of pyruvate to acetyl-CoA and 
CO2, and thereby linking the glycolytic pathway to the 












Idh3B 4 1 0.049 Facilitates the assembly and full activity of the enzyme which 















4 1 0.049 Catalyzes the initial, rate limiting catabolism of the tryptophan 
using the kynurenine pathway. Limits the growth of intracellular 
pathogens by depriving tryptophan. The tryptophan shortage 
blocks the division of T lymphocytes while the accumulation of 
tryptophan catabolites causes T-cell apoptosis and the 
differentiation of regulatory T-cells. Protects the fetus from 
maternal immune rejection. Involved in peripheral immune 
tolerance; this contributes to homeostasis via prevention of 
possible autoimmunity from uncontrolled/overreacting immune 
responses 
P00564 Creatine kinase 
M-type (EC 
2.7.3.2) (Creatine 







5 1 0.004 Reversibly stimulates the transfer of phosphate between ATP 
and other phosphogens (e.g. creatine phosphate). Creatine 
kinase isoenzymes play an essential role in energy transduction 
within tissues that have large, fluctuating energy demands, such 
as skeletal muscle, heart, brain and spermatozoa 






5 1 <0.001 Glycerol-3-phosphate biosynthesis. Involved in the subpathway 



















Got1 11 1 <0.001 Regulates levels of glutamate, a major excitatory 
neurotransmitter of the central nervous system in vertebrates. 
Provides brain neuroprotection by scavenging glutamate. The 
aspartate aminotransferase activity is involved in glucose 




te carrier protein 
(OGCP) (Solute 






4 0 <0.001 Active (and essential) in several metabolic processes, including 
gluconeogenesis from lactate, the oxoglutarate/isocitrate shuttle, 
malate-aspartate shuttle, and in nitrogen metabolism. Maintains 
mitochondrial fusion and fission events, as well as the 
organization and morphology of cristae. Involved in the 
















171 215 <0.001 Cell motility. Ubiquitously expressed in all eukaryotic cells 
P60711 Actin, cytoplasmic 
1 (Beta-actin) 
Actb 153 190 <0.001 Cell motility. Ubiquitously expressed in all eukaryotic cells 
P68136 Alpha-actin-1 Acta1 158 203 <0.001 Cell motility. Ubiquitously expressed in all eukaryotic cells 





77 93 0.020 The major component of microtubules 
P31000 Vimentin Vim 37 58 <0.001 Vimentins are class-III intermediate filaments found in several 
non-epithelial cells, especially mesenchymal cells. Located in 
the endoplasmic reticulum,mitochondria and attached to the 
nucleus. Is involved in the stabilization of type I collagen mRNAs 
P58775 Tropomyosin beta 
chain (Beta-
Tpm2 26 69 <0.001 Binds to actin filaments in muscle and non-muscle cells. Plays a 
essential role in calcium dependent contraction in striated 






interaction with caldesmon. In non-muscle cells it is implicated in 
the stabilization of cytoskeletal actin filaments 
P48675 Desmin Des 36 59 <0.001 A type III intermediate filament necessary for proper muscle 
structure and function. Plays an important role in the 
maintenance of the structure of sarcomeres, Z-disks and in the 
formation of myofibrils. It links them to the sarcolemmal 
cytoskeleton, the nucleus and mitochondria, thereby providing 
strength for the muscle fiber during activity 
P31000 Vimentin Vim 37 58 <0.001 Class-III intermediate filaments found in several non-epithelial 
cells, especially mesenchymal cells. Located in the endoplasmic 
reticulum, mitochondria and attached to the nucleus. Is involved 
in stabilizing type I collagen mRNAs 
Q10758 Keratin, type II 
cytoskeletal 8  
Krt8 
Krt2-8 
24 49 <0.001 Assists in linking the contractile apparatus to in striated muscle 






67 44 0.003 Calcium ion binding 










P62329 Thymosin beta-4 










8 28 <0.001 Plays an essental role in the organizing the cytoskeleton. Binds 
to and sequesters actin monomers (G actin) and thereby 
inhibiting actin polymerization. Blocks the entry of hematopoietic 
pluripotent stem cells into the S-phase of cell division 




Cnn1 16 26 0.004 Protein associated with the thin filament. Is involved in regulating 
and modulating smooth muscle contraction. Can bind to actin, 










11 20 0.002 Binds to actin filaments in muscle and non-muscle cells. Plays 
an important role in the regulation of striated muscle contraction 
(in association with the troponin complex). Smooth muscle 
contraction is regulated by interaction with caldesmon. In non-
muscle cells it stabilizes cytoskeletal actin filaments 
Q6AZ25 Tropomyosin 1, 
alpha, isoform 
CRA_m 





cytosolic protein 1 
Lcp1 30 17 0.005 Actin crosslink formation, actin filament bundle assembly 
Q4V7A4 Fibrous sheath 
CABYR-binding 
protein 
Fscb 24 14 0.029 May be involved in the later stages of fibrous sheath biogenesis. 
Binds calcium 























25 10 <0.001 Acts as an F-box protein exchange factor. Possibly enhances 












binding protein 1) 
(EB1) 
Mapre1 1 5 <0.001 Binds to microtubules and regulates the dynamics of the 
microtubule cytoskeleton. Promotes the nucleation and 
elongation of cytoplasmic microtubules. May be involved in 
spindle function by stabilizing microtubules and anchoring them 
at centrosomes. Tether non-centrosomal microtubules to the 
Golgi, an important step for polarized cell movement. 
Q5U302 Catenin (Cadherin 
associated 




protein), alpha 1, 
isoform CRA_b) 












8 2 0.004 Tubulin binding protein. Inhibits microtubule nucleation and 






D4A626 Calmin Clmn 6 2 0.0463 Actin binding 






5 1 0.049 Golgi organ organisation  





















4 1 0.049 Involved in regulating intracellular concentrations of taurine and 
glutamate. Negatively controls glutamate transport activity by 





Q9EPC6 Profilin-2 (Profilin 
II) 
Pfn2 3 1 0.046 Binds to actin to affect the structure of the cytoskeleton. 
Prevents the polymerization of actin at high concentrations, but 
enhances it at low concentrations 








Itga1 7 0 <0.001 A receptor for laminin and collagen. Takes part in the negative 
regulation of EGF-stimulated cell growth 








3 0 0.008 Interacts with microtubules. Localizes to the cytoplasm in 










100 151 <0.001 May help spermatozoa to undergo functional maturation while 









P0DP29 Calmodulin-1 Cam1, 
Cam2, 
Cam3 
37 48 0.027 Facilitates the control of numerous enzymes, ion channels, 
aquaporins and other proteins via calcium-binding. Stimulates 
protein kinases and phosphatases using a calcium-dependant 
mechanism. Together with centrin, it takes part in the genetic 
regulation of the centrosome cycle and progression through 








Oat 32 44 0.012 Expressed in the head and flagella of epididymal sperm (at 
protein level) .Amino-acid biosynthesis; L-proline biosynthesis; 
L-glutamate 5-semialdehyde from L-ornithine 






17 25 0.049 An anticoagulant protein. Acts as an indirect inhibitor of a 


















15 7 0.016 In the testis, isoform A2 and isoform B1 are expressed in 
spermatogonia and spermatocytes, but not spermatids or sperm. 
Condenses and stabilizes mRNA transcripts thereby minimizing 
tangling and knotting. Protects telomeric DNA repeat against 
endonuclease digestion by specifically binding to single-
stranded telomeric DNA sequences, Helps to regulate the 









Vdac2 14 6 0.020 Expressed in the head region of epididymal sperm. Facilitates 
the diffusion of small hydrophilic molecules by forming a channel 





Vdac3 7 2 0.022 Facilitates the diffusion of small hydrophilic molecules by 


















6 1 0.006 Sperm surface zona pellucida binding protein. Facilitates the 
high affinity binding of spermatozoa to the zona pellucida. 
Possibly functions to bind the zona pellucida and carbohydrates  
Q68FW9 COP9 
signalosome 






4 1 0.049 Takes part in numerous cellular and developmental processes. 
Essential in the regulation of the ubiquitin (Ubl) conjugation 
pathway. Important in maintain the survival of epiblast cells and 
the development of a postimplantation embryo  



















initiation factor 2, 
subunit 2 (Beta)) 
(Eukaryotic 
translation 
initiation factor 2, 















60 83 <0.001 Conjugates reduced glutathione (GSH) to exogenous and 





36 50 0.006 Plays a role in cell protection against oxidative stress by 










Catalyzes the reduction of hydrogen peroxide and organic 
hydroperoxides to water and alcohols, respectively. Can also 
reduce H2O2 and short chain organic, fatty acid, and 














22 32 0.148 Conjugates reduced glutathione to a variety of exogenous and 












22 32 0.015 Thiol-specific peroxidase that catalyzes the reduction of 
hydrogen peroxide and organic hydroperoxides to water and 
alcohols, respectively. Facilitates cell protection against 





peroxidase 2)  
hydrogen peroxide-mediated signaling events. May regulate the 
intracellular concentrations of H2O2  to control signalling 















22 12 0.019 Protects cells from oxidative stress by metabolizing numerous 
aldehydes derived from lipid peroxidation. Participates in lysine 
catabolism. Multifunctional enzyme which mediates important 












12 19 0.041 Involved in redox regulation of the cell. Acts as an antioxidant. 
Inhibits macrophage production of inflammatory cytokines. 
Expressed by the principal cells of the epididymis. Detected in 












2) (EC 3.6.3.8) 













Atp2a2 24 14 0.029 Magnesium-dependent enzyme. Production of mitochondrial 
ROS, thereby triggering Ca2+ signaling cascades that promote 













family 7 member 














22 12 0.019 Multifunctional enzyme mediating important protective effects. 
Metabolizes betaine aldehyde to betaine, an important cellular 
osmolyte and methyl donor. Protects cells from oxidative stress 






transferase Mu 5 
(EC 2.5.1.18) 
(GST class-mu 5) 
Gstm5 18 8 0.003 Conjugation of reduced glutathione to a wide number of 





Cisd1 3 8 0.021 Plays a key role in regulating maximal capacity for electron 
transport and oxidative phosphorylation. May be involved in Fe-
S cluster shuttling and/or in redox reactions 
P14942 Glutathione S-
transferase alpha-
4 (EC 2.5.1.18) 
(GST 8-8) (GST 




Gsta4 14 7 0.028 Conjugation of reduced glutathione to numerous exogenous and 
endogenous hydrophobic electrophiles 
A0A0G2K6L4 Glutathione S-










12 5 <0.001 Conjugation of reduced glutathione to numerous exogenous and 






P11232 Thioredoxin (Trx) Txn 
Txn1 
12 3 <0.001 Participates in various redox reactions. Plays a role in the 
reversible S-nitrosylation of cysteine residues in target proteins, 
and thereby contributes to the response to intracellular nitric 
oxide. Inhibits caspase-3 activity. Induces DNA binding activity 















Xdh 4 0 0.003 Key enzyme in purine degradation. Catalyzes the oxidation of 
hypoxanthine to xanthine. Catalyzes the oxidation of xanthine to 






P02770 Serum albumin Alb 449 536 <0.001 A protein with a binding capacity for water, plasma ions, fatty 
acids, hormones, bilirubin and drugs. A major zinc transporter 








264 311 <0.001 Binds ATP, opioids and phosphatidylethanolamine. Serine 
protease inhibitor which inhibits thrombin, neuropsin and 





Tf 113 132 0.013 Iron binding transport proteins which bind two Fe3+ ions in 
association with an anion, usually bicarbonate. Transports iron 
atoms from sites of absorption and heme degradation to sites of 
storage and utilization 




shock protein 90 






72 89 0.012 Molecular chaperone - processes and transports secreted 
proteins. Involved in endoplasmic reticulum associated 








84 111 <0.001 Endoplasmic reticulum chaperone. Necessary for correct folding 











protein family A 
member 5)  
Cellular response to glucose starvation, cellular response to 
interleukin-4 
F7FJQ3 NPC intracellular 
cholesterol 
transporter 2  
Npc2  43 55 0.026 Cholesterol efflux, cholesterol homeostasis, intracellular 








Hbb 60 72 0.047 Oxygen transport from the lung to peripheral tissues 





















35 50 0.003 Involved in vitamin D transport and storage, scavenging of 
extracellular G-actin, enhancement of the chemotactic activity of 













64 37 <0.001 Endopeptidase activity 









































11 2 <0.001 Adaptor protein complexes take part in protein transport via 
transport vesicles in different membrane traffic pathways. Are 
vesicle coat components and appear to be involved in cargo 
selection and vesicle formation. Clathrin-dependent endocytosis 
where cargo proteins are incorporated into vesicles surrounded 
by clathrin (clathrin-coated vesicles) and are destined for fusion 











Ment 3 0 0.014 Involved in control of cellular proliferation. Onconcogenic 









15 8 0.048  Protein modification, protein glycosylation. 
P50398 Rab GDP 
dissociation 
inhibitor alpha 









25 15 0.047 Controls the GDP/GTP exchange reaction of most Rab proteins 
by inhibiting the dissociation of GDP from these proteins, and 
the binding of GTP to them. Promotes the dissociation of GDP-












5 1 0.017 Mediates the nuclear export of cellular proteins (cargos) with a 
leucine-rich nuclear export signal (NES) and of RNAs. Involved 
in RNA transport from Cajal bodies to nucleoli 




factor L subunit) 
(MSF L) 
Ywhae 20 10 0.007 Adapter protein associated with the regulation of numerous 
general and specialized signaling pathways. Binds to a large 
number of partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the 
modulation of the activity of the binding partner. Positively 
regulates phosphorylated protein HSF1 nuclear export to the 
cytoplasm 










Psmd1 12 4 0.002 A component of the 26S proteasome, a complex of numerous 
proteins involved in ATP-dependent degradation of ubiquitinated 
proteins. This complex maintains protein homeostasis by 
removing misfolded or damaged proteins, that can impair 
cellular functions, and by removing proteins whose functions are 
no longer required. Therefore, the proteasome participates in 
numerous cellular processes, including cell cycle progression, 
















9 2 <0.001 Cleaves alpha 1,2-, alpha 1,3-, and alpha 1,6-linked mannose 
residues from glycoproteins. Involved in the degradation of free 







20 5 <0.001 Protein phosphatase that associates with > 200 regulatory 
proteins to form highly specific holoenzymes that 
dephosphorylate numerous of biological targets. Protein 
phosphatase (PP1) is essential for cell division, by participating 
in the regulation of glycogen metabolism, muscle contraction 
and protein synthesis. Involved in the control of chromatin 
structure and cell cycle progression during the transition from 






subunit (PP-1B)  






























12 5 0.015 Component of the 26S proteasome, a complex involved in the 
ATP-dependent degradation of ubiquitinated proteins. The 
complex plays an important role in maintaining protein 
homeostasis via the removal of misfolded or damaged proteins 
that could impair cellular functions, and by removing proteins 
whose functions are no longer required. Therefore, the 
proteasome participates in numerous cellular processes, 
including cell cycle progression, apoptosis, or DNA damage 
repair 












21 9 <0.001 Predicted to have endopeptidase activator activity. Predicted to 
be involved in antigen processing and the presentation of 
exogenous antigen to immune cells; regulates the G1/S 
transition of mitotic cell cycle; and regulates proteolysis. 




P68255 14-3-3 protein 
theta (14-3-3 
protein tau) 
Ywhaq 20 11 0.028 Adapter protein involved in the regulation of a numerous general 
and specialized signaling pathways. Binds to a large number of 
partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the 
modulation of the activity of the binding partner 
Q4G061 Eukaryotic 
translation 
initiation factor 3 
subunit B (eIF3b) 
(Eukaryotic 
translation 





8 2 0.008 RNA-binding component of the eukaryotic translation initiation 
factor 3 (eIF-3) complex, that is required for several steps in the 
initiation of protein synthesis. The eIF-3 complex stimulates 
mRNA recruitment and scanning of the mRNA for AUG 
recognition. This complex is also required for the disassembly 
and recycling of post-termination ribosomal complexes and 
thereby preventing the premature joining of the 40S and 60S 
ribosomal subunits prior to initiation. The eIF-3 complex 
specifically targets and initiates translation of a subset of 
mRNAs involved in cell proliferation, including cell cycling, 
differentiation and apoptosis, and uses different modes of RNA 
stem-loop binding to exert either translational activation or 
repression 






7 2 0.023 Component of the 26S proteasome, a multiprotein complex 
involved in the ATP-dependent degradation of ubiquitinated 
proteins. This complex plays an important role in the 













misfolded or damaged proteins, which could impair cellular 
functions, and via the removal of proteins whose functions are 
no longer required. Therefore, the proteasome participates in 
numerous cellular processes, including cell cycle progression, 
apoptosis, or DNA damage repair 









5 1 0.025 Plays a role in vesicular protein sorting 

































11 4 0.002 Catalyzes the two-step NADP-dependent conversion of GDP-4-
dehydro-6-deoxy-D-mannose to GDP-fucose, involving an 
epimerase and a reductase reaction 
P61206 ADP-ribosylation 







22 12 0.015 Involved in protein trafficking; may modulate vesicle budding and 
uncoating within the Golgi apparatus. 
Q68FS2 COP9 
signalosome 









5 2 0.035 Component of the COP9 signalosome complex (CSN), a 
complex involved in numerous cellular and developmental 
processes. The CSN complex is important in the regulation of 
the ubiquitin (Ubl) conjugation pathway. Involved in 
phosphorylation of p53/TP53, c-jun/JUN, IkappaBalpha/NFKBIA, 
ITPK1, IRF8/ICSBP and SNAPIN. CSN-dependent 
phosphorylation of TP53 and JUN promotes and protects 






Arf5 16 7 0.005 GTP-binding protein that functions as an allosteric activator of 
the cholera toxin catalytic subunit, an ADP-ribosyltransferase. 
Involved in protein trafficking; may modulate vesicle budding and 




Tm9sf2 12 1 <0.001 In the intracellular compartments, may function as a channel or 
small molecule transporter 
     0.023 Adapter protein involved in the regulation of various general and 
specialized signaling pathways. Binds to a numerous partners, 
usually by recognition of a phosphoserine or phosphothreonine 
motif. Binding generally results in the modulation of the activity 
of the binding partner 
B5DFC8 Eukaryotic 
translation 
initiation factor 3 
subunit C (eIF3c) 
(Eukaryotic 
translation 
initiation factor 3 




3 1 0.046 Component of the eukaryotic translation initiation factor 3 (eIF-3) 
complex, which is necessary for numerous steps in the initiation 
of protein synthesis. The eIF-3 complex is required for 
disassembly and recycling of post-termination ribosomal 
complexes and thereby preventing premature joining of the 40S 
and 60S ribosomal subunits prior to initiation. The eIF-3 complex 
specifically targets and initiates translation of a subset of 
mRNAs involved in cell proliferation, including cell cycling, 




























7 2 0.023 Calcium ion binding. Involved in regulation of vitamin K-
dependent carboxylation of multiple N-terminal glutamate 
residues 







6 11 0.037 Cytosolic protein complex that reversibly associates with Golgi 
non-clathrin-coated vesicles to mediate protein transport from 
the ER to the trans Golgi network. Required for budding from 
Golgi membranes, and is important in the retrograde Golgi-to-




membranes associated to ADP-ribosylation factors (ARFs), 
which are small GTP-binding proteins; thereby influencing the 
Golgi structural integrity, as well as the processing, activity, and 
endocytic recycling of LDL receptors 









Lars 3 0 0.014 Protein biosynthesis. Catalyzes the specific attachment of an 
amino acid to its cognate tRNA in a two-step reaction: the amino 
acid (AA) is first activated by ATP to form AA-AMP and then 
transferred to the acceptor end of the tRNA 
Q5U206 Calmodulin-like 
protein 3 
Calml3 5 16 <0.001 May function as a specific light chain of unconventional myosin-
10 (MYO10). Enhances MYO10 translation, possibly via its 
action as a chaperone for the emerging MYO10 heavy chain 
protein. May compete with calmodulin by binding, with different 
affinities, to cellular substrates 
Q811Q2 Chloride 
intracellular 
channel protein 6 
Clic6 
Clic6b 
10 3 0.009 Possibly inserts into membranes to form chloride ion channels. 
May play an important role in water-secreting cells, possibly 























13 3 <0.001 A major iron-binding and multifunctional protein found in 
exocrine fluids e.g. mucosal secretions. Has antimicrobial 




Nars 6 1 0.002 Protein synthesis. Catalyzes the attachment of asparagine to 
tRNA(Asn) 
Q66HM2 AP-2 complex 
subunit alpha 
Ap2a2 7 2 0.023 Adaptor protein complexes which function in protein transport 
via transport vesicles in different membrane traffic pathways. 
Adaptor protein complexes are vesicle coat components and are 
implicated in cargo selection and vesicle formation. AP-2 is 
directly involved in clathrin-dependent endocytosis where cargo 
proteins are incorporated into vesicles surrounded by clathrin 















7 14 0.013 May function as calcium sensor and modulator, contributing to 
cellular calcium signaling. May function by interacting with other 
proteins, and indirectly play a role in other physiological 
processes including reorganization of the actin cytoskeleton and 
cell motility. Binds 2 calcium ions.  
P16446 Phosphatidylinosit



















8 3 0.040 Ligase. ATP binding. Fatty acid catabolism. Is one of the 2 
subunits of the biotin-dependent propionyl-CoA carboxylase 
(PCC), a mitochondrial enzyme involved in the catabolism of 
odd chain fatty acids, branched-chain amino acids, isoleucine, 









e family member 



















12 4 0.005 Regulate pyrophosphate levels, controls bone mineralization 
and soft tissue calcification. PPi inhibits mineralization by 
binding to nascent hydroxyapatite (HA) crystals, thereby 
preventing further growth of these crystals. Preferentially 
hydrolyzes ATP, but can also hydrolyze other nucleoside 5' 
triphosphates such as GTP, CTP, TTP and UTP to their 
corresponding monophosphates with release of pyrophosphate 
and diadenosine polyphosphates, and also 3',5'-cAMP to AMP. 
May also be involved in the regulation of the availability of 
nucleotide sugars in the endoplasmic reticulum and Golgi, and 













11 5 0.013 Cytosolic protein complex that binds to dilysine motifs and 
reversibly associates with Golgi non-clathrin-coated vesicles, 
which mediate biosynthetic protein transport from the ER, via the 
Golgi up to the trans Golgi network. Required for budding from 
Golgi membranes, and is essential for the retrograde Golgi-to-
ER transport of dilysine-tagged proteins 




1 4 0.008 Histone H1 protein binds to linker DNA between nucleosomes 
forming the macromolecular structure known as the chromatin 
fiber. Histones H1 are necessary for the condensation of 
nucleosome chains into higher-order structured fibers. Acts also 
as a regulator of individual gene transcription through chromatin 








Fuca2 11 1 <0.001 Alpha-L-fucosidase is responsible for hydrolyzing the alpha-1,6-
linked fucose joined to the reducing-end N-acetylglucosamine of 







11 4 0.011 Ubiquitin: Exists either covalently attached to another protein, or 
free (unanchored). DNA repair; involved in ERAD (endoplasmic 










lysosomal degradation; kinase modification; protein degradation 
via the proteasome; endocytosis, DNA-damage responses as 
well as in signaling processes leading to activation of the 
transcription factor NF-kappa-B. Linear polymer chains formed 
via attachment by the initiator Met lead to cell signaling. When 
polyubiquitin is free (unanchored-polyubiquitin), it also has 
distinct roles, such as in activation of protein kinases, and in 
signaling. Component of the 40S subunit of the ribosome 






Ywhag 11 5 0.036 Adapter protein implicated in the regulation of a large spectrum 
of both general and specialized signaling pathways. Binds to a 
large number of partners, usually by recognition of a 
phosphoserine or phosphothreonine motif. Binding generally 













Idi1 7 2 0.040 Isomerase. Cholesterole biosynthetic process. Involved in step 1 
of the subpathway that synthesizes dimethylallyl diphosphate 





isomerase 1) (IPP 
isomerase 1) 
(IPPI1) 
A0A0G2K654 Histone cluster 1 








2 6 0.012 Chromosome condensation 
P28075 Proteasome 
subunit beta type-










Psmb5 5 1 0.003 Component of the 20S core proteasome complex involved in the 
proteolytic degradation of numerous intracellular proteins. The 
26S proteasome plays an important role in the maintenance of 
protein homeostasis by removing misfolded or damaged 
proteins that could impair cellular functions, and by removing 
proteins whose functions are no longer required. Associated with 
20S proteasome mediates of ubiquitin-independent protein 
degradation. This type of proteolysis is required in several 
pathways including spermatogenesis or generation of a subset 
of MHC class I-presented antigenic peptides. Within the 20S 







P62703 40S ribosomal 




3 0 0.022 Protein translation, RNA binding 
P61751 ADP-ribosylation 
factor 4 
Arf4 13 5 0.005 GTP-binding protein that functions as an allosteric activator of 
the cholera toxin catalytic subunit, an ADP-ribosyltransferase. 
Involved in protein trafficking; may modulate vesicle budding and 
uncoating within the Golgi apparatus. 









7 2 0.006 Plasma membrane to endosome transport. Endocytosis, 
intracellular protein transport. Neutrophil degranulation 






11 4 0.004 Has a strict specificity for hydrolysis of asparaginyl bonds. Can 
also cleave aspartyl bonds slowly, especially under acidic 
conditions. Required for normal lysosomal protein degradation in 
renal proximal tubules. Required for normal degradation of 
internalized EGFR. Plays a role in the regulation of cell 






the processing of proteins for MHC class II antigen presentation 






































































6 2 0.024 Protein glycosylation and sialylation. Catalyzes the transfer of N-
acetylneuraminyl groups onto glycan chains in glycoproteins 





5 1 0.003 ATPase required for the post-translational delivery of tail-










Recognizes and selectively binds the transmembrane domain of 
TA proteins in the cytosol.  
P62859 40S ribosomal 
protein S28 
















8 1 <0.001 Promotes integrin-mediated cell adhesion. May stimulate host 
defense against viruses and tumour cells. 
A0A0G2JZH0 Calcium-binding 
protein 39 
Cab39 4 0 <0.001 Signal transduction by protein phosphorylation. Protein 










complex chain Z) 
(Proteasome 
subunit Z) 
Psmb7 1 3 0.029 Component of the 20S core proteasome complex involved in the 
proteolytic degradation of numerous intracellular proteins. 
Associates with different regulatory particles. Participates in the 
ATP-dependent degradation of ubiquitinated proteins. The 26S 
proteasome plays an important role in protein homeostasis by 
removing misfolded or damaged proteins that could impair 
cellular functions, and removing proteins whose functions are no 
longer required. The 20S proteasome mediates ubiquitin-
independent protein degradation required in several pathways 
including spermatogenesis or generation of a subset of MHC 
class I-presented antigenic peptides. Displays a trypsin-like 
activity 
P17074 40S ribosomal 
protein S19 





Aprt 8 0 <0.001 Catalyzes a salvage reaction resulting in the formation of AMP, 
that is energically less costly than de novo synthesis 







5 2 0.035 Oxidoreductase. Oxidation-reduction process. Carboxylic acid 

















6 2 0.017 Serine protease inhibitor. The major targets of this inhibitor are 





1 4 0.021 Multifunctional GTPase involved in a variety of cellular 
processes including gene expression, cell migration, cell 
proliferation, oncogenic transformation and membrane 
trafficking. Accomplishes its multiple functions by interacting with 
distinct downstream effectors. Acts as a GTP sensor for GTP-
dependent exocytosis of dense core vesicles. Required both to 
stabilize the assembly of the exocyst complex and to localize 
functional exocyst complexes to the leading edge of migrating 
cells. Required for suppression of apoptosis. In late stages of 
cytokinesis, upon completion of the bridge formation between 






















5 0 <0.001 Catalyzes the hydrolytic deamination of enamine/imine 
intermediates that form during the course of normal metabolism. 
May facilitate the release of ammonia from these potentially 
toxic reactive metabolites, reducing their impact on cellular 
components. It may act on enamine/imine intermediates formed 
by several types of pyridoxal-5'-phosphate-dependent 
dehydratases including L-threonine dehydratase. May also 
function as an endoribonuclease, cleaving mRNA 
phosphodiester bonds of single-stranded RNA. Thereby, may 
inhibit protein translation 







4 1 0.013 May be involved sperm-egg plasma membrane adhesion and 





P62271 40S ribosomal 
protein S18 
Rps18 2 7 0.002 Located at the top of the head of the 40S subunit, it contacts 









4 1 0.049 Plays a role in the normal dynamic function of the endoplasmic 
reticulum (ER) and its associated microtubules. Required for 









1 4 0.004 This magnesium-dependent enzyme catalyzes the hydrolysis of 
ATP coupled with the transport of calcium 
D3ZAZ0 Eukaryotic 
translation 
initiation factor 3 









4 0 <0.001 Component of the eukaryotic translation initiation factor 3 (eIF-3) 
complex, required for several steps in the initiation of protein 
synthesis. The eIF-3 complex stimulates mRNA recruitment and 
scanning of the mRNA for AUG recognition. The complex is also 
required for disassembly and recycling of post-termination 
ribosomal complexes and subsequently prevents premature 
joining of the 40S and 60S ribosomal subunits prior to initiation. 
Specifically targets and initiates translation of a subset of 
mRNAs involved in cell proliferation, including cell cycling, 











6 1 0.004 Heterotrimeric guanine nucleotide-binding proteins (G proteins) 
function as transducers downstream of G protein-coupled 
receptors (GPCRs) in numerous signaling cascades. Signaling 
by an activated GPCR promotes GDP release and GTP binding. 
Both GDP release and GTP hydrolysis are modulated by 
numerous regulatory proteins. Signaling is mediated via effector 
proteins, such as adenylate cyclase. Inhibits adenylate cyclase 
activity, leading to decreased intracellular cAMP levels. 
Stimulates the activity of receptor-regulated K(+) channels. The 
active GTP-bound form prevents the association of RGS14 with 
centrosomes and is required for the translocation of RGS14 from 
the cytoplasm to the plasma membrane. May play a role in cell 
division 











Naca 3 1 0.029 Prevents inappropriate targeting of non-secretory polypeptides 
to the endoplasmic reticulum (ER). Binds to nascent polypeptide 
chains as they emerge from the ribosome and blocks their 
interaction with the signal recognition particle (SRP), which 
normally targets nascent secretory peptides to the ER. Also 




translocation sites in the ER membrane (M sites) (By similarity). 
Isoform 1 and isoform 2 appear to bind DNA and play roles in 
transcription. Isoform 1 may function as a specific coactivator for 








Arf6 4 0 <0.001 GTP-binding protein involved in protein trafficking that regulates 
endocytic recycling and cytoskeleton remodelling. Required for 
normal completion of mitotic cytokinesis. May also modulate 
vesicle budding and uncoating within the Golgi apparatus. Plays 
an important role in membrane trafficking, during junctional 
remodelling and epithelial polarization. Regulates surface levels 









Galnt5 4 0 <0.001 Catalyzes the initial reaction in O-linked oligosaccharide 
biosynthesis, which involves the transfer of an N-acetyl-D-
galactosamine residue to a serine or threonine residue on the 




















5 1 0.025 May be involved in vascular wall and kidney homeostasis. 
P61959 Small ubiquitin-










0 3 <0.001 Ubiquitin-like protein that can be covalently attached to proteins 
as a monomer or as a lysine-linked polymer. Post-translational 
modification on lysine residues of proteins plays an important 
role in a number of cellular processes such as nuclear transport, 
DNA replication and repair, mitosis and signal transduction. 
Polymeric SUMO2 chains are also susceptible to 
polyubiquitination which functions as a signal for proteasomal 










1 4 0.013 May have a role in the cell cycle 












3 0 0.001 Receptor 




Impact 4 0 <0.001 Translational regulator that ensures constant high levels of 
translation upon a variety of stress conditions, such as amino 
acid starvation, UV-C irradiation, proteasome inhibitor treatment 
and glucose deprivation. Plays a role as a negative regulator of 
kinase activity; impairs eIF-2-alpha phosphorylation and 
subsequent down-regulation of protein synthesis 
O35078 D-amino-acid 
oxidase (DAAO) 
(DAMOX) (DAO)  
Dao 
Dao1 
3 1 0.046 Controls the level of D-serine, a neuromodulator in the brain. 
Has high activity towards D-DOPA and contributes to dopamine 
synthesis. Possibly acts as a detoxifying agent which removes 















1 3 0.046 Reversible hydration of carbon dioxide. 
Immune-mediated 
D3ZJF8 Fc fragment of 
IgG-binding 
protein 
Fcgbp 17 6 <0.001 Possibly involved in the maintenance of the mucosal structure 
as a gel-like component of the mucosa. May play an important 






antigen CD26)  
Dpp4 
Cd26 
9 3 0.004 Cell surface glycoprotein receptor involved in the co-stimulation 
signal essential for T-cell receptor (TCR)-mediated T-cell 
activation. Induces T-cell proliferation and NF-kappa-B activation 
in a T-cell receptor/CD3-dependent manner. Regulates 
lymphocyte-epithelial cell adhesion. Possibly involved in the 
promotion of lymphatic endothelial cells adhesion, migration and 
tube formation. When overexpressed, enhances cell 
proliferation. Also regulates various physiological processes by 
cleaving peptides in the circulation, including many chemokines, 




Detected in the serum and the seminal fluid 






binding protein 1) 
Gbp2  4 1 0.049 Hydrolyzes GTP to GMP in two cleavage reactions, with the 
major reaction product being GDP. Promotes oxidative killing 
and delivers antimicrobial peptides to autophagolysosomes, 
providing broad host protection against different pathogen 
classes  
Q63663 Guanylate-binding 






protein 2) (p67) 













Calr 61 74 0.0355725
17069555 
Calcium-binding chaperone that promotes folding, oligomeric 
assembly and quality control in the endoplasmic reticulum (ER) 
via the calreticulin/calnexin cycle. This lectin interacts transiently 
with almost all of the monoglucosylated glycoproteins that are 
synthesized in the ER 
      
Involved in maternal gene expression regulation. May participate 








Vcp 53 74 <0.001 Involved in the fragmentation and reassembly of Golgi stacks 
during and after mitosis. Is part of a protein complex that binds 
ubiquitinated proteins and exports misfolded proteins from the 
ER to the cytoplasm to be degraded by the proteasome. 
Involved in a stress-induced mechanism that selectively controls 
the translocation of stressed/damaged mitochondrial outer-
membrane proteins to be degraded by proteasomes. Important 
for the clearance of ubiquitinated proteins via autophagy. May 
play a role in the ubiquitin-dependent sorting of membrane 
proteins to lysosomes where they undergo degradation. 
Important role in caveolin sorting within cells 
Involved in the DNA damage response and is recruitment to 
double-strand breaks 













37 72 <0.001 Catalyzes the formation, breakage and rearrangement of 
disulfide bonds. At the cell surface, appears to cleave disulfide 
bonds of proteins attached to the cell, thus causing structural 
modifications of proteins. Inside the cell, seems to 
form/rearrange disulfide bonds of new proteins. At high 
concentrations, functions as a chaperone that inhibits 
aggregation of misfolded proteins. At low concentrations, 
facilitates aggregation (anti-chaperone activity). Shows receptor 
activity, where activation increases disulfide reductase activity at 
the plasma membrane, altering the plasma membrane redox 
state and enhancing cell migration 
May be involved with other chaperones in the structural 
modification of the TG precursor in hormone biogenesis 
Also acts on structural subunits of various enzymes such as 







1) (Protein CAP1) 
Park7 
Cap1 
31 57 <0.001 Functions as a protein deglycase that glycates proteins. 
Deglycates cysteine, arginine and lysine residues in proteins, 
and thus reactivates these proteins by reversing glycation by 
glyoxals. Acts on early glycation intermediates to prevent the 
formation of advanced glycation end-products (AGE) which can 






deglycase that is able to repair glycated guanine in the free 
nucleotide pool (GTP, GDP, GMP, dGTP) and in DNA and RNA. 
Is therefore involved in a major nucleotide repair system named 
guanine glycation repair (GG repair), dedicated to reversing 
methylglyoxal and glyoxal damage via nucleotide sanitization 
and direct nucleic acid repair 
Plays an important role in cell protection against oxidative stress 
and cell death acting as an oxidative stress sensor and redox-
sensitive chaperone and protease 
It is involved in neuroprotective mechanisms. Regulates 
astrocyte inflammatory responses 
P10111 Peptidyl-prolyl cis-






(p1B15) (p31)  
Ppia 35 45 0.0400279
64263290
5 
 Exerts a strong chemotactic effect on leukocytes. Activates 
endothelial cells (ECs) in a proinflammatory manner by 
stimulating activation of NF-kappa-B and ERK, JNK and p38 
MAP-kinases. In response to oxidative stress, initiates 
proapoptotic and antiapoptotic signaling in ECs via activation 
of NF-kappa-B and AKT1 and up-regulation of antiapoptotic 
protein BCL2 (By similarity). Lipid droplet organisation. 



















Part of a large chaperone multiprotein complex. Involved in cell 
redox homeostasis; chaperone-mediated protein folding; 




















P18163 Acyl CoA 
Synthase (Long-
chain-fatty-acid-





87 79 0.049 Initiates fatty acid utilization by producing acyl CoA synthase from 
fatty acids. Results in the production of free fatty acids. Activation 
of long-chain fatty acids for both synthesis of cellular lipids, and 













Uqcrc1 16 33 0.005 This is a component of the ubiquinol-cytochrome c reductase 
complex, which is part of the mitochondrial respiratory chain. This 
protein may mediate formation of the complex between 







75 kDa subunit, 
mitochondrial 
Ndufs1 8 19 0.004 Core subunit of the mitochondrial membrane respiratory chain 
NADH dehydrogenase (Complex I) that is believed to belong to the 
minimal assembly required for catalysis. Complex I s in the transfer 
of electrons from NADH to the respiratory chain. The immediate 
electron acceptor for the enzyme is believed to be ubiquinone (By 
similarity). This is the largest subunit of complex I and it is a 
component of the iron-sulfur (IP) fragment of the enzyme. It may 










Pdha2 6 18 0.001 The pyruvate dehydrogenase complex catalyzes the overall 
conversion of pyruvate to acetyl-CoA and CO(2), and thereby links 
the glycolytic pathway to the tricarboxylic cycle.  






Idh3a 6 15 0.013 Catalytic subunit of the enzyme which catalyzes the 
decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The 
heterodimer composed of the alpha (IDH3A) and beta (IDH3B) 
subunits and the heterodimer composed of the alpha (IDH3A) and 










full activity of the heterotetramer (containing two subunits of 
IDH3A, one of IDH3B and one of IDH3G) requires the assembly 










complex II) (Fp) 
Sdha 4 12 0.0192191
87825555
9 
Flavoprotein (FP) subunit of succinate dehydrogenase (SDH) that 
is involved in complex II of the mitochondrial electron transport 
chain and is responsible for transferring electrons from succinate to 
















Ak2 5 12 0.037 Catalyzes the reversible transfer of the terminal phosphate group 
between ATP and AMP. Plays an important role in cellular energy 
homeostasis and in adenine nucleotide metabolism. Adenylate 
kinase activity is critical for regulation of the phosphate utilization 









ase II) (CPT II) 
Cpt2 
Cpt-2 
3 10 0.042 Involved in the pathway fatty acid beta-oxidation, which is part of 
















Core subunit of the mitochondrial membrane respiratory chain 
NADH dehydrogenase (Complex I) that is believed to belong to the 
minimal assembly required for catalysis. Complex I s in the transfer 
of electrons from NADH to the respiratory chain.  
Q6AYK3 Inositol-3-
phosphate 
synthase 1 (IPS 











Key enzyme in myo-inositol biosynthesis pathway that catalyzes 
the conversion of glucose 6-phosphate to 1-myo-inositol 1-
phosphate in a NAD-dependent manner. Rate-limiting enzyme in 




A0A0G2K502 Malic enzyme Me2 2 8 0.0041769
83831624
42 
Catalyze the oxidative decarboxylation of malate to produce 
pyruvate and carbon dioxide with the reduction of NAD(P) to 
NAD(P)H. ME2 is a mitochondrial isoform with a dual cofactor 
specificity for NAD and NADP, but has a higher affinity for NAD. 
Although the malic enzyme reaction is reversible, the flux of at 
least the cytosolic malic enzyme reaction is thought to be only in 
the direction of pyruvate formation in vivo 














Reversibly catalyzes the transfer of phosphate between ATP and 
various phosphogens (e.g. creatine phosphate). Creatine kinase 
isoenzymes play a central role in energy transduction in tissues 
with large, fluctuating energy demands, such as skeletal muscle, 























Key enzyme for ketone body catabolism. Transfers the CoA moiety 
from succinate to acetoacetate. Formation of the enzyme-CoA 
intermediate proceeds via an unstable anhydride species formed 
between the carboxylate groups of the enzyme and substrate (By 
similarity). {ECO:0000250|UniProtKB:P55809}. 





Etfa 0 3 0.0274341
21665561
5 
Heterodimeric electron transfer flavoprotein that accepts electrons 
from several mitochondrial dehydrogenases, including acyl-CoA 
dehydrogenases, glutaryl-CoA and sarcosine dehydrogenase. It 
transfers the electrons to the main mitochondrial respiratory chain 
via ETF-ubiquinone oxidoreductase (ETF dehydrogenase) 
(Probable). Required for normal mitochondrial fatty acid oxidation 





M0R8B6 Tubulin beta 
chain 
Tubb1 38 26 0.003 Tubulin is the major constituent of microtubules. It binds two moles 
of GTP, one at an exchangeable site on the beta chain and one at 
a non-exchangeable site on the alpha chain. 
G3V885 Myosin-6 Myh6 1 25 <0.001 Actin filament binding, protein kinase binding 
P08733 Myosin 
regulatory light 






5 22 <0.001 Contractile protein that plays a role in heart development. 
Following phosphorylation, plays a role in cross-bridge cycling 
kinetics and cardiac muscle contraction by increasing myosin lever 
arm stiffness and promoting myosin head diffusion; as a 
consequence of the increase in maximum contraction force and 
calcium sensitivity of contraction force. These events altogether 
slow down myosin kinetics and prolong duty cycle resulting in 
accumulated myosins being cooperatively recruited to actin binding 
sites to sustain thin filament activation as a means to fine-tune 
myofilament calcium sensitivity to force. During cardiogenesis 
plays an early role in cardiac contractility by promoting cardiac 
myofibril assembly. 
P16409 Myosin light 
chain 3 (Myosin 



















Q4PP99 Cardiac troponin 




Tnnc1 1 13 <0.001 Cytoskeletal protein. Troponin is the central regulatory protein of 
striated muscle contraction. Actin filament binding. 
Q6AXV2 Tektin-4 Tekt4 
Tek4 
4 12 0.020 Structural component of ciliary and flagellar microtubules. Forms 
filamentous polymers in the walls of ciliary and flagellar 
microtubules. 
D4A0A0 Dynein light 
chain roadblock 
Dynlrb2 16 10 0.044 Acts as one of several non-catalytic accessory components of the 
cytoplasmic dynein 1 complex that are thought to be involved in 




dynein . Cytoplasmic dynein 1 acts as a motor for the intracellular 






















0 4 0.004 Promotes ribosomal transcriptional activity in response to 
metabolic challenges in the adipocytes and plays an important role 
in the formation of the ribosomal transcriptional loop. Translocates 
to the cytoplasm from the caveolae upon insulin stimulation (By 
similarity). Colocalizes with calveolin-1 in lipid rafts in adipocytes. 






0 3 0.004 Troponin I is the inhibitory subunit of troponin, the thin filament 
regulatory complex which confers calcium-sensitivity to striated 





Reproduction specific  






Capza3 1 5 0.011 F-actin-capping proteins bind in a Ca(2+)-independent manner to 
the fast growing ends of actin filaments (barbed end) thereby 
blocking the exchange of subunits at these ends. Unlike other 
capping proteins (such as gelsolin and severin), these proteins do 













Hbb 70 62 0.049 Involved in oxygen transport from the lung to the various peripheral 
tissues 





16 29 0.050 Chaperonin implicated in mitochondrial protein import and 
macromolecular assembly. Together with Hsp10, facilitates the 









and promote the refolding and proper assembly of unfolded 
polypeptides generated under stress conditions in the 





3) (LAP-3)  
Lap3 3 14 <0.001 Presumably involved in the processing and regular turnover of 
intracellular proteins. Catalyzes the removal of unsubstituted N-
terminal amino acids from various peptides. 
Q6PDU6 Beta-glo Hbb-b1 
MGC72
973 












Glyctk 1 4 0.0494441
56941281
1 










Co-chaperonin implicated in mitochondrial protein import and 
macromolecular assembly. Together with Hsp60, facilitates the 
correct folding of imported proteins. May also prevent misfolding 
and promote the refolding and proper assembly of unfolded 
polypeptides generated under stress conditions in the 
mitochondrial matrix. 
Multifunctional 








6 2 0.008 May regulate the activity of kinases such as PKC and SRC via 
binding to integrin beta-1 (ITB1) and the receptor of activated 
protein C kinase 1 (RACK1). In complex with C1QBP is a high 
affinity receptor for kininogen-1/HMWK. 
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